Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Good Outcome" Isn't Good Enough: Cognitive Impairment, Depressive Symptoms, and Social Restrictions in Physically Recovered Stroke Patients.1 passage
• (untitled)1 passage
• 1/2SH: A Simple, Accurate, and Reliable Method of Calculating the Hematoma Volume of Spontaneous Intracerebral Hemorrhage.1 passage
• 20-Hydroxyeicosatetraenoic Acid as a Predictor of Neurological Deterioration in Acute Minor Ischemic Stroke.1 passage
• 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• 25-hydroxyvitamin D status is associated with chronic cerebral small vessel disease.1 passage
• 2B, 2C, or 3: What Should Be the Angiographic Target for Endovascular Treatment in Ischemic Stroke?1 passage
• 3K3A-Activated Protein C Variant Does Not Interfere With the Plasma Clot Lysis Activity of Tenecteplase.1 passage
• A Dedicated Spanish Language Line Increases Enrollment of Hispanics Into Prehospital Clinical Research.1 passage
• A Multicomponent Behavioral Intervention to Reduce Stroke Risk Factor Behaviors: The Stroke Health and Risk Education Cluster-Randomized Controlled Trial.1 passage
• A Nomogram for Predicting Stroke Recurrence Among Young Adults.1 passage
• A Novel Staging System to Evaluate Cerebral Hypoperfusion in Patients With Moyamoya Disease.1 passage
• A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association.1 passage
• A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent Stroke.1 passage
• A Robust Deep Learning Segmentation Method for Hematoma Volumetric Detection in Intracerebral Hemorrhage.1 passage
• A Systematic Literature Review of Patients With Carotid Web and Acute Ischemic Stroke.1 passage
• ABCA1/ApoE/HDL Pathway Mediates GW3965-Induced Neurorestoration After Stroke.1 passage
• ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2.1 passage
• AMOBES (Active Mobility Very Early After Stroke): A Randomized Controlled Trial.1 passage
• APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality.1 passage
• APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.1 passage
• ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.1 passage
• ASCOD Phenotyping of Stroke With Anterior Large Vessel Occlusion Treated by Mechanical Thrombectomy.1 passage
• ASPECTS (Alberta Stroke Program Early CT Score) Assessment of the Perfusion-Diffusion Mismatch.1 passage
• ASPECTS (Alberta Stroke Program Early CT Score) Measurement Using Hounsfield Unit Values When Selecting Patients for Stroke Thrombectomy.1 passage
• Abnormal Blood Flow on Transcranial Duplex Sonography Predicts Poor Outcome After Stroke Thrombectomy.1 passage
• Abnormal P-Wave Axis and Ischemic Stroke: The ARIC Study (Atherosclerosis Risk In Communities).1 passage
• Absence of Consistent Sex Differences in Outcomes From Symptomatic Carotid Endarterectomy and Stenting Randomized Trials.1 passage
• Absence of a Transcranial Magnetic Stimulation-Induced Lower Limb Corticomotor Response Does Not Affect Walking Speed in Chronic Stroke Survivors.1 passage
• Absent Filling of Ipsilateral Superficial Middle Cerebral Vein Is Associated With Poor Outcome After Reperfusion Therapy.1 passage
• Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia.1 passage
• Accuracy and Reliability of Stroke Diagnosis in the Pediatric Emergency Department.1 passage
• Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke.1 passage
• Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III.1 passage
• Acetazolamide-Challenged Arterial Spin Labeling Detects Augmented Cerebrovascular Reserve After Surgery for Moyamoya.1 passage
• Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity.1 passage
• Achieving More Rapid Door-to-Needle Times and Improved Outcomes in Acute Ischemic Stroke in a Nationwide Quality Improvement Intervention.1 passage
• Acupuncture Therapy and Incidence of Depression After Stroke.1 passage
• Acupuncture efficacy on ischemic stroke recovery: multicenter randomized controlled trial in China.1 passage
• Acute Cerebral Venous Thrombosis: Three-Dimensional Visualization and Quantification of Hemodynamic Alterations Using 4-Dimensional Flow Magnetic Resonance Imaging.1 passage
• Acute Cerebrovascular Events With COVID-19 Infection.1 passage
• Acute Cerebrovascular Events in Hospitalized COVID-19 Patients.1 passage
• Acute Diffusivity Biomarkers for Prediction of Motor and Language Outcome in Mild-to-Severe Stroke Patients.1 passage
• Acute Ischemic Stroke After Moderate to Severe Traumatic Brain Injury: Incidence and Impact on Outcome.1 passage
• Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients.1 passage
• Acute Loss of miR-221 and miR-222 in the Atherosclerotic Plaque Shoulder Accompanies Plaque Rupture.1 passage
• Acute Neurological Deterioration in Large Vessel Occlusions and Mild Symptoms Managed Medically.1 passage
• Acute Occlusions of Dual-Layer Carotid Stents After Endovascular Emergency Treatment of Tandem Lesions.1 passage
• Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona.1 passage
• Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities.1 passage
• Acute Stroke Imaging Research Roadmap IV: Imaging Selection and Outcomes in Acute Stroke Clinical Trials and Practice.1 passage
• Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?1 passage
• Acute Stroke Presentation, Care, and Outcomes in Community Hospitals in Northern California During the COVID-19 Pandemic.1 passage
• Acute Stroke With Large Ischemic Core Treated by Thrombectomy.1 passage
• Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study.1 passage
• Acute Transient Vestibular Syndrome: Prevalence of Stroke and Efficacy of Bedside Evaluation.1 passage
• Acute Viral Illnesses and Ischemic Stroke: Pathophysiological Considerations in the Era of the COVID-19 Pandemic.1 passage
• Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke.1 passage
• Acute reperfusion therapy and stroke care in Asia after successful endovascular trials.1 passage
• Acute-Phase Blood Pressure Levels Correlate With a High Risk of Recurrent Strokes in Young-Onset Ischemic Stroke.1 passage
• Added Value of Vessel Wall Magnetic Resonance Imaging for Differentiation of Nonocclusive Intracranial Vasculopathies.1 passage
• Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.1 passage
• Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.1 passage
• Additional diagnostic value of computed tomography perfusion for detection of acute ischemic stroke in the posterior circulation.1 passage
• Additive Effect of Coexisting Aneurysms Increases Subarachnoid Hemorrhage Risk in Patients With Multiple Aneurysms.1 passage
• Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain Infarction in a Nonhuman Primate Model of Stroke.1 passage
• Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.1 passage
• Adherence to a Healthy Nordic Diet and Risk of Stroke: A Danish Cohort Study.1 passage
• Adherence to a Mediterranean diet and prediction of incident stroke.1 passage
• Adiposity and Outcome After Ischemic Stroke: Obesity Paradox for Mortality and Obesity Parabola for Favorable Functional Outcomes.1 passage
• Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment.1 passage
• Admission Brain Cortical Volume: An Independent Determinant of Poststroke Cognitive Vulnerability.1 passage
• Admission Diffusion-Weighted Imaging Lesion Volume in Patients With Large Vessel Occlusion Stroke and Alberta Stroke Program Early CT Score of ≥6 Points: Serial Computed Tomography-Magnetic Resonance Imaging Collateral Measurements.1 passage
• Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke.1 passage
• Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies.1 passage
• Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis.1 passage
• Admission Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker of Outcomes in Large Vessel Occlusion Strokes.1 passage
• Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale.1 passage
• Advanced Neuroimaging in Stroke Patient Selection for Mechanical Thrombectomy.1 passage
• Advances in Stroke: Digital Health.1 passage
• Advances in Stroke: Therapies Targeting Stroke Recovery.1 passage
• Advancing Stroke Recovery Through Improved Articulation of Nonpharmacological Intervention Dose.1 passage
• Affective Prosody and Depression After Stroke: A Pilot Study.1 passage
• Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation.1 passage
• Age and Sex Differences in Ischemic Stroke Treatment in a Nationwide Analysis of 1.11 Million Hospitalized Cases.1 passage
• Age at Menopause and Risk of Ischemic and Hemorrhagic Stroke.1 passage
• Age-Period-Cohort Analysis of Stroke Mortality Attributable to High Sodium Intake in China and Japan.1 passage
• Age-Period-Cohort Analysis of Stroke Mortality in China: Data From the Global Burden of Disease Study 2013.1 passage
• Age-Specific Associations of Renal Impairment With Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Transient Ischemic Attack and Stroke.1 passage
• Age-Specific Sex Differences in Magnetic Resonance Imaging-Depicted Carotid Intraplaque Hemorrhage.1 passage
• Agreement Among Stroke Faculty and Fellows in Treating Ischemic Stroke Patients With Tissue-Type Plasminogen Activator and Thrombectomy.1 passage
• Air Pollution Is Associated With Ischemic Stroke via Cardiogenic Embolism.1 passage
• Air Pollution and Ischemic Stroke Among Young Adults.1 passage
• Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke.1 passage
• Alberta stroke program early computed tomographic scoring performance in a series of patients undergoing computed tomography and MRI: reader agreement, modality agreement, and outcome prediction.1 passage
• Alcohol consumption at midlife and risk of stroke during 43 years of follow-up: cohort and twin analyses.1 passage
• Alkaline Phosphatase and Outcomes in Patients With Preserved Renal Function: Results From China National Stroke Registry.1 passage
• All-Cause Mortality up to and After Coronary Heart Disease and Stroke Events in European Middle-Aged Men: The PRIME Study.1 passage
• Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years: Pooled Analyses of Individual Patient Data.1 passage
• Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.1 passage
• Altered Expression of Long Noncoding RNAs in Blood After Ischemic Stroke and Proximity to Putative Stroke Risk Loci.1 passage
• Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis: Association With the Risk of Recurrence.1 passage
• Alternative Payment Models and Associations With Stroke Outcomes, Spending, and Service Utilization: A Systematic Review.1 passage
• Ambient Coarse Particulate Matter and Hospital Admissions for Ischemic Stroke.1 passage
• Ambient PM1 passage
• Ambient Particulate Matter Concentrations and Hospitalization for Stroke in 26 Chinese Cities: A Case-Crossover Study.1 passage
• Ambulance Clinical Triage for Acute Stroke Treatment: Paramedic Triage Algorithm for Large Vessel Occlusion.1 passage
• An International Standard Set of Patient-Centered Outcome Measures After Stroke.1 passage
• Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany.1 passage
• Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study.1 passage
• Anemia After Aneurysmal Subarachnoid Hemorrhage Is Associated With Poor Outcome and Death.1 passage
• Anesthesia Technique and Outcomes of Mechanical Thrombectomy in Patients With Acute Ischemic Stroke.1 passage
• Anesthesia-Related Outcomes for Endovascular Stroke Revascularization: A Systematic Review and Meta-Analysis.1 passage
• Angioedema in Stroke Patients With Thrombolysis.1 passage
• Angiographic Correlates of Cerebral Hemodynamic Changes With Diamox Challenge Assessed by Quantitative Magnetic Resonance Angiography.1 passage
• Angiographic and Clinical Characteristics of Thoracolumbar Spinal Epidural and Dural Arteriovenous Fistulas.1 passage
• Angiographic and Hemodynamic Features in Asymptomatic Hemispheres of Patients With Moyamoya Disease.1 passage
• Ankle-Brachial Index and Recurrent Stroke Risk: Meta-Analysis.1 passage
• Anticoagulation After Stroke in Patients With Atrial Fibrillation.1 passage
• Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.1 passage
• Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.1 passage
• Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation.1 passage
• Antidepressant Use After Aneurysmal Subarachnoid Hemorrhage: A Population-Based Case-Control Study.1 passage
• Antidepressant Use Is Associated With an Increased Risk of Developing Microbleeds.1 passage
• Antiepileptic Drugs to Prevent Seizures After Spontaneous Intracerebral Hemorrhage.1 passage
• Antihyperglycemic Agents Are Inversely Associated With Intracranial Aneurysm Rupture.1 passage
• Antihypertensive Drug Use, Blood Pressure Variability, and Incident Stroke Risk in Older Adults: Three-City Cohort Study.1 passage
• Antihypertensive Drugs for Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.1 passage
• Antiphosphatidylserine Antibodies and Clinical Outcomes in Patients With Acute Ischemic Stroke.1 passage
• Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania: A Community-Based Case-Control Study.1 passage
• Antiphospholipid Antibody and Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis.1 passage
• Antiphospholipid Syndrome With Isolated Isotype M Anticardiolipin and/or Anti-B2GPI Antibody Is Associated With Stroke.1 passage
• Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.1 passage
• Antiplatelet Therapy After Noncardioembolic Stroke.1 passage
• Antiplatelet Therapy After Spontaneous Intracerebral Hemorrhage and Functional Outcomes.1 passage
• Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.1 passage
• Antiplatelet Therapy, Cerebral Microbleeds, and Intracerebral Hemorrhage: A Meta-Analysis.1 passage
• Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review.1 passage
• Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial.1 passage
• Antipsychotic Use Among 1144 Patients After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure.1 passage
• Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.1 passage
• Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis.1 passage
• Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.1 passage
• Anxiety After Stroke: The Importance of Subtyping.1 passage
• Anxiety and the Risk of Stroke: The Rotterdam Study.1 passage
• Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial.1 passage
• Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia.1 passage
• Aortic Stiffness, Increased White Matter Free Water, and Altered Microstructural Integrity: A Continuum of Injury.1 passage
• Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility Progress Despite Best Medical Management: The OXVASC Cohort.1 passage
• Aortic Valve Calcification and Risk of Stroke: The Rotterdam Study.1 passage
• Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.1 passage
• Applicability of Clinical Trials in an Unselected Cohort of Patients With Intracerebral Hemorrhage.1 passage
• Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial.1 passage
• Approaches to Studying Determinants of Racial-Ethnic Disparities in Stroke and Its Sequelae.1 passage
• Arsenic Exposure in Relation to Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.1 passage
• Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke.1 passage
• Arterial Spin Labeling Magnetic Resonance Imaging Estimation of Antegrade and Collateral Flow in Unilateral Middle Cerebral Artery Stenosis.1 passage
• Arterial Spin Labeling Perfusion Magnetic Resonance Imaging Performed in Acute Perinatal Stroke Reveals Hyperperfusion Associated With Ischemic Injury.1 passage
• Arterial Spin Labeling for the Etiological Workup of Intracerebral Hemorrhage in Children.1 passage
• Arterial Stiffness Is Associated With Basal Ganglia Enlarged Perivascular Spaces and Cerebral Small Vessel Disease Load.1 passage
• Arterial Tortuosity: An Imaging Biomarker of Childhood Stroke Pathogenesis?1 passage
• Arterial Wall Imaging in Pediatric Stroke.1 passage
• Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management.1 passage
• Artificial Neural Network Computer Tomography Perfusion Prediction of Ischemic Core.1 passage
• Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative.1 passage
• Aspiration Thrombectomy After Intravenous Alteplase Versus Intravenous Alteplase Alone.1 passage
• Aspiration Versus Stent Retriever Thrombectomy for Posterior Circulation Stroke.1 passage
• Aspirin and Growth of Small Unruptured Intracranial Aneurysm: Results of a Prospective Cohort Study.1 passage
• Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis.1 passage
• Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.1 passage
• Assessing the Predictive Validity of Simple Dementia Risk Models in Harmonized Stroke Cohorts.1 passage
• Assessment Model to Identify Patients With Stroke With a High Possibility of Discharge to Home: A Retrospective Cohort Study.1 passage
• Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries.1 passage
• Assessment of the Most Optimal Control Tissue for Intracranial Aneurysm Gene Expression Studies.1 passage
• Associated Factors and Long-Term Prognosis of 24-Hour Worsening of Arterial Patency After Ischemic Stroke.1 passage
• Association Between Absolute Eosinophil Count and Complex Aortic Arch Plaque in Patients With Acute Ischemic Stroke.1 passage
• Association Between Acute Kidney Disease and Intravenous Dye Administration in Patients With Acute Stroke: A Population-Based Study.1 passage
• Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke.1 passage
• Association Between Anemia and Cerebral Venous Thrombosis: Case-Control Study.1 passage
• Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.1 passage
• Association Between Brain-Derived Neurotrophic Factor Genotype and Upper Extremity Motor Outcome After Stroke.1 passage
• Association Between CT Angiogram Collaterals and CT Perfusion in the Interventional Management of Stroke III Trial.1 passage
• Association Between Carotid Bulb Diaphragm and Ischemic Stroke in Young Afro-Caribbean Patients: A Population-Based Case-Control Study.1 passage
• Association Between Cerebral Small Vessel Disease With Antidepressant Use and Depression: 3C Dijon Magnetic Resonance Imaging Study.1 passage
• Association Between Endogenous Testosterone and Cerebrovascular Disease in the ARIC Study (Atherosclerosis Risk in Communities).1 passage
• Association Between Heart Rate and Subclinical Cerebrovascular Disease in the Elderly.1 passage
• Association Between Heart Transplantation and Subsequent Risk of Stroke Among Patients With Heart Failure.1 passage
• Association Between High-Sensitivity Cardiac Troponin and Risk of Stroke in 96 702 Individuals: A Meta-Analysis.1 passage
• Association Between Hyperacute Stage Blood Pressure Variability and Outcome in Patients With Spontaneous Intracerebral Hemorrhage.1 passage
• Association Between Immigration Status and Acute Stroke Care: A Retrospective Study.1 passage
• Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.1 passage
• Association Between Low Blood Pressure and Clinical Outcomes in Patients With Acute Ischemic Stroke.1 passage
• Association Between Midlife Cardiorespiratory Fitness and Risk of Stroke: The Cooper Center Longitudinal Study.1 passage
• Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke.1 passage
• Association Between Possible Osteoporosis and Shunt-Dependent Hydrocephalus After Subarachnoid Hemorrhage.1 passage
• Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes.1 passage
• Association Between Reported Long Working Hours and History of Stroke in the CONSTANCES Cohort.1 passage
• Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort Study.1 passage
• Association Between Sociodemographic Determinants and Disparities in Stroke Symptom Awareness Among US Young Adults.1 passage
• Association Between Thrombus Perviousness Assessed on Computed Tomography and Stroke Cause.1 passage
• Association Between Time From Stroke Onset and Fluid-Attenuated Inversion Recovery Lesion Intensity Is Modified by Status of Collateral Circulation.1 passage
• Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion.1 passage
• Association Between Unruptured Intracranial Aneurysms and Downstream Stroke.1 passage
• Association Between Walking Pace and Stroke Incidence: Findings From the UK Biobank Prospective Cohort Study.1 passage
• Association Between the Onset Pattern of Adult Moyamoya Disease and Risk Factors for Stroke.1 passage
• Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study.1 passage
• Association between socioeconomic deprivation and functional impairment after stroke: the South London Stroke Register.1 passage
• Association of ApoE Genotypes and Recovery From Intracerebral Hemorrhage in Very Low Birth Weight Infants.1 passage
• Association of Atrial Fibrillation With White Matter Disease.1 passage
• Association of Baseline Cardiac Troponin With Acute Myocardial Infarction in Stroke Patients Presenting Within 4.5 Hours.1 passage
• Association of Basilar Bifurcation Aneurysms With Age, Sex, and Bifurcation Geometry.1 passage
• Association of Blood Pressure During Thrombectomy for Acute Ischemic Stroke With Functional Outcome: A Systematic Review.1 passage
• Association of Blood Pressure With Short- and Long-Term Functional Outcome After Stroke Thrombectomy: Post Hoc Analysis of the SIESTA Trial.1 passage
• Association of Breakfast Intake With Incident Stroke and Coronary Heart Disease: The Japan Public Health Center-Based Study.1 passage
• Association of Cancer Cell Type and Extracellular Vesicles With Coagulopathy in Patients With Lung Cancer and Stroke.1 passage
• Association of Computed Tomography Ischemic Lesion Location With Functional Outcome in Acute Large Vessel Occlusion Ischemic Stroke.1 passage
• Association of Dietary Protein Consumption With Incident Silent Cerebral Infarcts and Stroke: The Atherosclerosis Risk in Communities (ARIC) Study.1 passage
• Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.1 passage
• Association of Extrapyramidal Tracts' Integrity With Performance in Fine Motor Skills After Stroke.1 passage
• Association of Genetic Variants With Moyamoya Disease in 13 000 Individuals: A Meta-Analysis.1 passage
• Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke.1 passage
• Association of Hypotension During Thrombectomy and Outcomes Differs With the Posterior Communicating Artery Patency.1 passage
• Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia.1 passage
• Association of Intraplaque Hemorrhage and Acute Infarction in Patients With Basilar Artery Plaque.1 passage
• Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission.1 passage
• Association of Lesion Location and Depressive Symptoms Poststroke.1 passage
• Association of Leukoaraiosis With Convalescent Rehabilitation Outcome in Patients With Ischemic Stroke.1 passage
• Association of Lipids With Ischemic and Hemorrhagic Stroke: A Prospective Cohort Study Among 267 500 Chinese.1 passage
• Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation.1 passage
• Association of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype.1 passage
• Association of Magnetic Resonance Imaging Markers of Cerebrovascular Disease Burden and Cognition.1 passage
• Association of Major Depressive Episodes With Stroke Risk in a Prospective Study of 0.5 Million Chinese Adults.1 passage
• Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial.1 passage
• Association of Oxidized Low-Density Lipoprotein With Prognosis of Stroke and Stroke Subtypes.1 passage
• Association of Perforator Stroke After Basilar Artery Stenting With Negative Remodeling.1 passage
• Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.1 passage
• Association of Prediabetes and Type 2 Diabetes With Cognitive Function After Stroke: A STROKOG Collaboration Study.1 passage
• Association of Progression of Carotid Artery Wall Volume and Recurrent Transient Ischemic Attack or Stroke: A Magnetic Resonance Imaging Study.1 passage
• Association of Retinopathy and Retinal Microvascular Abnormalities With Stroke and Cerebrovascular Disease.1 passage
• Association of Secondhand Smoke With Stroke Outcomes.1 passage
• Association of Serum IL-6 (Interleukin 6) With Functional Outcome After Intracerebral Hemorrhage.1 passage
• Association of Socioeconomic Status With Ischemic Stroke Survival.1 passage
• Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women.1 passage
• Association of White Matter Hyperintensities With Short-Term Outcomes in Patients With Minor Cerebrovascular Events.1 passage
• Association of postural instability with asymptomatic cerebrovascular damage and cognitive decline: the Japan Shimanami health promoting program study.1 passage
• Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension.1 passage
• Association of white matter integrity and cognitive functions in patients with subcortical silent lacunar infarcts.1 passage
• Associations Between 30-Day Mortality, Specialist Nursing, and Daily Physician Ward Rounds in a National Stroke Registry.1 passage
• Associations Between Collateral Status and Thrombus Characteristics and Their Impact in Anterior Circulation Stroke.1 passage
• Associations Between Left Ventricular Structure, Function, and Cerebral Amyloid: The ARIC-PET Study.1 passage
• Associations Between Sleep Apnea and Subclinical Carotid Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.1 passage
• Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.1 passage
• Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study.1 passage
• Associations of Ischemic Lesion Volume With Functional Outcome in Patients With Acute Ischemic Stroke: 24-Hour Versus 1-Week Imaging.1 passage
• Associations of Perioperative Variables With the 30-Day Risk of Stroke or Death in Carotid Endarterectomy for Symptomatic Carotid Stenosis.1 passage
• Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study.1 passage
• Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack.1 passage
• Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease.1 passage
• Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source.1 passage
• Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).1 passage
• Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.1 passage
• Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes.1 passage
• Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death.1 passage
• Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.1 passage
• Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities.1 passage
• Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke: A Swedish Stroke Register (Riksstroke) Study.1 passage
• Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.1 passage
• Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial.1 passage
• Attention deficits after aneurysmal subarachnoid hemorrhage measured using the test of variables of attention.1 passage
• Augmented Dyadic Therapy Boosts Recovery of Language Function in Patients With Nonfluent Aphasia.1 passage
• Automated Brain Perfusion Imaging in Acute Ischemic Stroke: Interpretation Pearls and Pitfalls.1 passage
• Automated CT Perfusion Ischemic Core Volume and Noncontrast CT ASPECTS (Alberta Stroke Program Early CT Score): Correlation and Clinical Outcome Prediction in Large Vessel Stroke.1 passage
• Automated Calculation of Alberta Stroke Program Early CT Score: Validation in Patients With Large Hemispheric Infarct.1 passage
• Automated Detection of Intracranial Large Vessel Occlusions on Computed Tomography Angiography: A Single Center Experience.1 passage
• Automated Electronic Phenotyping of Cardioembolic Stroke.1 passage
• Automated Measurement of Cerebral Atrophy and Outcome in Endovascular Thrombectomy.1 passage
• Automated Quantification of Reduced Sulcal Volume Identifies Early Brain Injury After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.1 passage
• Autonomic Dysfunction Predicts Clinical Outcomes After Acute Ischemic Stroke: A Prospective Observational Study.1 passage
• Autonomic Parameter and Stress Profile Predict Secondary Ischemic Events After Transient Ischemic Attack or Minor Stroke.1 passage
• Average Lifespan Shortened due to Stroke in Canada: A Nationwide Descriptive Study From 1990 to 2015.1 passage
• Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage.1 passage
• B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis.1 passage
• BE-FAST (Balance, Eyes, Face, Arm, Speech, Time): Reducing the Proportion of Strokes Missed Using the FAST Mnemonic.1 passage
• Balloon Guide Catheter Is Beneficial in Endovascular Treatment Regardless of Mechanical Recanalization Modality.1 passage
• Baroreflex Impairment After Subarachnoid Hemorrhage Is Associated With Unfavorable Outcome.1 passage
• Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands).1 passage
• Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.1 passage
• Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project.1 passage
• Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial.1 passage
• Baseline Hemodynamic Impairment and Future Stroke Risk in Adult Idiopathic Moyamoya Phenomenon: Results of a Prospective Natural History Study.1 passage
• Baseline Plasma Zinc and Risk of First Stroke in Hypertensive Patients: A Nested Case-Control Study.1 passage
• Baseline Predictors of Poor Outcome in Patients Too Good to Treat With Intravenous Thrombolysis.1 passage
• Baseline Quality of Life and Risk of Stroke in the ALLHAT Study (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).1 passage
• Benchmarking Telestroke Proficiency: Page-to-Needle Time Among Neurovascular Fellows and Attendings.1 passage
• Beneficial Effects of Implementing Stroke Protocols Require Establishment of a Geographically Distinct Unit.1 passage
• Benefit of Endovascular Thrombectomy by Mode of Onset: Secondary Analysis of the DAWN Trial.1 passage
• Benefit of Intravenous Thrombolysis in Acute Ischemic Stroke Patients With High Cerebral Microbleed Burden.1 passage
• Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke.1 passage
• Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack.1 passage
• Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).1 passage
• Benefits of Stroke Treatment Using a Mobile Stroke Unit Compared With Standard Management: The BEST-MSU Study Run-In Phase.1 passage
• Better Collaterals Are Independently Associated With Post-Thrombolysis Recanalization Before Thrombectomy.1 passage
• Beyond Large Vessel Occlusion Strokes: Distal Occlusion Thrombectomy.1 passage
• Beyond the Brain: Systematic Review of Extracerebral Phenotypes Associated With Monogenic Cerebral Small Vessel Disease.1 passage
• Big Data Approaches to Phenotyping Acute Ischemic Stroke Using Automated Lesion Segmentation of Multi-Center Magnetic Resonance Imaging Data.1 passage
• Bilateral Transcutaneous Electrical Nerve Stimulation Improves Upper Limb Motor Recovery in Stroke: A Randomized Controlled Trial.1 passage
• Bilirubin and Stroke Risk Using a Mendelian Randomization Design.1 passage
• Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study.1 passage
• Black Hole Sign: Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage.1 passage
• Black-White Differences in Ischemic Stroke Risk Factor Burden in Young Adults.1 passage
• Blacks Are Less Likely to Present With Strokes During the COVID-19 Pandemic: Observations From the Buckle of the Stroke Belt.1 passage
• Blend Sign on Computed Tomography: Novel and Reliable Predictor for Early Hematoma Growth in Patients With Intracerebral Hemorrhage.1 passage
• Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.1 passage
• Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.1 passage
• Blood Flow Into Basilar Tip Aneurysms: A Predictor for Recanalization After Coil Embolization.1 passage
• Blood Flow Lateralization and Collateral Compensatory Mechanisms in Patients With Carotid Artery Stenosis.1 passage
• Blood Pressure After Endovascular Thrombectomy: Modeling for Outcomes Based on Recanalization Status.1 passage
• Blood Pressure Drop and Penumbral Tissue Loss in Nonrecanalized Emergent Large Vessel Occlusion.1 passage
• Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke: PRASTRO-I.1 passage
• Blood Pressure Trajectory Groups and Outcome After Endovascular Thrombectomy: A Multicenter Study.1 passage
• Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage.1 passage
• Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.1 passage
• Blood Pressure Variability and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.1 passage
• Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study.1 passage
• Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): A Multicenter Prospective Cohort Study.1 passage
• Blood Pressure and Outcome After Mechanical Thrombectomy With Successful Revascularization.1 passage
• Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke.1 passage
• Blood Pressure, Carotid Flow Pulsatility, and the Risk of Stroke: A Community-Based Study.1 passage
• Blood Pressure-Attained Analysis of ATACH 2 Trial.1 passage
• Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy.1 passage
• Blood-Brain Barrier Leakage: A New Biomarker in Transient Ischemic Attacks.1 passage
• Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.1 passage
• Blood-brain barrier compromise does not predict perihematoma edema growth in intracerebral hemorrhage.1 passage
• Blowing up Neural Repair for Stroke Recovery: Preclinical and Clinical Trial Considerations.1 passage
• Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS Trial.1 passage
• Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.1 passage
• Body mass index and stroke risk among patients with type 2 diabetes mellitus.1 passage
• Bone Marrow Mononuclear Cells Activate Angiogenesis via Gap Junction-Mediated Cell-Cell Interaction.1 passage
• Boosted Tree Model Reforms Multimodal Magnetic Resonance Imaging Infarct Prediction in Acute Stroke.1 passage
• Brain Activity and Cerebral Oxygenation After Perinatal Arterial Ischemic Stroke Are Associated With Neurodevelopment.1 passage
• Brain Arteriovenous Malformation Recurrence After Apparent Microsurgical Cure: Increased Risk in Children Who Present With Arteriovenous Malformation Rupture.1 passage
• Brain Atrophy and the Risk of Futile Endovascular Reperfusion in Acute Ischemic Stroke.1 passage
• Brain Connectivity Measures Improve Modeling of Functional Outcome After Acute Ischemic Stroke.1 passage
• Brain Glucose Metabolism in Cerebral Amyloid Angiopathy: An FDG-PET Study.1 passage
• Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.1 passage
• Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AF1 passage
• Brain Network Dysfunction in Poststroke Delirium and Spatial Neglect: An fMRI Study.1 passage
• Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event.1 passage
• Break in the Stroke Chain of Survival due to COVID-19.1 passage
• Bridging May Increase the Risk of Symptomatic Intracranial Hemorrhage in Thrombectomy Patients With Low Alberta Stroke Program Early Computed Tomography Score.1 passage
• Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion: An Updated Meta-Analysis.1 passage
• Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial.1 passage
• Brief Educational Intervention Improves Emergency Medical Services Stroke Recognition.1 passage
• Brief Screening of Vascular Cognitive Impairment in Patients With Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Without Dementia.1 passage
• Bright vessel appearance on arterial spin labeling MRI for localizing arterial occlusion in acute ischemic stroke.1 passage
• Brush Sign Is Associated With Increased Severity in Cerebral Venous Thrombosis.1 passage
• Burden of Dilated Perivascular Spaces, an Emerging Marker of Cerebral Small Vessel Disease, Is Highly Heritable.1 passage
• Burden of Intracranial Atherosclerosis Is Associated With Long-Term Vascular Outcome in Patients With Ischemic Stroke.1 passage
• Burden of Stroke in Europe: Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years.1 passage
• Bypassing the Closest Stroke Center for Thrombectomy Candidates: What Additional Delay to Thrombolysis Is Acceptable?1 passage
• C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers.1 passage
• CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage.1 passage
• CHA3 passages
• COOLIST (Cooling for Ischemic Stroke Trial): A Multicenter, Open, Randomized, Phase II, Clinical Trial.1 passage
• COVID-19 and Decompressive Hemicraniectomy for Acute Ischemic Stroke.1 passage
• CTA-for-All: Impact of Emergency Computed Tomographic Angiography for All Patients With Stroke Presenting Within 24 Hours of Onset.1 passage
• Calculation of Prognostic Scores, Using Delayed Imaging, Outperforms Baseline Assessments in Acute Intracerebral Hemorrhage.1 passage
• Canagliflozin and Stroke in Type 2 Diabetes Mellitus.1 passage
• Cancer and Embolic Stroke of Undetermined Source.1 passage
• Cancer in young adults with ischemic stroke.1 passage
• Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile.1 passage
• Cannabis Use and Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage.1 passage
• Cannabis and stroke: systematic appraisal of case reports.1 passage
• Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men.1 passage
• Carbon Monoxide Preserves Circadian Rhythm to Reduce the Severity of Subarachnoid Hemorrhage in Mice.1 passage
• Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project.1 passage
• Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.1 passage
• Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.1 passage
• Cardiovascular Health and Stroke in Older British Men: Prospective Findings From the British Regional Heart Study.1 passage
• Cardiovascular Risk Scores to Predict Perioperative Stroke in Noncardiac Surgery.1 passage
• Cardiovascular and Cerebrovascular Mortality Associated With Acute Exposure to PM1 passage
• Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.1 passage
• Care Received by Elderly US Stroke Survivors May Be Underestimated.1 passage
• Care of the Patient With Acute Ischemic Stroke (Endovascular/Intensive Care Unit-Postinterventional Therapy): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association.1 passage
• Care of the Patient With Acute Ischemic Stroke (Posthyperacute and Prehospital Discharge): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association.1 passage
• Care of the Patient With Acute Ischemic Stroke (Prehospital and Acute Phase of Care): Update to the 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association.1 passage
• Caregiver-Delivered Stroke Rehabilitation in Rural China.1 passage
• Carotid Artery Plaque Calcifications: Lessons From Histopathology to Diagnostic Imaging.1 passage
• Carotid Atheroma From Men Has Significantly Higher Levels of Inflammation and Iron Metabolism Enabled by Macrophages.1 passage
• Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.1 passage
• Carotid Atherosclerotic Plaque Characteristics on Magnetic Resonance Imaging Relate With History of Stroke and Coronary Heart Disease.1 passage
• Carotid Intima-Media Thickness Is Associated With White Matter Hyperintensities: The Northern Manhattan Study.1 passage
• Carotid Intima-Media Thickness and the Risk of First Stroke in Patients With Hypertension.1 passage
• Carotid Plaque Inflammation Imaged by1 passage
• Carotid Plaque Morphological Classification Compared With Biomechanical Cap Stress: Implications for a Magnetic Resonance Imaging-Based Assessment.1 passage
• Carotid Plaque Morphology Is Significantly Associated With Sex, Age, and History of Neurological Symptoms.1 passage
• Carotid Plaque Neovascularization Detected With Superb Microvascular Imaging Ultrasound Without Using Contrast Media.1 passage
• Carotid Plaque Positron Emission Tomography Imaging and Cerebral Ischemic Disease.1 passage
• Carotid Plaque With High-Risk Features in Embolic Stroke of Undetermined Source: Systematic Review and Meta-Analysis.1 passage
• Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.1 passage
• Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-Analysis.1 passage
• Carotid Web (Intimal Fibromuscular Dysplasia) Has High Stroke Recurrence Risk and Is Amenable to Stenting.1 passage
• Carotid intima-media thickness is associated with the progression of cognitive impairment in older adults.1 passage
• Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques.1 passage
• Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study.1 passage
• Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease: A Mendelian Randomization Analysis.1 passage
• Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.1 passage
• Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease.1 passage
• Cavernous Sinus Thrombosis in Children: Imaging Characteristics and Clinical Outcomes.1 passage
• Cell-Based Therapy for Stroke: Musing With Muse Cells.1 passage
• Center for Experimental Biomedicine, University of Würzburg, Germany (J.V., B.N.)4 Fluro Agro Chemicals (Organic24 passages
• Centre at University College London29 passages
• Centre, Foothills Medical Centre, 1403-29th24 passages
• Centre, Molecular and Clinical Sciences Research Institute, St. George’s, University of London, United Kingdom (E.Z., T.R.B.).Correspondence to24 passages
• Centre–Cardiovascular Theme, Glenfield Hospital, United Kingdom (N.P., E.M.L.C.)3 Department of Medical Physics, University Hospitals of30 passages
• Cerebellar Cortical Infarct Cavities: Correlation With Risk Factors and MRI Markers of Cerebrovascular Disease.1 passage
• Cerebellar Hematoma Location: Implications for the Underlying Microangiopathy.1 passage
• Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy.1 passage
• Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy.1 passage
• Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.1 passage
• Cerebral Amyloid Angiopathy With Vascular Iron Accumulation and Calcification.1 passage
• Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target?1 passage
• Cerebral Aneurysm Morphology Before and After Rupture: Nationwide Case Series of 29 Aneurysms.1 passage
• Cerebral Arteriovenous Malformation Flow Is Associated With Venous Intimal Hyperplasia.1 passage
• Cerebral Blood Flow Predicts the Infarct Core: New Insights From Contemporaneous Diffusion and Perfusion Imaging.1 passage
• Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.1 passage
• Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid Angiopathy.1 passage
• Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation: Systematic Review and Meta-Analysis.1 passage
• Cerebral Ischemia in Patients on Direct Oral Anticoagulants.1 passage
• Cerebral Microbleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients.1 passage
• Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting With Minor Cerebrovascular Events.1 passage
• Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19.1 passage
• Cerebral Microbleeds and the Risk of Incident Ischemic Stroke in CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy).1 passage
• Cerebral Microbleeds as Predictors of Mortality: The Framingham Heart Study.1 passage
• Cerebral Near-Infrared Spectroscopy: A Potential Approach for Thrombectomy Monitoring.1 passage
• Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus.1 passage
• Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors.1 passage
• Cerebral Small Vessel Disease, Risk Factors, and Cognition in Tenants of Precarious Housing.1 passage
• Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia.1 passage
• Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study.1 passage
• Cerebral Venous Thrombosis in Older Patients.1 passage
• Cerebral Venous Thrombosis: Finnish Nationwide Trends.1 passage
• Cerebral computed tomography-graded white matter lesions are associated with worse outcome after thrombolysis in patients with stroke.1 passage
• Cerebral venous thrombosis in the absence of headache.1 passage
• Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.1 passage
• Cerebroprotection for Acute Ischemic Stroke: Looking Ahead.1 passage
• Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.1 passage
• Cerebrovascular Complications of COVID-19.1 passage
• Cerebrovascular Disease in Rheumatic Diseases: A Systematic Review and Meta-Analysis.1 passage
• Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis.1 passage
• Cerebrovascular Risk-Factors of Prevalent and Incident Brain Infarcts in the General Population: The AGES-Reykjavik Study.1 passage
• Cervical Carotid Pseudo-Occlusions and False Dissections: Intracranial Occlusions Masquerading as Extracranial Occlusions.1 passage
• Cervical Spinal Involvement in a Chinese Pedigree With Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy Caused by a 3' Untranslated Region Mutation of COL4A1 Gene.1 passage
• Challenge and Yield of Enrolling Racially and Ethnically Diverse Patient Populations in Low Event Rate Clinical Trials.1 passage
• Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak.1 passage
• Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting.1 passage
• Challenges of Outcome Prediction for Acute Stroke Treatment Decisions.1 passage
• Challenging the Ischemic Core Concept in Acute Ischemic Stroke Imaging.1 passage
• Change in Body Weight and Long-Term Risk of Stroke and Death in Healthy Men.1 passage
• Change in Life's Simple 7 Measure of Cardiovascular Health After Incident Stroke: The REGARDS Study.1 passage
• Changes in Depressive Symptoms and Subsequent Risk of Stroke in the Cardiovascular Health Study.1 passage
• Changes in Patient Volumes and Outcomes After Adding Thrombectomy Capability.1 passage
• Changes in functional outcome over the first year after stroke: an observational study from the Swedish stroke register.1 passage
• Changes in the Employment Status and Risk of Stroke and Stroke Types.1 passage
• Changes in wall shear stress of cerebral arteriovenous malformation feeder arteries after embolization and surgery.1 passage
• Changes of pH and energy state in subacute human ischemia assessed by multinuclear magnetic resonance spectroscopy.1 passage
• Changing Patterns of Carotid Endarterectomy Between 2011 and 2017 in England.1 passage
• Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry.1 passage
• Characteristics and Outcomes of Retinal Artery Occlusion: Nationally Representative Data.1 passage
• Characteristics and Outcomes of Very Elderly Enrolled in a Prehospital Stroke Research Study.1 passage
• Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.1 passage
• Characteristics of Intracranial Aneurysms According to Levels of Coronary Artery Calcium.1 passage
• Characteristics of Randomized Trials Focusing on Stroke due to Intracerebral Hemorrhage: Systematic Review.1 passage
• Characterization of Carotid Atherosclerotic Plaques Using 3-Dimensional MERGE Magnetic Resonance Imaging and Correlation With Stroke Risk Factors.1 passage
• Characterization of Heterozygous1 passage
• Characterizing Cathepsin Activity and Macrophage Subtypes in Excised Human Carotid Plaques.1 passage
• Childhood Stature and Growth in Relation to First Ischemic Stroke or Intracerebral Hemorrhage.1 passage
• Cholesterol Variability and Cranial Magnetic Resonance Imaging Findings in Older Adults: The Cardiovascular Health Study.1 passage
• Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke.1 passage
• Chronic Cortical Cerebral Microinfarcts Slow Down Cognitive Recovery After Acute Ischemic Stroke.1 passage
• Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.1 passage
• Chronic Kidney Disease as Risk Factor for Enlarged Perivascular Spaces in Patients With Stroke and Relation to Racial Group.1 passage
• Chronic Kidney Disease in Patients With Lacunar Stroke: Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease.1 passage
• Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease.1 passage
• Cigarette Smoking History and Functional Outcomes After Spontaneous Intracerebral Hemorrhage.1 passage
• Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.1 passage
• Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial.1 passage
• Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial.1 passage
• Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis.1 passage
• Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities.1 passage
• Circadian Biology and Stroke.1 passage
• Circulating Circular RNAs as Biomarkers for the Diagnosis and Prediction of Outcomes in Acute Ischemic Stroke.1 passage
• Circulating DNAs, a Marker of Neutrophil Extracellular Traposis and Cancer-Related Stroke: The OASIS-Cancer Study.1 passage
• Circulating Endothelial Markers in Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.1 passage
• Circulating FABP4 (Fatty Acid-Binding Protein 4) Is a Novel Prognostic Biomarker in Patients With Acute Ischemic Stroke.1 passage
• Circulating MicroRNAs as Novel Biomarkers of Stenosis Progression in Asymptomatic Carotid Stenosis.1 passage
• Circulating Multiple Metals and Incident Stroke in Chinese Adults.1 passage
• Circulating SHBG (Sex Hormone-Binding Globulin) and Risk of Ischemic Stroke: Findings From the WHI.1 passage
• Circulating Tissue Factor Levels and Risk of Stroke: Findings From the EPICOR Study.1 passage
• Circulating Vascular Growth Factors and Magnetic Resonance Imaging Markers of Small Vessel Disease and Atrophy in Middle-Aged Adults.1 passage
• Circulating Vimentin Is Associated With Future Incidence of Stroke in a Population-Based Cohort Study.1 passage
• Circulatory MicroRNAs as Potential Biomarkers for Stroke Risk: The Rotterdam Study.1 passage
• Classification of Bleeding Events: Comparison of ECASS III (European Cooperative Acute Stroke Study) and the New Heidelberg Bleeding Classification.1 passage
• Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.1 passage
• Climatic and Seasonal Circumstances of Hypertensive Intracerebral Hemorrhage in a Worldwide Cohort.1 passage
• Clinical Characteristics and In-Hospital Outcomes of Varying Definitions of Minor Stroke: From a Large-Scale Nation-Wide Longitudinal Registry.1 passage
• Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.1 passage
• Clinical Correlates, Ethnic Differences, and Prognostic Implications of Perivascular Spaces in Transient Ischemic Attack and Ischemic Stroke.1 passage
• Clinical Course and Mortality of Stroke Patients With Coronavirus Disease 2019 in Wuhan, China.1 passage
• Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.1 passage
• Clinical Effects of Early Edaravone Use in Acute Ischemic Stroke Patients Treated by Endovascular Reperfusion Therapy.1 passage
• Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia.1 passage
• Clinical Implications and Determinants of Left Atrial Mechanical Dysfunction in Patients With Stroke.1 passage
• Clinical Implications of Changes in Individual Platelet Reactivity to Aspirin Over Time in Acute Ischemic Stroke.1 passage
• Clinical Outcome After Endovascular Thrombectomy in 3 Triage Concepts: A Prospective, Observational Study (NEUROSQUAD).1 passage
• Clinical Outcome of Anticoagulant Treatment in Head or Neck Infection-Associated Cerebral Venous Thrombosis.1 passage
• Clinical Outcome of Patients With Large Vessel Occlusion and Low National Institutes of Health Stroke Scale Scores: Subanalysis of the RESCUE-Japan Registry 2.1 passage
• Clinical Outcomes and Identification of Patients With Persistent Penumbral Profiles Beyond 24 Hours From Last Known Well: Analysis From DEFUSE 3.1 passage
• Clinical Outcomes and Neuroimaging Profiles in Nondisabled Patients With Anticoagulant-Related Intracerebral Hemorrhage.1 passage
• Clinical Outcomes of Posterior Versus Anterior Circulation Infarction With Low National Institutes of Health Stroke Scale Scores.1 passage
• Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.1 passage
• Clinical Performance Measures for Adults Hospitalized With Intracerebral Hemorrhage: Performance Measures for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Clinical Performance Measures for Stroke Rehabilitation: Performance Measures From the American Heart Association/American Stroke Association.1 passage
• Clinical Prediction Rules to Classify Types of Stroke at Prehospital Stage.1 passage
• Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry.1 passage
• Clinical Relevance of Cortical Cerebral Microinfarcts on 1.5T Magnetic Resonance Imaging in the Late-Adult Population.1 passage
• Clinical Role of Microembolic Signals in Adult Moyamoya Disease With Ischemic Stroke.1 passage
• Clinical Scales Do Not Reliably Identify Acute Ischemic Stroke Patients With Large-Artery Occlusion.1 passage
• Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry).1 passage
• Clinical Significance of Fluid-Attenuated Inversion Recovery Vascular Hyperintensities in Borderzone Infarcts.1 passage
• Clinical Significance of Isolated Atypical Transient Symptoms in a Cohort With Transient Ischemic Attack.1 passage
• Clinical Significance of Wall Changes After Recanalization Therapy in Acute Stroke: High-Resolution Vessel Wall Imaging.1 passage
• Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.1 passage
• Clinical and Demographic Characteristics Associated With Suboptimal Primary Stroke and Transient Ischemic Attack Prevention: Retrospective Analysis.1 passage
• Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.1 passage
• Clinical and Imaging Determinants of Collateral Status in Patients With Acute Ischemic Stroke in MR CLEAN Trial and Registry.1 passage
• Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy.1 passage
• Clinical and Imaging Markers Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke.1 passage
• Clinical and Imaging Parameters Associated With Hyperacute Infarction Growth in Large Vessel Occlusion Stroke.1 passage
• Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy.1 passage
• Clinical and Procedural Predictors of Outcomes From the Endovascular Treatment of Posterior Circulation Strokes.1 passage
• Clinical prediction algorithm (BRAIN) to determine risk of hematoma growth in acute intracerebral hemorrhage.1 passage
• Clinical predictors of accurate prehospital stroke recognition.1 passage
• Clinical, radiological, and flow-related risk factors for growth of untreated, unruptured intracranial aneurysms.1 passage
• Clinically Confirmed Stroke With Negative Diffusion-Weighted Imaging Magnetic Resonance Imaging: Longitudinal Study of Clinical Outcomes, Stroke Recurrence, and Systematic Review.1 passage
• Clinicopathological Insights From Vessel Wall Imaging of Unruptured Intracranial Aneurysms.1 passage
• Clipping and Coiling of Unruptured Intracranial Aneurysms Among Medicare Beneficiaries, 2000 to 2010.1 passage
• Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.1 passage
• Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.1 passage
• Clot Burden Score on Baseline Computerized Tomographic Angiography and Intra-Arterial Treatment Effect in Acute Ischemic Stroke.1 passage
• Clot Migration Is Associated With Intravenous Thrombolysis in the Setting of Acute Ischemic Stroke.1 passage
• Clot-Based Radiomics Predict a Mechanical Thrombectomy Strategy for Successful Recanalization in Acute Ischemic Stroke.1 passage
• Clot-Derived Contaminants in Transplanted Bone Marrow Mononuclear Cells Impair the Therapeutic Effect in Stroke.1 passage
• Cluster Randomized Controlled Trial: Clinical and Cost-Effectiveness of a System of Longer-Term Stroke Care.1 passage
• Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.1 passage
• Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke.1 passage
• Cocaine Use and Risk of Ischemic Stroke in Young Adults.1 passage
• Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke.1 passage
• Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy.1 passage
• Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study.1 passage
• Collagen Turnover in Relation to Risk Factors and Hemodynamics in Human Intracranial Aneurysms.1 passage
• Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion.1 passage
• Collateral Circulation in Moyamoya Disease: A New Grading System.1 passage
• Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial.1 passage
• Collateral Clock Is More Important Than Time Clock for Tissue Fate.1 passage
• Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease.1 passage
• Collateral Status on Baseline Computed Tomographic Angiography and Intra-Arterial Treatment Effect in Patients With Proximal Anterior Circulation Stroke.1 passage
• Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin).1 passage
• Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial.1 passage
• Combined Effect of Age and Baseline Alberta Stroke Program Early Computed Tomography Score on Post-Thrombectomy Clinical Outcomes in the MR CLEAN Registry.1 passage
• Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study.1 passage
• Combined Multimodal Computed Tomography Score Correlates With Futile Recanalization After Thrombectomy in Patients With Acute Stroke.1 passage
• Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage.1 passage
• Combining Neurovascular and Neurodegenerative Magnetic Resonance Imaging Measures in Stroke.1 passage
• Combining Spot Sign and Intracerebral Hemorrhage Score to Estimate Functional Outcome: Analysis From the PREDICT Cohort.1 passage
• Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.1 passage
• Common NOTCH3 Variants and Cerebral Small-Vessel Disease.1 passage
• Community-Based Intervention to Improve Cardiometabolic Targets in Patients With Stroke: A Randomized Controlled Trial.1 passage
• Community-Level Knowledge and Perceptions of Stroke in Rural Malawi.1 passage
• Community-based case-control study of childhood stroke risk associated with congenital heart disease.1 passage
• Comorbid Psychiatric Disease Is Associated With Lower Rates of Thrombolysis in Ischemic Stroke.1 passage
• Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients.1 passage
• Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke: A Nationwide, Multicenter Registry-Based Study.1 passage
• Comparative Effectiveness of Endovascular Thrombectomy in Elderly Stroke Patients.1 passage
• Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.1 passage
• Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.1 passage
• Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.1 passage
• Comparing National Institutes of Health Stroke Scale among a stroke team and helicopter emergency medical service providers.1 passage
• Comparison Between Perfusion- and Collateral-Based Triage for Endovascular Thrombectomy in a Late Time Window.1 passage
• Comparison Between the Original and Shortened Versions of the National Institutes of Health Stroke Scale in Ischemic Stroke Patients of Intermediate Severity.1 passage
• Comparison of Acute Stroke Preparedness Strategies to Decrease Emergency Department Arrival Time in a Multiethnic Cohort: The Stroke Warning Information and Faster Treatment Study.1 passage
• Comparison of Associations of Reduced Estimated Glomerular Filtration Rate With Stroke Outcomes Between Hypertension and No Hypertension.1 passage
• Comparison of Perfusion CT Software to Predict the Final Infarct Volume After Thrombectomy.1 passage
• Comparison of Risk Factor Control in the Year After Discharge for Ischemic Stroke Versus Acute Myocardial Infarction.1 passage
• Comparison of Rupture Risk of Intracranial Aneurysms Between Familial and Sporadic Patients.1 passage
• Comparison of Two Automated Computed Tomography Perfusion Applications to Predict the Final Infarct Volume After Thrombolysis in Cerebral Infarction 3 Recanalization.1 passage
• Comparison of the 2 Most Popular Deconvolution Techniques for the Detection of Penumbral Flow in Acute Stroke.1 passage
• Compliance With Imaging Guidelines for Workup of Transient Ischemic Attack: Evidence From the Nationwide Emergency Department Sample.1 passage
• Comprehensive Stroke Care and Outcomes: Time for a Paradigm Shift.1 passage
• Computed Tomographic Blend Sign Is Associated With Computed Tomographic Angiography Spot Sign and Predicts Secondary Neurological Deterioration After Intracerebral Hemorrhage.1 passage
• Computed Tomographic Perfusion Predicts Poor Outcomes in a Randomized Trial of Endovascular Therapy.1 passage
• Computed Tomographic Perfusion Selection and Clinical Outcomes After Endovascular Therapy in Large Vessel Occlusion Stroke.1 passage
• Computed Tomography Angiography Collateral Profile Is Directly Linked to Early Edema Progression Rate in Acute Ischemic Stroke.1 passage
• Computed Tomography Angiography Versus Digital Subtraction Angiography for Postclipping Aneurysm Obliteration Detection.1 passage
• Computed Tomography Perfusion After Thrombectomy: An Immediate Surrogate Marker of Outcome After Recanalization in Acute Stroke.1 passage
• Computed Tomography Perfusion Identifies Patients With Stroke With Impaired Cardiac Function.1 passage
• Computed Tomography Perfusion-Based Machine Learning Model Better Predicts Follow-Up Infarction in Patients With Acute Ischemic Stroke.1 passage
• Computed tomography identifies patients at high risk for stroke after transient ischemic attack/nondisabling stroke: prospective, multicenter cohort study.1 passage
• Concentration of Lp(a) (Lipoprotein[a]) in Aneurysm Sac Is Associated With Wall Enhancement of Unruptured Intracranial Aneurysm.1 passage
• Concordance in Aneurysm Size at Time of Rupture in Familial Intracranial Aneurysms.1 passage
• Confirmatory Study of Time-Dependent Computed Tomographic Perfusion Thresholds for Use in Acute Ischemic Stroke.1 passage
• Confounding by Pre-Morbid Functional Status in Studies of Apparent Sex Differences in Severity and Outcome of Stroke.1 passage
• Confounding of Cerebral Blood Flow Velocity by Blood Pressure During Breath Holding or Hyperventilation in Transient Ischemic Attack or Stroke.1 passage
• Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States.1 passage
• Consumer-Based Physical Activity Monitor as a Practical Way to Measure Walking Intensity During Inpatient Stroke Rehabilitation.1 passage
• Contact Aspiration Versus Stent Retriever in Patients With Acute Ischemic Stroke With M2 Occlusion in the ASTER Randomized Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization).1 passage
• Continuation or Discontinuation of Anticoagulation in the Early Phase After Acute Ischemic Stroke.1 passage
• Contralateral Hemispheric Cerebral Blood Flow Measured With Arterial Spin Labeling Can Predict Outcome in Acute Stroke.1 passage
• Contralaterally Controlled Functional Electrical Stimulation Improves Hand Dexterity in Chronic Hemiparesis: A Randomized Trial.1 passage
• Contralesional Brain-Computer Interface Control of a Powered Exoskeleton for Motor Recovery in Chronic Stroke Survivors.1 passage
• Contrast-Associated Acute Kidney Injury in Endovascular Thrombectomy Patients With and Without Baseline Renal Impairment.1 passage
• Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke.1 passage
• Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults.1 passage
• Contribution of convexal subarachnoid hemorrhage to disease progression in cerebral amyloid angiopathy.1 passage
• Contributions of Stepping Intensity and Variability to Mobility in Individuals Poststroke.1 passage
• Contributors to the Excess Stroke Mortality in Rural Areas in the United States.1 passage
• Copeptin Kinetics in Acute Ischemic Stroke May Differ According to Revascularization Strategies: Pilot Data.1 passage
• Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics.1 passage
• Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study.1 passage
• Corneal Confocal Microscopy Detects Corneal Nerve Damage in Patients Admitted With Acute Ischemic Stroke.1 passage
• Coronary and Basilar Artery Ectasia Are Associated: Results From an Autopsy Case-Control Study.1 passage
• Correction for Delay and Dispersion Results in More Accurate Cerebral Blood Flow Ischemic Core Measurement in Acute Stroke.1 passage
• Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Correlating Ex Vivo Carotid Calcification Measurements With Cerebrovascular Symptoms: A Proof-of-Concept Study.1 passage
• Correlation of Alberta Stroke Program Early Computed Tomography Score With Computed Tomography Perfusion Core in Large Vessel Occlusion in Delayed Time Windows.1 passage
• Cortical Cerebral Microinfarcts on 3T Magnetic Resonance Imaging in Patients With Carotid Artery Stenosis.1 passage
• Cortical Microinfarcts Associated With Worse Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment.1 passage
• Cortical Microinfarcts Detected by 3-Tesla Magnetic Resonance Imaging: Differentiation Between Cerebral Amyloid Angiopathy and Embolism.1 passage
• Cortical Microinfarcts on 3T Magnetic Resonance Imaging in Cerebral Amyloid Angiopathy.1 passage
• Cortical Sparing in Preterm Ischemic Arterial Stroke.1 passage
• Cortical Superficial Siderosis Evolution.1 passage
• Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease.1 passage
• Cortical Venous Filling on Dynamic Computed Tomographic Angiography: A Novel Predictor of Clinical Outcome in Patients With Acute Middle Cerebral Artery Stroke.1 passage
• Cortical Venous Redness Represents Tissue Circulation Status in Patients With Moyamoya Disease.1 passage
• Cortical microinfarcts detected in vivo on 3 Tesla MRI: clinical and radiological correlates.1 passage
• Corticospinal Fibers With Different Origins Impact Motor Outcome and Brain After Subcortical Stroke.1 passage
• Corticospinal Tract Injury Estimated From Acute Stroke Imaging Predicts Upper Extremity Motor Recovery After Stroke.1 passage
• Corticospinal Tract Microstructure Correlates With Beta Oscillatory Activity in the Primary Motor Cortex After Stroke.1 passage
• Cost of Alteplase Has More Than Doubled Over the Past Decade.1 passage
• Cost-Effectiveness of Computed Tomography Angiography in Management of Tiny Unruptured Intracranial Aneurysms in the United States.1 passage
• Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.1 passage
• Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review.1 passage
• Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.1 passage
• Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.1 passage
• Cost-Effectiveness of Mechanical Thrombectomy for Treatment of Nonminor Ischemic Stroke Across Europe.1 passage
• Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.1 passage
• Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.1 passage
• Cost-Effectiveness of Quantitative Magnetic Resonance Angiography Screening and Submaximal Angioplasty for Symptomatic Vertebrobasilar Disease.1 passage
• Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke).1 passage
• Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke.1 passage
• Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke: The THRACE Randomized Controlled Trial.1 passage
• Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China.1 passage
• Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke.1 passage
• Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage.1 passage
• Course and Recognition of Poststroke Delirium: A Prospective Noninferiority Trial of Delirium Screening Tools.1 passage
• Critical Appraisal on the Quality of Reporting on Safety and Efficacy of Transcarotid Artery Stenting With Flow Reversal.1 passage
• Critical Illness-Associated Cerebral Microbleeds.1 passage
• Cross-National Key Performance Measures of the Quality of Acute Stroke Care in Western Europe.1 passage
• Cumulative Concussion and Odds of Stroke in Former National Football League Players.1 passage
• Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.1 passage
• Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China: A Real-World Nationwide Registry.1 passage
• Cutting the Prehospital On-Scene Time of Stroke Thrombolysis in Helsinki: A Prospective Interventional Study.1 passage
• Cysteine-Altering1 passage
• Cysteine-sparing CADASIL mutations in NOTCH3 show proaggregatory properties in vitro.1 passage
• D-Dimer Is Associated With First-Ever Intracerebral Hemorrhage.1 passage
• D-Dimer as Predictor of Large Vessel Occlusion in Acute Ischemic Stroke.1 passage
• DEFUSE 3 Non-DAWN Patients.1 passage
• DNA Content in Ischemic Stroke Thrombi Can Help Identify Cardioembolic Strokes Among Strokes of Undetermined Cause.1 passage
• DWI-ASPECTS (Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Scores) and DWI-FLAIR (Diffusion-Weighted Imaging-Fluid Attenuated Inversion Recovery) Mismatch in Thrombectomy Candidates: An Intrarater and Interrater Agreement Study.1 passage
• Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.1 passage
• Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation.1 passage
• Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke.1 passage
• Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.1 passage
• Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.1 passage
• Daily Total Physical Activity and Incident Stroke: The Japan Public Health Center-Based Prospective Study.1 passage
• Damage to the Left Precentral Gyrus Is Associated With Apraxia of Speech in Acute Stroke.1 passage
• Day 1 Extracranial Internal Carotid Artery Patency Is Associated With Good Outcome After Mechanical Thrombectomy for Tandem Occlusion.1 passage
• Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry.1 passage
• Day-by-Day Blood Pressure Variability in the Subacute Stage of Ischemic Stroke and Long-Term Recurrence.1 passage
• De Novo Aneurysm Formation in Carriers of Saccular Intracranial Aneurysm Disease in Eastern Finland.1 passage
• Death From Stroke in End-Stage Kidney Disease.1 passage
• Decision Analysis Model for Prehospital Triage of Patients With Acute Stroke.1 passage
• Decline in Regional Trends in Mortality of Stroke Subtypes in Germany From 1998 to 2015.1 passage
• Decline in Stroke Presentations During COVID-19 Surge.1 passage
• Decline in the Severity of Carotid Atherosclerosis and Associated Risk Factors From 2002 to 2014.1 passage
• Declining Incidence of Ischemic Stroke: What Is the Impact of Changing Risk Factors? The Tromsø Study 1995 to 2012.1 passage
• Declining Rate and Severity of Hospitalized Stroke From 2004 to 2013: The National Acute Stroke Israeli Registry.1 passage
• Decompressive Hemicraniectomy for Large Hemispheric Strokes.1 passage
• Deconstruction of Interhospital Transfer Workflow in Large Vessel Occlusion: Real-World Data in the Thrombectomy Era.1 passage
• Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era.1 passage
• Decreased Adiponectin-Mediated Signaling Through the AdipoR2 Pathway Is Associated With Carotid Plaque Instability.1 passage
• Decreases in Blood Pressure During Thrombectomy Are Associated With Larger Infarct Volumes and Worse Functional Outcome.1 passage
• Deep Cerebral Perforators: Anatomical Distribution and Clinical Symptoms: An Overview.1 passage
• Deep Gray Matter Iron Deposition and Its Relationship to Clinical Features in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients: A 7.0-T Magnetic Resonance Imaging Study.1 passage
• Deep Learning Based Software to Identify Large Vessel Occlusion on Noncontrast Computed Tomography.1 passage
• Deep Learning Detection of Penumbral Tissue on Arterial Spin Labeling in Stroke.1 passage
• Deep Learning Natural Language Processing Successfully Predicts the Cerebrovascular Cause of Transient Ischemic Attack-Like Presentations.1 passage
• Deep Learning for Automated Measurement of Hemorrhage and Perihematomal Edema in Supratentorial Intracerebral Hemorrhage.1 passage
• Deep Learning-Derived High-Level Neuroimaging Features Predict Clinical Outcomes for Large Vessel Occlusion.1 passage
• Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways.1 passage
• Deferral of Consent in Acute Stroke Trials.1 passage
• Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1.1 passage
• Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.1 passage
• Defining a Target Population to Effectively Test a Neuroprotective Drug.1 passage
• Defining the ischemic penumbra using magnetic resonance oxygen metabolic index.1 passage
• Degeneration of the Inferior Cerebellar Peduncle After Middle Cerebral Artery Stroke: Another Perspective on Crossed Cerebellar Diaschisis.1 passage
• Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results.1 passage
• Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage in Patients With a History of Migraine.1 passage
• Delayed Resolution of Cerebral Edema Is Associated With Poor Outcome After Nontraumatic Subarachnoid Hemorrhage.1 passage
• Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.1 passage
• Delays in Stroke Onset to Hospital Arrival Time During COVID-19.1 passage
• Delays in the Air or Ground Transfer of Patients for Endovascular Thrombectomy.1 passage
• Delirium in an Acute Stroke Setting, Occurrence, and Risk Factors.1 passage
• Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke.1 passage
• Depressive Symptoms After Ischemic Stroke: Population-Based Comparisons of Patients and Caregivers With Matched Controls.1 passage
• Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.1 passage
• Derivation and Validation of a Novel Prognostic Scale (Modified-Stroke Subtype, Oxfordshire Community Stroke Project Classification, Age, and Prestroke Modified Rankin) to Predict Early Mortality in Acute Stroke.1 passage
• Derivo Embolization Device for the Treatment of Intracranial Aneurysms.1 passage
• Design and validation of a prehospital scale to predict stroke severity: Cincinnati Prehospital Stroke Severity Scale.1 passage
• Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).1 passage
• Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke).1 passage
• Detecting Intracranial Vessel Wall Lesions With 7T-Magnetic Resonance Imaging: Patients With Posterior Circulation Ischemia Versus Healthy Controls.1 passage
• Detection and Predictive Value of Fractional Anisotropy Changes of the Corticospinal Tract in the Acute Phase of a Stroke.1 passage
• Detection and Quantification of Symptomatic Atherosclerotic Plaques With High-Resolution Imaging in Cryptogenic Stroke.1 passage
• Detection of Advanced Lesions of Atherosclerosis in Carotid Arteries Using 3-Dimensional Motion-Sensitized Driven-Equilibrium Prepared Rapid Gradient Echo (3D-MERGE) Magnetic Resonance Imaging as a Screening Tool.1 passage
• Detection of Anterior Circulation Large Artery Occlusion in Ischemic Stroke Using Noninvasive Cerebral Oximetry.1 passage
• Detection of Large Vessel Occlusion Stroke in the Prehospital Setting: Electroencephalography as a Potential Triage Instrument.1 passage
• Detection of Left Ventricular Thrombus by Cardiac Magnetic Resonance in Embolic Stroke of Undetermined Source.1 passage
• Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication.1 passage
• Determinants in Adolescence of Stroke-Related Hospital Stay Duration in Men: A National Cohort Study.1 passage
• Determinants of Case Fatality After Hospitalization for Stroke in France 2010 to 2015.1 passage
• Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage.1 passage
• Determinants of Emergency Medical Services Utilization Among Acute Ischemic Stroke Patients in Hubei Province in China.1 passage
• Determinants of Informal Care, Burden, and Risk of Burnout in Caregivers of Stroke Survivors: The CONOCES Study.1 passage
• Determinants of Stroke in a General Male Population.1 passage
• Determinants of the Presence and Size of Intracranial Aneurysms in the General Population: The Rotterdam Study.1 passage
• Determining the Number of Ischemic Strokes Potentially Eligible for Endovascular Thrombectomy: A Population-Based Study.1 passage
• Detrimental Effect of Chronic Hypertension on Leptomeningeal Collateral Flow in Acute Ischemic Stroke.1 passage
• Development and Validation of a Bilingual Stroke Preparedness Assessment Instrument.1 passage
• Development and Validation of a Grading Scale for Primary Pontine Hemorrhage.1 passage
• Development and Validation of a Predictive Model for Functional Outcome After Stroke Rehabilitation: The Maugeri Model.1 passage
• Development and Validation of a Prognostic Tool for Direct Enteral Tube Insertion After Acute Stroke.1 passage
• Development and Validation of an Automatic Segmentation Algorithm for Quantification of Intracerebral Hemorrhage.1 passage
• Development of a Mobile Tool That Semiautomatically Screens Patients for Stroke Clinical Trials.1 passage
• Development of a Novel Prognostic Model to Predict 6-Month Swallowing Recovery After Ischemic Stroke.1 passage
• Deviation From Personalized Blood Pressure Targets Is Associated With Worse Outcome After Subarachnoid Hemorrhage.1 passage
• Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease.1 passage
• Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study.1 passage
• Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group.1 passage
• Diagnosis of Transient Ischemic Attack: Sex-Specific Differences From a Retrospective Cohort Study.1 passage
• Diagnostic Accuracy of Positive Airway Pressure Device for Sleep Apnea Detection in Acute Stroke Patients.1 passage
• Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study.1 passage
• Diagnostic Utility of Computed Tomographic Angiography in Giant-Cell Arteritis.1 passage
• Diagnostic Yield and Safety of Brain Biopsy for Suspected Primary Central Nervous System Angiitis.1 passage
• Diagnostic procedures, treatments, and outcomes in stroke patients admitted to different types of hospitals.1 passage
• Diagnostic work-up for detection of paroxysmal atrial fibrillation after acute ischemic stroke: cross-sectional survey on German stroke units.1 passage
• Dialysis Requiring Acute Kidney Injury in Acute Cerebrovascular Accident Hospitalizations.1 passage
• Diastolic Blood Pressure Is Associated With Regional White Matter Lesion Load: The Northern Manhattan Study.1 passage
• Dietary Approaches to Stop Hypertension Diet and Incidence of Stroke: Results From 2 Prospective Cohorts.1 passage
• Dietary Protein Intake and Stroke Risk in a General Japanese Population: The Hisayama Study.1 passage
• Dietary Sodium to Potassium Ratio and Risk of Stroke in a Multiethnic Urban Population: The Northern Manhattan Study.1 passage
• Dietary cysteine and other amino acids and stroke incidence in women.1 passage
• Differences Between US and UK Adults in Stroke Preparedness: Evidence From Parallel Population-Based Community Surveys.1 passage
• Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization.1 passage
• Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage.1 passage
• Differences in Brain Areas Affecting Language Function After Stroke.1 passage
• Differences in Characteristics and Outcomes Between Asian and Non-Asian Patients in the TIAregistry.org.1 passage
• Differences in Common Genetic Predisposition to Ischemic Stroke by Age and Sex.1 passage
• Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin.1 passage
• Different Imaging Strategies in Patients With Possible Basilar Artery Occlusion: Cost-Effectiveness Analysis.1 passage
• Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial.1 passage
• Differential Effect of White-Matter Lesions and Covert Brain Infarcts on the Risk of Ischemic Stroke and Intracerebral Hemorrhage.1 passage
• Differential Impact of Risk Factors on Stroke Occurrence Among Men Versus Women in West Africa.1 passage
• Differential Vascular Pathophysiologic Types of Intracranial Atherosclerotic Stroke: A High-Resolution Wall Magnetic Resonance Imaging Study.1 passage
• Differential effect of B-vitamin therapy by antiplatelet use on risk of recurrent vascular events after stroke.1 passage
• Differentiating Childhood Stroke From Mimics in the Emergency Department.1 passage
• Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage and Risk of Stroke: A MISTIE III and ATACH-2 Analysis.1 passage
• Direct Mechanical Intervention Versus Bridging Therapy in Stroke Patients Eligible for Intravenous Thrombolysis: A Pooled Analysis of 2 Registries.1 passage
• Direct Mechanical Intervention Versus Combined Intravenous and Mechanical Intervention in Large Artery Anterior Circulation Stroke: A Matched-Pairs Analysis.1 passage
• Direct Transfer to Angio-Suite Versus Computed Tomography-Transit in Patients Receiving Mechanical Thrombectomy: A Randomized Trial.1 passage
• Direct Transfer to Angio-Suite to Reduce Workflow Times and Increase Favorable Clinical Outcome.1 passage
• Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation.1 passage
• Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.1 passage
• Discharge Disposition After Stroke in Patients With Liver Disease.1 passage
• Disconnectomics of the Rich Club Impacts Motor Recovery After Stroke.1 passage
• Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.1 passage
• Disentangling Sex Differences in Use of Reperfusion Therapy in Patients With Acute Ischemic Stroke.1 passage
• Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.1 passage
• Disparities and Trends in Door-to-Needle Time: The FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).1 passage
• Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.1 passage
• Disparities in the Use of Seizure Medications After Intracerebral Hemorrhage.1 passage
• Disrupted Rest-Activity Rhythms and Cerebral Small Vessel Disease Pathology in Older Adults.1 passage
• Dissociation of Early and Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Distance to thrombus in acute middle cerebral artery occlusion: a predictor of outcome after intravenous thrombolysis for acute ischemic stroke.1 passage
• Distinct Hippocampal Subfields Atrophy in Older People With Vascular Brain Injuries.1 passage
• Distinct Short-Term Outcomes in Patients With Mild Versus Rapidly Improving Stroke Not Treated With Thrombolytics.1 passage
• Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes: A Systematic Review and Meta-Analysis.1 passage
• Distribution of Lacunar Infarcts in Asians With Intracerebral Hemorrhage: A Magnetic Resonance Imaging and Amyloid Positron Emission Tomography Study.1 passage
• Distributions of Subclinical Cardiovascular Disease in a Socioeconomically and Racially Diverse Sample.1 passage
• Diurnal Variations in the First 24/7 Mobile Stroke Unit.1 passage
• Do Cerebral Small Vessel Disease and Multiple Sclerosis Share Common Mechanisms of White Matter Injury?1 passage
• Do Clinicians Overestimate the Severity of Intracerebral Hemorrhage?1 passage
• Do Intracerebral Hemorrhage Nonexpanders Actually Expand Into the Ventricular Space?1 passage
• Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?1 passage
• Do Women With Atrial Fibrillation Experience More Severe Strokes? Results From the Austrian Stroke Unit Registry.1 passage
• Documentation of Improved Outcomes for Intracranial Aneurysm Management Over a 15-Year Interval.1 passage
• Does Admission to Hospital Affect Trends in Survival and Dependency After Stroke Using the South London Stroke Register?1 passage
• Does Chronic Kidney Disease Predict Stroke Risk Independent of Blood Pressure?: A Systematic Review and Meta-Regression.1 passage
• Does Contralesional Hand Function After Neonatal Stroke Only Depend on Lesion Characteristics?1 passage
• Does Device Selection Impact Recanalization Rate and Neurological Outcome?: An Analysis of the Save ChildS Study.1 passage
• Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?1 passage
• Does Intravenous Thrombolysis Within 4.5 to 9 Hours Increase Clot Migration Leading to Endovascular Inaccessibility?1 passage
• Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke?1 passage
• Does Small Vessel Disease Burden Impact Collateral Circulation in Ischemic Stroke Treated by Mechanical Thrombectomy?1 passage
• Does Stroke Contribute to Racial Differences in Cognitive Decline?1 passage
• Does b1000-b0 Mismatch Challenge Diffusion-Weighted Imaging-Fluid Attenuated Inversion Recovery Mismatch in Stroke?1 passage
• Does respiratory muscle training improve cough flow in acute stroke? Pilot randomized controlled trial.1 passage
• Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?1 passage
• Dolichoectasia and Small Vessel Disease in Young Patients With Transient Ischemic Attack and Stroke.1 passage
• Door-in-Door-Out Time at Primary Stroke Centers May Predict Outcome for Emergent Large Vessel Occlusion Patients.1 passage
• Door-in-Door-Out Time of 60 Minutes for Stroke With Emergent Large Vessel Occlusion at a Primary Stroke Center.1 passage
• Door-to-Imaging Time for Acute Stroke Patients Is Adversely Affected by Emergency Department Crowding.1 passage
• Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach.1 passage
• Dorsal Medullary Infarction: Distinct Syndrome of Isolated Central Vestibulopathy.1 passage
• Dosage Matters.1 passage
• Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis.1 passage
• Dose-Dependent Effect of Statin Pretreatment on Preventing the Periprocedural Complications of Carotid Artery Stenting.1 passage
• Drinking Patterns and Risk of Ischemic Stroke in Middle-Aged Adults: Do Beneficial Drinking Habits Indeed Exist?1 passage
• Drip 'n Ship Versus Mothership for Endovascular Treatment: Modeling the Best Transportation Options for Optimal Outcomes.1 passage
• Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes.1 passage
• Drugs Associated With Ischemic Stroke: A Review for Clinicians.1 passage
• Dual Antiplatelet Therapy Improves Functional Outcome in Patients With Progressive Lacunar Strokes.1 passage
• Dual Versus Mono Antiplatelet Therapy in Large Atherosclerotic Stroke.1 passage
• Dual-Task Exercise Reduces Cognitive-Motor Interference in Walking and Falls After Stroke.1 passage
• Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis.1 passage
• Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.1 passage
• Dynamic Arterial Compression in Pediatric Vertebral Arterial Dissection.1 passage
• Dynamic Cerebral Autoregulation Is an Independent Functional Outcome Predictor of Mild Acute Ischemic Stroke.1 passage
• Dynamic Detection of Delayed Cerebral Ischemia: A Study in 3 Centers.1 passage
• Dynamic Evolution of Diffusion-Weighted Imaging Lesions in Patients With Minor Ischemic Stroke.1 passage
• Dynamic Magnetic Resonance Angiography Provides Collateral Circulation and Hemodynamic Information in Acute Ischemic Stroke.1 passage
• Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis.1 passage
• Dynamic Regional Brain Atrophy Rates in the First Year After Ischemic Stroke.1 passage
• Dysbiosis of Gut Microbiome Is Associated With Rupture of Cerebral Aneurysms.1 passage
• ERASER.1 passage
• Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.1 passage
• Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients.1 passage
• Early Cerebral Vein After Endovascular Ischemic Stroke Treatment Predicts Symptomatic Reperfusion Hemorrhage.1 passage
• Early Detection and Quantification of Cerebral Venous Thrombosis by Magnetic Resonance Black-Blood Thrombus Imaging.1 passage
• Early Dysphagia Screening by Trained Nurses Reduces Pneumonia Rate in Stroke Patients: A Clinical Intervention Study.1 passage
• Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source.1 passage
• Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients With Symptomatic Stenosis of the Internal Carotid Artery: Results From 4 Randomized Controlled Trials.1 passage
• Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator-Ineligible Patients.1 passage
• Early Fiber Number Ratio Is a Surrogate of Corticospinal Tract Integrity and Predicts Motor Recovery After Stroke.1 passage
• Early Fibrinogen Depletion and Symptomatic Intracranial Hemorrhage After Reperfusion Therapy.1 passage
• Early Imaging Prediction of Malignant Cerebellar Edema Development in Acute Ischemic Stroke.1 passage
• Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes: Analysis From the SELECT Study.1 passage
• Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.1 passage
• Early Loss of Immediate Reperfusion While Stent Retriever in Place Predicts Successful Final Reperfusion in Acute Ischemic Stroke Patients.1 passage
• Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage: Individual Patient Data Meta-Analysis.1 passage
• Early Magnetic Resonance Imaging and Cognitive Markers of Hereditary Cerebral Amyloid Angiopathy.1 passage
• Early Mobilization After Stroke Is Not Associated With Cognitive Outcome.1 passage
• Early NT-ProBNP (N-Terminal Probrain Natriuretic Peptide) Elevation Predicts Malignant Edema and Death After Reperfusion Therapy in Acute Ischemic Stroke Patients.1 passage
• Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome.1 passage
• Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease.1 passage
• Early Prediction of Delayed Ischemia and Functional Outcome in Acute Subarachnoid Hemorrhage: Role of Diffusion Tensor Imaging.1 passage
• Early Prediction of Malignant Brain Edema After Ischemic Stroke.1 passage
• Early Recanalization With Alteplase in Stroke Because of Large Vessel Occlusion in the ESCAPE Trial.1 passage
• Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation.1 passage
• Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study.1 passage
• Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.1 passage
• Early Supported Discharge by Caregiver-Mediated Exercises and e-Health Support After Stroke: A Proof-of-Concept Trial.1 passage
• Early Thrombectomy Protects the Internal Capsule in Patients With Proximal Middle Cerebral Artery Occlusion.1 passage
• Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times).1 passage
• Early outcomes after carotid artery stenting compared with endarterectomy for asymptomatic carotid stenosis.1 passage
• Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.1 passage
• Echoing Plaque Activity of the Coronary and Intracranial Arteries in Patients With Stroke.1 passage
• Economic Evaluation of Endovascular Treatment for Acute Ischemic Stroke.1 passage
• Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.1 passage
• Edaravone Reduces Hyperperfusion-Related Neurological Deficits in Adult Moyamoya Disease: Historical Control Study.1 passage
• Educating Paramedics on the Finger-to-Nose Test Improves Recognition of Posterior Stroke.1 passage
• Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods.1 passage
• Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial.1 passage
• Effect of Adjusted Antiplatelet Therapy on Preventing Ischemic Events After Stenting for Intracranial Aneurysms.1 passage
• Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.1 passage
• Effect of Antihypertensive Medication on Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.1 passage
• Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis.1 passage
• Effect of COVID-19 on Emergent Stroke Care: A Regional Experience.1 passage
• Effect of Cognitive Reserve on Risk of Cognitive Impairment and Recovery After Stroke: The KOSCO Study.1 passage
• Effect of Cumulative Case Volume on Procedural and Clinical Outcomes in Endovascular Thrombectomy.1 passage
• Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial.1 passage
• Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke.1 passage
• Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke.1 passage
• Effect of Enzyme Replacement Therapy on Basilar Artery Diameter in Male Patients With Fabry Disease.1 passage
• Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).1 passage
• Effect of Exercise Interventions on Health-Related Quality of Life After Stroke and Transient Ischemic Attack: A Systematic Review and Meta-Analysis.1 passage
• Effect of Exhaust- and Nonexhaust-Related Components of Particulate Matter on Long-Term Survival After Stroke.1 passage
• Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke.1 passage
• Effect of Heart Rate Variability on the Association Between the Apnea-Hypopnea Index and Cerebral Small Vessel Disease.1 passage
• Effect of Heart Rate on Stroke Recurrence and Mortality in Acute Ischemic Stroke With Atrial Fibrillation.1 passage
• Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.1 passage
• Effect of Interhospital Transfer on Endovascular Treatment for Acute Ischemic Stroke.1 passage
• Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.1 passage
• Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis.1 passage
• Effect of Long-Term Vascular Care on Progression of Cerebrovascular Lesions: Magnetic Resonance Imaging Substudy of the PreDIVA Trial (Prevention of Dementia by Intensive Vascular Care).1 passage
• Effect of Moderate and Severe Persistent Hyperglycemia on Outcomes in Patients With Intracerebral Hemorrhage.1 passage
• Effect of Osteoporotic Condition on Ventriculomegaly and Shunt-Dependent Hydrocephalus After Subarachnoid Hemorrhage.1 passage
• Effect of Pre- and In-Hospital Delay on Reperfusion in Acute Ischemic Stroke Mechanical Thrombectomy.1 passage
• Effect of Recanalization on Cerebral Edema in Ischemic Stroke Treated With Thrombolysis and/or Endovascular Therapy.1 passage
• Effect of Right Insular Involvement on Death and Functional Outcome After Acute Ischemic Stroke in the IST-3 Trial (Third International Stroke Trial).1 passage
• Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.1 passage
• Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men.1 passage
• Effect of Steady and Dynamic Blood Pressure Parameters During Thrombectomy According to the Collateral Status.1 passage
• Effect of Workflow Improvements in Endovascular Stroke Treatment.1 passage
• Effect of a broad-specificity chemokine-binding protein on brain leukocyte infiltration and infarct development.1 passage
• Effect of patching on reducing restenosis in the carotid revascularization endarterectomy versus stenting trial.1 passage
• Effect of public awareness campaigns on calls to ambulance across Australia.1 passage
• Effect of seasonal and monthly variation in weather and air pollution factors on stroke incidence in Seoul, Korea.1 passage
• Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.1 passage
• Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.1 passage
• Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.1 passage
• Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.1 passage
• Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.1 passage
• Effectiveness of an Intervention to Improve Risk Factor Knowledge in Patients With Stroke: A Randomized Controlled Trial.1 passage
• Effectiveness of diagnostic strategies in suspected delayed cerebral ischemia: a decision analysis.1 passage
• Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.1 passage
• Effects of Arterial Stiffness on Brain Integrity in Young Adults From the Framingham Heart Study.1 passage
• Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke.1 passage
• Effects of Blood Pressure in the Early Phase of Ischemic Stroke and Stroke Subtype on Poststroke Cognitive Impairment.1 passage
• Effects of Centralizing Acute Stroke Services on Stroke Care Provision in Two Large Metropolitan Areas in England.1 passage
• Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial.1 passage
• Effects of Collateral Status on Infarct Distribution Following Endovascular Therapy in Large Vessel Occlusion Stroke.1 passage
• Effects of Electrical Stimulation in Spastic Muscles After Stroke: Systematic Review and Meta-Analysis of Randomized Controlled Trials.1 passage
• Effects of Exercise Therapy on Balance Capacity in Chronic Stroke: Systematic Review and Meta-Analysis.1 passage
• Effects of Hypothetical Interventions on Ischemic Stroke Using Parametric G-Formula.1 passage
• Effects of Induced Hypertension on Cerebral Perfusion in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.1 passage
• Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease.1 passage
• Effects of Physical Activity on Poststroke Cognitive Function: A Meta-Analysis of Randomized Controlled Trials.1 passage
• Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency.1 passage
• Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke.1 passage
• Effects of a Disease Management Program for Preventing Recurrent Ischemic Stroke.1 passage
• Effects of a Feedback-Demanding Stroke Clock on Acute Stroke Management: A Randomized Study.1 passage
• Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke.1 passage
• Effects of prostacyclin on cerebral blood flow and vasospasm after subarachnoid hemorrhage: randomized, pilot trial.1 passage
• Effects of stroke education of junior high school students on stroke knowledge of their parents: Tochigi project.1 passage
• Efficacy and Safety of Individualized Coaching After Stroke: the LAST Study (Life After Stroke): A Pragmatic Randomized Controlled Trial.1 passage
• Efficacy and Safety of Recanalization Therapy for Acute Ischemic Stroke With Large Vessel Occlusion: A Systematic Review.1 passage
• Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis.1 passage
• Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.1 passage
• Efficacy of Clopidogrel for Prevention of Stroke Based on1 passage
• Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in1 passage
• Efficacy of Endovascular Therapy in Acute Ischemic Stroke Depends on Age and Clinical Severity.1 passage
• Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study.1 passage
• Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke).1 passage
• Efficacy of Upper Extremity Robotic Therapy in Subacute Poststroke Hemiplegia: An Exploratory Randomized Trial.1 passage
• Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.1 passage
• Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.1 passage
• Electrocardiographic ST-T Abnormities Are Associated With Stroke Risk in the REGARDS Study.1 passage
• Electrocardiomatrix Facilitates Accurate Detection of Atrial Fibrillation in Stroke Patients.1 passage
• Electroencephalography Might Improve Diagnosis of Acute Stroke and Large Vessel Occlusion.1 passage
• Elevated International Normalized Ratio Is Associated With Ruptured Aneurysms.1 passage
• Elevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy.1 passage
• Elevated Neutrophil and Presence of Intracranial Artery Stenosis Increase the Risk of Recurrent Stroke.1 passage
• Elevated Plasma D-Dimer Level Is Associated With Short-Term Risk of Ischemic Stroke in Patients With Acute Heart Failure.1 passage
• Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality.1 passage
• Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.1 passage
• Eligibility and Predictors for Acute Revascularization Procedures in a Stroke Center.1 passage
• Eligibility for Endovascular Trial Enrollment in the 6- to 24-Hour Time Window: Analysis of a Single Comprehensive Stroke Center.1 passage
• Elucidating the Structural and Functional Correlates of Upper-Limb Poststroke Motor Impairment.1 passage
• Embolic Stroke of Undetermined Source and Sleep Disorders.1 passage
• Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.1 passage
• Embolic Stroke of Undetermined Source: Approaches in Risk Stratification for Cardioembolism.1 passage
• Embolic Strokes of Undetermined Source in the Athens Stroke Registry: An Outcome Analysis.1 passage
• Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis.1 passage
• Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.1 passage
• Emergency Department Door-to-Puncture Time Since 2014.1 passage
• Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist.1 passage
• Emergent Carotid Stenting Plus Thrombectomy After Thrombolysis in Tandem Strokes: Analysis of the TITAN Registry.1 passage
• Emergent Large Vessel Occlusion Screen Is an Ideal Prehospital Scale to Avoid Missing Endovascular Therapy in Acute Stroke.1 passage
• Emergent Large Vessel Occlusion Stroke During New York City's COVID-19 Outbreak: Clinical Characteristics and Paraclinical Findings.1 passage
• Emergent Management of Tandem Lesions in Acute Ischemic Stroke.1 passage
• Emerging Risk Factors for Recurrent Vascular Events in Patients With Embolic Stroke of Undetermined Source.1 passage
• Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.1 passage
• Emphysema: A Potential Risk Factor for Subarachnoid Hemorrhage and Ruptured Aortic Aneurysm1 passage
• Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients.1 passage
• End-of-Treatment Intracerebral and Ventricular Hemorrhage Volume Predicts Outcome: A Secondary Analysis of MISTIE III.1 passage
• Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition.1 passage
• Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19.1 passage
• Endothelial Progenitor Cell Secretome and Oligovascular Repair in a Mouse Model of Prolonged Cerebral Hypoperfusion.1 passage
• Endovascular Hypothermia in Acute Ischemic Stroke: Pilot Study of Selective Intra-Arterial Cold Saline Infusion.1 passage
• Endovascular Intervention Versus Surgery in Ruptured Intracranial Aneurysms in Equipoise: A Systematic Review.1 passage
• Endovascular Recanalization for Nonacute Intracranial Vertebral Artery Occlusion According to a New Classification.1 passage
• Endovascular Stroke Therapy Trends From 2011 to 2017 Show Significant Improvement in Clinical and Economic Outcomes.1 passage
• Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients.1 passage
• Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.1 passage
• Endovascular Therapy for Stroke due to Basilar Artery Occlusion: A BASIC Challenge at BEST.1 passage
• Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset: A Real-World Experience.1 passage
• Endovascular Thrombectomy for Acute Ischemic Strokes: Current US Access Paradigms and Optimization Methodology.1 passage
• Endovascular Thrombectomy for Anterior Circulation Stroke: Systematic Review and Meta-Analysis.1 passage
• Endovascular Thrombectomy for Mild Strokes: How Low Should We Go?1 passage
• Endovascular Thrombectomy for Treatment of Acute Ischemic Stroke During Pregnancy and the Early Postpartum Period.1 passage
• Endovascular Thrombectomy in Young Patients With Stroke: A MR CLEAN Registry Study.1 passage
• Endovascular Thrombectomy.1 passage
• Endovascular Treatment for Acute Ischemic Stroke in Children: Experience From the MR CLEAN Registry.1 passage
• Endovascular Treatment for Acute Ischemic Stroke in Patients on Oral Anticoagulants: Results From the MR CLEAN Registry.1 passage
• Endovascular Treatment for Acute Ischemic Stroke in the Setting of Anticoagulation.1 passage
• Endovascular Treatment for Posterior Circulation Stroke in Routine Clinical Practice: Results of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry.1 passage
• Endovascular Treatment in the DEFUSE 3 Study.1 passage
• Endovascular Treatment of Acute Ischemic Stroke With the Penumbra System in Routine Practice: COMPLETE Registry Results.1 passage
• Endovascular Treatment: The Role of Dominant Caliber M2 Segment Occlusion in Ischemic Stroke.1 passage
• Endovascular clot retrieval therapy: implications for the organization of stroke systems of care in North America.1 passage
• Enhanced Detection of Edema in Malignant Anterior Circulation Stroke (EDEMA) Score: A Risk Prediction Tool.1 passage
• Enhanced Effective Connectivity Between Primary Motor Cortex and Intraparietal Sulcus in Well-Recovered Stroke Patients.1 passage
• Enhanced interhemispheric functional connectivity compensates for anatomical connection damages in subcortical stroke.1 passage
• Enlightenment and Challenges Offered by DAWN Trial (DWI or CTP Assessment With Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo).1 passage
• Enrollment Yield and Reasons for Screen Failure in a Large Prehospital Stroke Trial.1 passage
• Eosinophil Cationic Protein, Carotid Plaque, and Incidence of Stroke.1 passage
• Epidemiological Surveillance of the Impact of the COVID-19 Pandemic on Stroke Care Using Artificial Intelligence.1 passage
• Epidemiology of Transient Ischemic Attacks Using Time- or Tissue-Based Definitions: A Population-Based Study.1 passage
• Epigenome-Wide Association Study Indicates Hypomethylation of MTRNR2L8 in Large-Artery Atherosclerosis Stroke.1 passage
• Erythrocyte Fraction Within Retrieved Thrombi Contributes to Thrombolytic Response in Acute Ischemic Stroke.1 passage
• Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease.1 passage
• Establishing Recommendations for Stroke Systems in the Thrombectomy Era: The Upstate New York Stakeholder Proceedings.1 passage
• Establishing the first mobile stroke unit in the United States.1 passage
• Estimated Impact of Emergency Medical Service Triage of Stroke Patients on Comprehensive Stroke Centers: An Urban Population-Based Study.1 passage
• Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging.1 passage
• Estimating Weight of Patients With Acute Stroke When Dosing for Thrombolysis.1 passage
• Estimating the Risks of Adverse Radiation Effects After Gamma Knife Radiosurgery for Arteriovenous Malformations.1 passage
• Estimation of Ischemic Core Volume Using Computed Tomographic Perfusion.1 passage
• Ethnic Comparison of 30-Day Potentially Preventable Readmissions After Stroke in Hawaii.1 passage
• Ethnic Comparison of Clinical Characteristics and Ischemic Stroke Subtypes Among Young Adult Patients With Stroke in Hawaii.1 passage
• Ethnic Differences in 90-Day Poststroke Medication Adherence.1 passage
• Ethnic Differences in Poststroke Quality of Life in the Brain Attack Surveillance in Corpus Christi (BASIC) Project.1 passage
• Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.1 passage
• Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.1 passage
• Etiological Subtypes of Transient Ischemic Attack and Ischemic Stroke in Chronic Kidney Disease: Population-Based Study.1 passage
• European Multicenter Study of ET-COVID-19.1 passage
• Evaluating Hematoma Expansion Scores in Acute Spontaneous Intracerebral Hemorrhage: A Systematic Scoping Review.1 passage
• Evaluation of Diffusion Lesion Volume Measurements in Acute Ischemic Stroke Using Encoder-Decoder Convolutional Network.1 passage
• Evaluation of a telephone advice system for remote intravenous thrombolysis in ischemic stroke: data from a United kingdom network.1 passage
• Evaluation of an Extended Stroke Rehabilitation Service (EXTRAS): A Randomized Controlled Trial and Economic Analysis.1 passage
• Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke: Meta-Analysis of 5 Randomized Trials.1 passage
• Evolution of a US County System for Acute Comprehensive Stroke Care.1 passage
• Examining Barriers and Practices to Recruitment and Retention in Stroke Clinical Trials.1 passage
• Examining Differences in Patterns of Sensory and Motor Recovery After Stroke With Robotics.1 passage
• Excess Cerebrovascular Mortality in the United States During the COVID-19 Pandemic.1 passage
• Executive Function Declines in the First 6 Months After a Transient Ischemic Attack or Transient Neurological Attack.1 passage
• Exome Array Analysis of Early-Onset Ischemic Stroke.1 passage
• Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging.1 passage
• Exploratory longitudinal cohort study of associations of fatigue after stroke.1 passage
• Exploring Factors Contributing to Race Differences in Poststroke Disability.1 passage
• Exploring Reperfusion Following Endovascular Thrombectomy.1 passage
• Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom.1 passage
• Extent to Which Network Hubs Are Affected by Ischemic Stroke Predicts Cognitive Recovery.1 passage
• External Performance of the HAVOC Score for the Prediction of New Incident Atrial Fibrillation.1 passage
• External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers.1 passage
• External Validation of Risk Prediction Models to Improve Selection of Patients for Carotid Endarterectomy.1 passage
• External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients.1 passage
• External Validation of the ASTRAL and DRAGON Scores for Prediction of Functional Outcome in Stroke.1 passage
• Extracellular Mitochondria in Cerebrospinal Fluid and Neurological Recovery After Subarachnoid Hemorrhage.1 passage
• Extreme Phenotype Approach Suggests Taste Transduction Pathway for Carotid Plaque in a Multi-Ethnic Cohort.1 passage
• Extubation Readiness in Critically Ill Stroke Patients.1 passage
• FABS: An Intuitive Tool for Screening of Stroke Mimics in the Emergency Department.1 passage
• FADD (Fas-Associated Protein With Death Domain), Caspase-3, and Caspase-8 and Incidence of Ischemic Stroke.1 passage
• Factors Associated With 90-Day Readmission After Stroke or Transient Ischemic Attack: Linked Data From the Australian Stroke Clinical Registry.1 passage
• Factors Associated With Focal Computed Tomographic Perfusion Abnormalities in Supratentorial Transient Ischemic Attacks.1 passage
• Factors Associated With Ischemic Stroke Survival and Recovery in Older Adults.1 passage
• Factors Associated With Participation in the Chronic Disease Self-Management Program: Findings From the SUCCEED Trial.1 passage
• Factors Associated With Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial.1 passage
• Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic Stroke.1 passage
• Factors influencing sex differences in poststroke functional outcome.1 passage
• Familial Risk for Moyamoya Disease Among First-Degree Relatives, Based on a Population-Based Aggregation Study in Korea.1 passage
• Family History and Risk of Recurrent Stroke.1 passage
• Family History in Young Patients With Stroke.1 passage
• Farmalarm.1 passage
• Fast Automatic Detection of Large Vessel Occlusions on CT Angiography.1 passage
• Fast Outcome Categorization of the Upper Limb After Stroke.1 passage
• Fatal Stroke in Pregnancy and the Puerperium.1 passage
• Favorable Venous Outflow Profiles Correlate With Favorable Tissue-Level Collaterals and Clinical Outcome.1 passage
• Feasibility and Diagnostic Value of Cardiovascular Magnetic Resonance Imaging After Acute Ischemic Stroke of Undetermined Origin.1 passage
• Feasibility of Multiple Burr Hole With Erythropoietin in Acute Moyamoya Patients.1 passage
• Feasibility of Thrombectomy in Treating Acute Ischemic Stroke Because of Cervical Artery Dissection.1 passage
• Feasibility platform for stroke studies: an online tool to improve eligibility criteria for clinical trials.1 passage
• Features and Determinants of Lacune Shape: Relationship With Fiber Tracts and Perforating Arteries.1 passage
• Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin.1 passage
• Female Stroke: Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic Stroke.1 passage
• Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.1 passage
• Fibrin and Platelet-Rich Composition in Retrieved Thrombi Hallmarks Stroke With Active Cancer.1 passage
• Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.1 passage
• Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage: Nested Case-Control Study.1 passage
• Fibroblast growth factor 23 and risk of incident stroke in community-living adults.1 passage
• Field Assessment Stroke Triage for Emergency Destination: A Simple and Accurate Prehospital Scale to Detect Large Vessel Occlusion Strokes.1 passage
• Field Validation of the Los Angeles Motor Scale as a Tool for Paramedic Assessment of Stroke Severity.1 passage
• First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?1 passage
• First Pass Effect With Neurothrombectomy for Acute Ischemic Stroke: Analysis of the Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke Registry.1 passage
• First Pass Effect: A New Measure for Stroke Thrombectomy Devices.1 passage
• First Year After Stroke: An Integrated Approach Focusing on Participation Goals Aiming to Reduce Depressive Symptoms.1 passage
• First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.1 passage
• First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina.1 passage
• First-Pass Effect in Basilar Artery Occlusions: Insights From the Endovascular Treatment of Ischemic Stroke Registry.1 passage
• Five-Year Mortality After Transient Ischemic Attack: Focus on Cardiometabolic Comorbidity and Hospital Readmission.1 passage
• Five-Year Outcome in Stroke Patients Submitted to Thrombolysis.1 passage
• Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage.1 passage
• Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke.1 passage
• Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study.1 passage
• Flat Panel Computed Tomography Pooled Blood Volume and Infarct Prediction in Endovascular Stroke Treatment.1 passage
• Flow Diverter Therapy With the Pipeline Embolization Device Is Associated With an Elevated Rate of Delayed Fluid-Attenuated Inversion Recovery Lesions.1 passage
• Flow Diverters for Intracranial Aneurysms: The DIVERSION National Prospective Cohort Study.1 passage
• Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection.1 passage
• Fluid-Attenuated Inversion Recovery Vascular Hyperintensities-Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization.1 passage
• Fluid-Attenuated Inversion Recovery Vascular Hyperintensity Topography, Novel Imaging Marker for Revascularization in Middle Cerebral Artery Occlusion.1 passage
• Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial.1 passage
• Focal Cerebral Arteriopathy in Young Adult Patients With Stroke.1 passage
• Focal Cerebral Arteriopathy of Childhood: Novel Severity Score and Natural History.1 passage
• Focal Cerebral Arteriopathy: Do Steroids Improve Outcome?1 passage
• Focal Macroscopic Cortical Lesions in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.1 passage
• Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.1 passage
• For-Profit Hospital Status and Carotid Artery Stent Utilization in US Hospitals Performing Carotid Revascularization.1 passage
• Four-year follow-up of transient ischemic attacks, strokes, and mimics: a retrospective transient ischemic attack clinic cohort study.1 passage
• Frequency and Impact of Cerebral Infarctions in Patients With Tuberculous Meningitis.1 passage
• Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial.1 passage
• Frequency and Predictors of Dysphagia in Patients With Recent Small Subcortical Infarcts.1 passage
• Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial.1 passage
• Frequency and Prognostic Significance of Clinical Fluctuations Before Hospital Arrival in Stroke.1 passage
• Frequency of Blood-Brain Barrier Disruption Post-Endovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients.1 passage
• Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke.1 passage
• Frequency, Characteristics, and Outcomes of Endovascular Thrombectomy in Patients With Stroke Beyond 6 Hours of Onset in US Clinical Practice.1 passage
• Frequent Cognitive Impairment in Patients With Disorders Along the Heart-Brain Axis.1 passage
• From Perviousness to Plaque Imaging in Acute Basilar Occlusions: The Impact of Underlying Stenosis and How to Detect It.1 passage
• Frontal networks associated with command following after hemorrhagic stroke.1 passage
• Fully Automated Segmentation Algorithm for Hematoma Volumetric Analysis in Spontaneous Intracerebral Hemorrhage.1 passage
• Fully Automated Segmentation Algorithm for Perihematomal Edema Volumetry After Spontaneous Intracerebral Hemorrhage.1 passage
• Functional Gain After Inpatient Stroke Rehabilitation: Correlates and Impact on Long-Term Survival.1 passage
• Functional Outcome Following Stroke Thrombectomy in Clinical Practice.1 passage
• Functional Trajectories, Cognition, and Subclinical Cerebrovascular Disease.1 passage
• Functional and motor outcome 5 years after stroke is equivalent to outcome at 2 months: follow-up of the collaborative evaluation of rehabilitation in stroke across Europe.1 passage
• Functional outcome after common poststroke complications occurring in the first 90 days.1 passage
• Futile Interhospital Transfer for Endovascular Treatment in Acute Ischemic Stroke: The Madrid Stroke Network Experience.1 passage
• GPR68 Is a Neuroprotective Proton Receptor in Brain Ischemia.1 passage
• GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke.1 passage
• Gait measures as predictors of poststroke cognitive function: evidence from the TABASCO study.1 passage
• Gait-Synchronized Rhythmic Brain Stimulation Improves Poststroke Gait Disturbance: A Pilot Study.1 passage
• Gastrointestinal Disorders and Risk of First-Ever Ischemic Stroke.1 passage
• General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke.1 passage
• General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke).1 passage
• Genes from a translational analysis support a multifactorial nature of white matter hyperintensities.1 passage
• Genetic Architecture of Lacunar Stroke.1 passage
• Genetic Associations With White Matter Hyperintensities Confer Risk of Lacunar Stroke.1 passage
• Genetic Determinants of Unruptured Intracranial Aneurysms in the General Population.1 passage
• Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke.1 passage
• Genetic Factors Influencing Coagulation Factor XIII B-Subunit Contribute to Risk of Ischemic Stroke.1 passage
• Genetic Imbalance Is Associated With Functional Outcome After Ischemic Stroke.1 passage
• Genetic Predisposition to Ischemic Stroke: A Polygenic Risk Score.1 passage
• Genetic Study of White Matter Integrity in UK Biobank (N=8448) and the Overlap With Stroke, Depression, and Dementia.1 passage
• Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic stroke.1 passage
• Genetic overlap between diagnostic subtypes of ischemic stroke.1 passage
• Genetic study of intracranial aneurysms.1 passage
• Genetically Determined FXI (Factor XI) Levels and Risk of Stroke.1 passage
• Genetically Determined Risk of Depression and Functional Outcome After Ischemic Stroke.1 passage
• Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2.1 passage
• Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke.1 passage
• Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke.1 passage
• Genome-Wide Polygenic Score and the Risk of Ischemic Stroke in a Prospective Cohort: The Hisayama Study.1 passage
• Geographic Modeling to Quantify the Impact of Primary and Comprehensive Stroke Center Destination Policies.1 passage
• Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation.1 passage
• Geographic and Regional Variability in Racial and Ethnic Disparities in Stroke Thrombolysis in the United States.1 passage
• Global Assessment of Mendelian Stroke Genetic Prevalence in 101 635 Individuals From 7 Ethnic Groups.1 passage
• Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.1 passage
• Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry.1 passage
• Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis.1 passage
• Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke.1 passage
• Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.1 passage
• Goal Setting Improves Cognitive Performance in a Randomized Trial of Chronic Stroke Survivors.1 passage
• Good Clinical Outcome Decreases With Number of Retrieval Attempts in Stroke Thrombectomy: Beyond the First-Pass Effect.1 passage
• Good Intracranial Collaterals Trump Poor ASPECTS (Alberta Stroke Program Early CT Score) for Intravenous Thrombolysis in Anterior Circulation Acute Ischemic Stroke.1 passage
• Googling Service Boundaries for Endovascular Clot Retrieval Hub Hospitals in a Metropolitan Setting: Proof-of-Concept Study.1 passage
• Green Tea and Coffee Consumption and All-Cause Mortality Among Persons With and Without Stroke or Myocardial Infarction.1 passage
• Group, Department of Clinical Neurosciences, University of Cambridge, United Kingdom (A.M.D., R.Y.Y.T., J.T., M.T., H.S.M.)2 Department of Radiology, Cambridge University23 passages
• Group, University of Cambridge, United Kingdom.Correspondence to22 passages
• Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• HEADS-UP: Understanding and Problem-Solving: Seeking Hands-Down Solutions to Major Inequities in Stroke.1 passage
• Haptoglobin Hp2 Variant Promotes Premature Cardiovascular Death in Stroke Survivors.1 passage
• Has Outcome of Subarachnoid Hemorrhage Changed With Improvements in Neurosurgical Services?1 passage
• Headache Outcomes After Treatment of Unruptured Intracranial Aneurysm: A Systematic Review and Meta-Analysis.1 passage
• Health-Related Quality of Life in Young Adults Following Pediatric Arterial Ischemic Stroke.1 passage
• Heart Failure in Ischemic Stroke: Relevance for Acute Care and Outcome.1 passage
• Heart Rate Variability and Incident Stroke: The Atherosclerosis Risk in Communities Study.1 passage
• Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.1 passage
• Heme-Hemopexin Scavenging Is Active in the Brain and Associates With Outcome After Subarachnoid Hemorrhage.1 passage
• Hemodynamic Characteristics of Cerebral Arteriovenous Malformation Feeder Vessels With and Without Aneurysms.1 passage
• Hemodynamic Features of Symptomatic Vertebrobasilar Disease.1 passage
• Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.1 passage
• Hemorrhage Expansion After Pediatric Intracerebral Hemorrhage.1 passage
• Hemorrhage Risk of Brain Arteriovenous Malformations During Pregnancy and Puerperium in a North American Cohort.1 passage
• Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.1 passage
• Hemorrhagic Moyamoya Disease in Children: Clinical, Angiographic features, and Long-Term Surgical Outcome.1 passage
• Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome: Features and Mechanisms.1 passage
• Hemorrhagic Stroke Risk in Armed Forces Veterans: The Role of Post-Traumatic Stress Disorder and Its Treatment.1 passage
• Hemorrhagic Transformation After Thrombectomy for Tandem Occlusions.1 passage
• Hepatocyte Growth Factor Is Positively Associated With Risk of Stroke: The MESA (Multi-Ethnic Study of Atherosclerosis).1 passage
• Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management.1 passage
• Heritability and Genome-Wide Association Analyses of Intracranial Carotid Artery Calcification: The Rotterdam Study.1 passage
• Heterogeneity of Cerebral White Matter Lesions and Clinical Correlates in Older Adults.1 passage
• High Admission Glucose Is Associated With Poor Outcome After Endovascular Treatment for Ischemic Stroke.1 passage
• High Dietary Inflammatory Index Is Associated With Increased Plaque Vulnerability of Carotid in Patients With Ischemic Stroke.1 passage
• High Neutrophil-to-Lymphocyte Ratio Predicts Stroke-Associated Pneumonia.1 passage
• High Serum Level of Matrix Metalloproteinase-7 Is Associated With Increased Risk of Spontaneous Subarachnoid Hemorrhage.1 passage
• High Variability in Neuronal Loss.1 passage
• High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage.1 passage
• High-Resolution Magnetic Resonance Imaging of Cervicocranial Artery Dissection: Imaging Features Associated With Stroke.1 passage
• High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial.1 passage
• High-Sensitivity CRP (C-Reactive Protein) Is Associated With Incident Carotid Artery Plaque in Chinese Aged Adults.1 passage
• High-Sensitivity Cardiac Troponin T and Cognitive Function in Patients With Ischemic Stroke.1 passage
• High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source.1 passage
• High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.1 passage
• Higher Doses Improve Walking Recovery During Stroke Inpatient Rehabilitation.1 passage
• Higher Flow Is Present in Unruptured Arteriovenous Malformations With Silent Intralesional Microhemorrhages.1 passage
• Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants.1 passage
• Higher Plaque Burden of Middle Cerebral Artery Is Associated With Recurrent Ischemic Stroke: A Quantitative Magnetic Resonance Imaging Study.1 passage
• Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.1 passage
• Higher-Quality Data Collection Is Critical to Establish the Safety and Efficacy of Pediatric Mechanical Thrombectomy.1 passage
• Histological Clot Composition Is Associated With Preinterventional Clot Migration in Acute Stroke Patients.1 passage
• Histopathologic Analysis of Retrieved Thrombi Associated With Successful Reperfusion After Acute Stroke Thrombectomy.1 passage
• Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging.1 passage
• History of Stroke Is Independently Associated With In-Hospital Death in Patients With COVID-19.1 passage
• Home-Time Is a Feasible and Valid Stroke Outcome Measure in National Datasets.1 passage
• Home-Time as a Surrogate Marker for Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.1 passage
• Homocysteine, Ischemic Stroke, and Coronary Heart Disease in Hypertensive Patients: A Population-Based, Prospective Cohort Study.1 passage
• Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men.1 passage
• Hospital Presentations in Long-Term Survivors of Stroke: Causes and Associated Factors in a Linked Data Study.1 passage
• Hospital Readmission Rates Among Mechanically Ventilated Patients With Stroke.1 passage
• Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research).1 passage
• Hospital costs associated with atrial fibrillation for patients with ischemic stroke aged 18-64 years in the United States.1 passage
• Hospitalization within the first year after stroke: the Dijon stroke registry.1 passage
• Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown.1 passage
• Hospitalized Infection as a Trigger for Acute Ischemic Stroke: The Atherosclerosis Risk in Communities Study.1 passage
• Hounsfield Unit Value of Interpeduncular Cistern Hematomas Can Predict Symptomatic Vasospasm.1 passage
• How Patient Demographics, Imaging, and Beliefs Influence Tissue-Type Plasminogen Activator Use: A Survey of North American Neurologists.1 passage
• How Well Do Neurochecks Perform After Stroke?1 passage
• How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis.1 passage
• How sustained is 24-hour diffusion-weighted imaging lesion reversal? Serial magnetic resonance imaging in a patient cohort thrombolyzed within 4.5 hours of stroke onset.1 passage
• How to Be Savvy About Gender Disparities in Academic Stroke Medicine: Five Practical Strategies.1 passage
• How to Establish the Outer Limits of Reperfusion Therapy.1 passage
• Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events.1 passage
• Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model.1 passage
• Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke.1 passage
• Hyperacute Recanalization Strategies and Childhood Stroke in the Evidence Age.1 passage
• Hyperintense Plaque on Intracranial Vessel Wall Magnetic Resonance Imaging as a Predictor of Artery-to-Artery Embolic Infarction.1 passage
• Hyperintense Vessels, Collateralization, and Functional Outcome in Patients With Stroke Receiving Endovascular Treatment.1 passage
• Hypertension Management in Stroke Prevention: Time to Consider Primary Aldosteronism.1 passage
• Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.1 passage
• Hypoperfusion Intensity Ratio Is Correlated With Patient Eligibility for Thrombectomy.1 passage
• Hypoperfusion Symptoms Poorly Predict Hemodynamic Compromise and Stroke Risk in Vertebrobasilar Disease.1 passage
• Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome.1 passage
• Hypothetical Lifestyle Strategies in Middle-Aged Women and the Long-Term Risk of Stroke.1 passage
• Hypoxic viable tissue in human chronic cerebral ischemia because of unilateral major cerebral artery steno-occlusive disease.1 passage
• ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for Brain Hemorrhage: A Multicenter Randomized Controlled Trial.1 passage
• IER-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Thrombectomy for Stroke.1 passage
• IL (Interleukin)-15 Bridges Astrocyte-Microglia Crosstalk and Exacerbates Brain Injury Following Intracerebral Hemorrhage.1 passage
• Iatrogenic Diffusion-Weighted Imaging Lesions: What Is Their Impact and How Can It Be Measured?1 passage
• Identification and Validation of Hematoma Volume Cutoffs in Spontaneous, Supratentorial Deep Intracerebral Hemorrhage.1 passage
• Identification of Corticospinal Tract Lesion for Predicting Outcome in Small Perfusion Stroke.1 passage
• Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.1 passage
• Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.1 passage
• Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [1 passage
• Identifying Patients at High Risk of Coronary Events After Stroke: A Prerequisite for Better Prevention.1 passage
• Imaging Characteristics of Growing and Ruptured Vertebrobasilar Non-Saccular and Dolichoectatic Aneurysms.1 passage
• Imaging Characteristics of Venous Parenchymal Abnormalities.1 passage
• Imaging Inflammation in Cerebrovascular Disease.1 passage
• Imaging Markers of Brain Frailty and Outcome in Patients With Acute Ischemic Stroke.1 passage
• Imaging Parameters Predict Recurrence After Transient Ischemic Attack or Minor Stroke Stratified by ABCD1 passage
• Imaging Predictors of Neurologic Outcome After Pediatric Arterial Ischemic Stroke.1 passage
• Imaging and Baseline Predictors of Cognitive Performance in Minor Ischemic Stroke and Patients With Transient Ischemic Attack at 90 Days.1 passage
• Immediate Vascular Imaging Needed for Efficient Triage of Patients With Acute Ischemic Stroke Initially Admitted to Nonthrombectomy Centers.1 passage
• Immediate and Delayed Procedural Stroke or Death in Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis.1 passage
• Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS Registry.1 passage
• Impact of Antiplatelet Therapy During Endovascular Therapy for Tandem Occlusions: A Collaborative Pooled Analysis.1 passage
• Impact of Balloon Guide Catheter Use on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry.1 passage
• Impact of Bilingualism on Cognitive Outcome After Stroke.1 passage
• Impact of Body Temperature Before and After Endovascular Thrombectomy for Large Vessel Occlusion Stroke.1 passage
• Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke.1 passage
• Impact of Cerebral Small Vessel Disease on Functional Recovery After Intracerebral Hemorrhage.1 passage
• Impact of Clinical Trial Results on the Temporal Trends of Carotid Endarterectomy and Stenting From 2002 to 2014.1 passage
• Impact of Collateral Status Evaluated by Dynamic Computed Tomographic Angiography on Clinical Outcome in Patients With Ischemic Stroke.1 passage
• Impact of Delirium and Its Motor Subtypes on Stroke Outcomes.1 passage
• Impact of Delirium on Outcomes After Intracerebral Hemorrhage.1 passage
• Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease.1 passage
• Impact of Endovascular Therapy in Patients With Large Ischemic Core: Subanalysis of Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism Japan Registry 21 passage
• Impact of Expanding the Prehospital Stroke Bypass Time Window in a Large Geographic Region.1 passage
• Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of Interventional Management of Stroke (IMS) III Trial.1 passage
• Impact of Glucose on Outcomes in Patients Treated With Mechanical Thrombectomy: A Post Hoc Analysis of the Solitaire Flow Restoration With the Intention for Thrombectomy Study.1 passage
• Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With1 passage
• Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage: Randomized Controlled Trial.1 passage
• Impact of Guidelines on Clinical Practice: Intravenous Heparin Use for Acute Ischemic Stroke.1 passage
• Impact of Hyperglycemia According to the Collateral Status on Outcomes in Mechanical Thrombectomy.1 passage
• Impact of Hypothermia Initiation and Duration on Perihemorrhagic Edema Evolution After Intracerebral Hemorrhage.1 passage
• Impact of Infection on the Risk of Recurrent Stroke Among Patients With Acute Ischemic Stroke.1 passage
• Impact of Initial Diffusion-Weighted Imaging Lesion Growth Rate on the Success of Endovascular Reperfusion Therapy.1 passage
• Impact of Initial Imaging Protocol on Likelihood of Endovascular Stroke Therapy.1 passage
• Impact of Intracerebral Hematoma Evacuation During Decompressive Hemicraniectomy on Functional Outcomes.1 passage
• Impact of Leukoaraiosis Burden on Hemispheric Lateralization of the National Institutes of Health Stroke Scale Deficit in Acute Ischemic Stroke.1 passage
• Impact of Low Ankle-Brachial Index on the Risk of Recurrent Vascular Events.1 passage
• Impact of Multiple Social Determinants of Health on Incident Stroke.1 passage
• Impact of Periprocedural and Technical Factors and Patient Characteristics on Revascularization and Outcome in the DAWN Trial.1 passage
• Impact of Preexisting Cognitive Impairment and Race/Ethnicity on Functional Outcomes Following Intracerebral Hemorrhage.1 passage
• Impact of Prehospital Triage Scales to Detect Large Vessel Occlusion on Resource Utilization and Time to Treatment.1 passage
• Impact of Prior Antiplatelet Therapy on Outcomes After Endovascular Therapy for Acute Stroke: Endovascular Treatment in Ischemic Stroke Registry Results.1 passage
• Impact of Rehabilitation on Outcomes in Patients With Ischemic Stroke: A Nationwide Retrospective Cohort Study in Japan.1 passage
• Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation.1 passage
• Impact of Reperfusion for Nonagenarians Treated by Mechanical Thrombectomy: Insights From the ETIS Registry.1 passage
• Impact of Sleep Apnea on Cardioembolic Risk in Patients With Atrial Fibrillation: Data From the ESADA Cohort.1 passage
• Impact of Sleep-Disordered Breathing on Functional Outcomes in Ischemic Stroke: A Cardiopulmonary Coupling Analysis.1 passage
• Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study.1 passage
• Impact of Statins on Hematoma, Edema, Seizures, Vascular Events, and Functional Recovery After Intracerebral Hemorrhage.1 passage
• Impact of Stent Retriever Size on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry.1 passage
• Impact of Stereotactic Ventriculocisternostomy on Delayed Cerebral Infarction and Outcome After Subarachnoid Hemorrhage.1 passage
• Impact of Strategy on Clinical Outcome in Large Vessel Occlusion Stroke Successfully Reperfused: ETIS Registry Results.1 passage
• Impact of Stroke Center Certification on Mortality After Ischemic Stroke: The Medicare Cohort From 2009 to 2013.1 passage
• Impact of Stroke Risk Factors on Ethnic Stroke Disparities Among Midlife Mexican Americans and Non-Hispanic Whites.1 passage
• Impact of Target Arterial Residual Stenosis on Outcome After Endovascular Revascularization.1 passage
• Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial.1 passage
• Impact of Transcranial Doppler Ultrasound on Logistics and Outcomes in Stroke Thrombolysis: Results From the SITS-ISTR.1 passage
• Impact of Treatment Delay on Outcome in the International Subarachnoid Aneurysm Trial.1 passage
• Impact of Visceral Adipose Tissue on Clinical Outcomes After Acute Ischemic Stroke.1 passage
• Impact of language barriers on stroke care and outcomes.1 passage
• Impact of perioperative infarcts after cardiac surgery.1 passage
• Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions.1 passage
• Impact on Prehospital Delay of a Stroke Preparedness Campaign: A SW-RCT (Stepped-Wedge Cluster Randomized Controlled Trial).1 passage
• Impaired Higher-Level Functional Capacity as a Predictor of Stroke in Community-Dwelling Older Adults: The Ohasama Study.1 passage
• Impairment and Plasticity of Language-Related White Matter in Patients With Brain Arteriovenous Malformations.1 passage
• Implementation of High-Intensity Stepping Training During Inpatient Stroke Rehabilitation Improves Functional Outcomes.1 passage
• Implementing Caregiver Support Programs in a Regional Stroke System.1 passage
• Implementing a simple care bundle is associated with improved outcomes in a national cohort of patients with ischemic stroke.1 passage
• Implication of the recent positive endovascular intervention trials for organizing acute stroke care: European perspective.1 passage
• Importance of Occlusion Site for Thrombectomy Technique in Stroke: Comparison Between Aspiration and Stent Retriever.1 passage
• Improved Detectability of Brain Stem Ischemia by Combining Axial and Coronal Diffusion-Weighted Imaging.1 passage
• Improved Neurological Outcome With Mild Hypothermia in Surviving Patients With Massive Cerebral Hemispheric Infarction.1 passage
• Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.1 passage
• Improved prehospital triage of patients with stroke in a specialized stroke ambulance: results of the pre-hospital acute neurological therapy and optimization of medical care in stroke study.1 passage
• Improving Access to Thrombolysis and Inhospital Management Times in Ischemic Stroke: A Stepped-Wedge Randomized Trial.1 passage
• Improving Adherence to Secondary Stroke Prevention Strategies Through Motivational Interviewing: Randomized Controlled Trial.1 passage
• Improving Clinical Detection of Acute Lacunar Stroke: Analysis From the IST-3.1 passage
• Improving Community Stroke Preparedness in the HHS (Hip-Hop Stroke) Randomized Clinical Trial.1 passage
• Improving Outcomes After Stroke: From Stroke Units to Mobile Stroke Units.1 passage
• Improving Stroke Care in Times of the COVID-19 Pandemic Through Simulation: Practice Your Protocols!1 passage
• In Vitro Assessment of Histology Verified Intracranial Atherosclerotic Disease by 1.5T Magnetic Resonance Imaging: Concentric or Eccentric?1 passage
• In What Scenarios Does a Mobile Stroke Unit Predict Better Patient Outcomes?: A Modeling Study.1 passage
• In-Hospital Delays in Stroke Thrombolysis: Every Minute Counts.1 passage
• In-Hospital Outcomes of Urgent, Early, or Late Revascularization for Symptomatic Carotid Artery Stenosis.1 passage
• In-Patient Code Stroke: A Quality Improvement Strategy to Overcome Knowledge-to-Action Gaps in Response Time.1 passage
• In-Transit Telemedicine Speeds Ischemic Stroke Treatment: Preliminary Results.1 passage
• In-hospital stroke recurrence and stroke after transient ischemic attack: frequency and risk factors.1 passage
• Inaugural Health Equity and Actionable Disparities in Stroke: Understanding and Problem-Solving Symposium.1 passage
• Incidence and Association of Reperfusion Therapies With Poststroke Seizures: A Systematic Review and Meta-Analysis.1 passage
• Incidence and Etiologies of Stroke Mimics After Incident Stroke or Transient Ischemic Attack.1 passage
• Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population.1 passage
• Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS).1 passage
• Incidence and Outcomes of Myocardial Infarction in Patients Admitted With Acute Ischemic Stroke.1 passage
• Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.1 passage
• Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion: A Population-Based Study (Dijon Stroke Registry).1 passage
• Incidence of Atrial Fibrillation in Patients With Recent Ischemic Stroke Versus Matched Controls.1 passage
• Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population: The AGES-Reykjavik Study (Age Gene/Environment Susceptibility-Reykjavik Study).1 passage
• Incidence of Ischemic Stroke in Individuals With and Without Aortic Valve Stenosis: A Danish Retrospective Cohort Study.1 passage
• Incidence of Stroke After Pneumonectomy and Lobectomy.1 passage
• Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry.1 passage
• Incidence of Transient Ischemic Attack in Auckland, New Zealand, in 2011 to 2012.1 passage
• Incidence, Locations, and Longitudinal Course of Cerebral Microbleeds in European Moyamoya.1 passage
• Incident Cerebral Microbleeds After Intracerebral Hemorrhage.1 passage
• Incident Cerebral Microbleeds in a Cohort of Intracerebral Hemorrhage.1 passage
• Incorporating Stroke Severity Into Hospital Measures of 30-Day Mortality After Ischemic Stroke Hospitalization.1 passage
• Increase in [18F]-Fluoroacetate Uptake in Patients With Chronic Hemodynamic Cerebral Ischemia.1 passage
• Increase of Stroke Incidence in Young Adults in a Middle-Income Country: A 10-Year Population-Based Study.1 passage
• Increased Access to and Use of Endovascular Therapy Following Implementation of a 2-Tiered Regional Stroke System.1 passage
• Increased Blood Pressure Variability Contributes to Worse Outcome After Intracerebral Hemorrhage.1 passage
• Increased COVID-19 Mortality in People With Previous Cerebrovascular Disease: A Population-Based Cohort Study.1 passage
• Increased Frontal Lobe Activation After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.1 passage
• Increased Incidence of Stroke, but Not Coronary Heart Disease, in Elderly Patients With Sleep Apnea.1 passage
• Increased Ipsilateral Posterior Cerebral Artery P2-Segment Flow Velocity Predicts Hemodynamic Impairment.1 passage
• Increased Mortality and Vascular Phenotype in a Knock-In Mouse Model of Retinal Vasculopathy With Cerebral Leukoencephalopathy and Systemic Manifestations.1 passage
• Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.1 passage
• Increased Risk of Pregnancy Complications After Stroke: The FUTURE Study (Follow-Up of Transient Ischemic Attack and Stroke Patients and Unelucidated Risk Factor Evaluation).1 passage
• Increased Risk of Traffic Injury After a Cerebrovascular Event.1 passage
• Increased Serum Complement C3 Levels Are Associated With Adverse Clinical Outcomes After Ischemic Stroke.1 passage
• Increased Serum Netrin-1 Is Associated With Improved Prognosis of Ischemic Stroke.1 passage
• Increased Stroke Burdens Among the Low-Income Young and Middle Aged in Rural China.1 passage
• Increased Use of Ticagrelor After Myocardial Infarction Is Not Associated With Intracranial Hemorrhage.1 passage
• Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke.1 passage
• Increased Wall Enhancement During Follow-Up as a Predictor of Subsequent Aneurysmal Growth.1 passage
• Increased risk for intracranial arterial stenosis in subjects with coronary artery calcification.1 passage
• Incremental predictive value of carotid inflammation in acute ischemic stroke.1 passage
• Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time.1 passage
• Individual and Combined Impact of Heart Failure and Atrial Fibrillation on Ischemic Stroke Outcomes.1 passage
• Individual and System Contributions to Race and Sex Disparities in Thrombolysis Use for Stroke Patients in the United States.1 passage
• Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.1 passage
• Induced Hypertension in Preventing Cerebral Infarction in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.1 passage
• Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.1 passage
• Infarct Pattern and Collateral Status in Adult Moyamoya Disease: A Multimodal Magnetic Resonance Imaging Study.1 passage
• Infarct Volume Before Hemicraniectomy in Large Middle Cerebral Artery Infarcts Poorly Predicts Catastrophic Outcome.1 passage
• Infarct in a New Territory After Treatment Administration in the ESCAPE Randomized Controlled Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times).1 passage
• Infarct volume-based subgroup selection in acute ischemic stroke trials.1 passage
• Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time.1 passage
• Infection During Delivery Hospitalization and Risk of Readmission for Postpartum Stroke.1 passage
• Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.1 passage
• Infection as a Stroke Trigger.1 passage
• Infections Increase the Risk of 30-Day Readmissions Among Stroke Survivors.1 passage
• Infections and Risk of Peripartum Stroke During Delivery Admissions.1 passage
• Inflammation and Stroke Risk: A New Target for Prevention.1 passage
• Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence.1 passage
• Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study.1 passage
• Inflammatory Stroke Extracellular Vesicles Induce Macrophage Activation.1 passage
• Inflated Estimates of Proportional Recovery From Stroke: The Dangers of Mathematical Coupling and Compression to Ceiling.1 passage
• Influence of Amyloid-β on Cognitive Decline After Stroke/Transient Ischemic Attack: Three-Year Longitudinal Study.1 passage
• Influence of Cardiovascular Fitness and Muscle Strength in Early Adulthood on Long-Term Risk of Stroke in Swedish Men.1 passage
• Influence of Device Choice on the Effect of Intra-Arterial Treatment for Acute Ischemic Stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands).1 passage
• Influence of Distance to Scene on Time to Thrombolysis in a Specialized Stroke Ambulance.1 passage
• Influence of Guidelines in Endovascular Therapy Decision Making in Acute Ischemic Stroke: Insights From UNMASK EVT.1 passage
• Influence of Hemoglobin Concentration on Stroke Recurrence and Composite Vascular Events.1 passage
• Influence of Intracerebral Hemorrhage Location on Outcomes in Patients With Severe Intraventricular Hemorrhage.1 passage
• Influence of Penumbral Reperfusion on Clinical Outcome Depends on Baseline Ischemic Core Volume.1 passage
• Influence of Preexisting Cognitive Impairment on Clinical Severity of Ischemic Stroke: The Dijon Stroke Registry.1 passage
• Influence of Pregnancy on Hemorrhage Risk in Women With Cerebral and Spinal Cavernous Malformations.1 passage
• Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.1 passage
• Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.1 passage
• Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study.1 passage
• Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke: The Society of Vascular and Interventional Neurology Multicenter Collaboration.1 passage
• Infratentorial Intracerebral Hemorrhage.1 passage
• Infratentorial Microbleeds: Another Sign of Microangiopathy in Migraine.1 passage
• Inhalational Versus Intravenous Anesthetic Conditioning for Subarachnoid Hemorrhage-Induced Delayed Cerebral Ischemia.1 passage
• Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.1 passage
• Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.1 passage
• Innovative Magnetic Resonance Imaging Markers of Hereditary Cerebral Amyloid Angiopathy at 7 Tesla.1 passage
• Institute Maastricht (CARIM), the Netherlands (R.J.v.O., W.H.v.Z.).Correspondence to Daniel Bos, MD, PhD, Department of Radiology and Nuclear Medicine and Department of Epidemiology,24 passages
• Institute Maastricht, Maastricht University Medical Center, the Netherlands.the MR CLEAN Investigators Berkhemer33 passages
• Institute at the University of Edinburgh, Chancellor’s Building (G.M., J.M.W.)13 Department of Medicine, Dalhousie University and Queen21 passages
• Institute, St George’s University of London, United Kingdom (O.A.W., E.A.Z., C.L., T.R.B.)2 Department of Radiology, Charing Cross Hospital campus, Imperial31 passages
• Institute, University of Newcastle, Newcastle, Australia (M.N.).Correspondence to27 passages
• Institute, Weill Cornell Medical College, New York, NY (J.A.).Correspondence to22 passages
• Insular cortex lesions, cardiac troponin, and detection of previously unknown atrial fibrillation in acute ischemic stroke: insights from the troponin elevation in acute ischemic stroke study.1 passage
• Insulin Resistance Is a Risk Factor for Silent Lacunar Infarction.1 passage
• Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke: The ACROSS-China Study (Abnormal Glucose Regulation in Patients With Acute Stroke Across China).1 passage
• Integrated Stroke System Model Expands Availability of Endovascular Therapy While Maintaining Quality Outcomes.1 passage
• Integration of Computed Tomographic Angiography Spot Sign and Noncontrast Computed Tomographic Hypodensities to Predict Hematoma Expansion.1 passage
• Integrative Mouse and Human Studies Implicate ANGPT1 and ZBTB7C as Susceptibility Genes to Ischemic Injury.1 passage
• Intended Bridging Therapy or Intravenous Thrombolysis Alone in Minor Stroke With Basilar Artery Occlusion.1 passage
• Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.1 passage
• Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.1 passage
• Intensive Continuous Positive Airway Pressure Adherence Program During Stroke Rehabilitation.1 passage
• Intensive Statin Therapy Compromises the Adiponectin-AdipoR Pathway in the Human Monocyte-Macrophage Lineage.1 passage
• Intensive Versus Distributed Aphasia Therapy: A Nonrandomized, Parallel-Group, Dosage-Controlled Study.1 passage
• Inter- and Intra-Rater Reliability of the Visual Vertical in Subacute Stroke.1 passage
• Inter-Rater Reliability of the CASCADE Criteria: Challenges in Classifying Arteriopathies.1 passage
• Interaction of Recanalization, Intracerebral Hemorrhage, and Cerebral Edema After Intravenous Thrombolysis.1 passage
• Interactions Between the Corticospinal Tract and Premotor-Motor Pathways for Residual Motor Output After Stroke.1 passage
• Interfacility Transfer Directly to the Neuroangiography Suite in Acute Ischemic Stroke Patients Undergoing Thrombectomy.1 passage
• Interhospital Transfers for Endovascular Therapy for Acute Ischemic Stroke.1 passage
• Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis.1 passage
• Interrater and Intrarater Measurement Reliability of Noncontrast Computed Tomography Predictors of Intracerebral Hemorrhage Expansion.1 passage
• Interventionalist perspective on the new endovascular trials.1 passage
• Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment.1 passage
• Intima-Media Thickness and Cognitive Function in Stroke-Free Middle-Aged Adults: Findings From the Coronary Artery Risk Development in Young Adults Study.1 passage
• Intra-Arterial Adjunctive Medications for Acute Ischemic Stroke During Mechanical Thrombectomy: A Meta-Analysis.1 passage
• Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial.1 passage
• Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions.1 passage
• Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke.1 passage
• Intracerebral Hematoma Morphologic Appearance on Noncontrast Computed Tomography Predicts Significant Hematoma Expansion.1 passage
• Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use: A Population Study.1 passage
• Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.1 passage
• Intracerebral Hemorrhage in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prevalence, Clinical and Neuroimaging Features and Risk Factors.1 passage
• Intracranial Aneurysm-Associated Single-Nucleotide Polymorphisms Alter Regulatory DNA in the Human Circle of Willis.1 passage
• Intracranial Aneurysms Are Associated With Marfan Syndrome: Single Cohort Retrospective Study in 118 Patients Using Brain Imaging.1 passage
• Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.1 passage
• Intracranial Arterial Dolichoectasia and Stenosis: Risk Factors and Relation to Cerebral Small Vessel Disease.1 passage
• Intracranial Artery Stenosis and Its Association With Conventional Risk Factors in a General Population of Japanese Men.1 passage
• Intracranial Carotid Artery Calcification Relates to Recanalization and Clinical Outcome After Mechanical Thrombectomy.1 passage
• Intracranial Carotid Artery Calcification and Effect of Endovascular Stroke Treatment.1 passage
• Intracranial Carotid Calcification on Cranial Computed Tomography: Visual Scoring Methods, Semiautomated Scores, and Volume Measurements in Patients With Stroke.1 passage
• Intracranial Extension of Extracranial Vertebral Dissection Is Associated With an Increased Risk of Ischemic Events.1 passage
• Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.1 passage
• Intracranial Pulsatility in Relation to Severity and Progression of Cerebral White Matter Hyperintensities.1 passage
• Intracranial Vessel Wall Lesions on 7T MRI (Magnetic Resonance Imaging).1 passage
• Intraluminal Thrombi in the Cervico-Cephalic Arteries.1 passage
• Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment.1 passage
• Intraluminal thrombus, intraplaque hemorrhage, plaque thickness, and current smoking optimally predict carotid stroke.1 passage
• Intraoperative Completion Studies, Local Anesthesia, and Antiplatelet Medication Are Associated With Lower Risk in Carotid Endarterectomy.1 passage
• Intravenous Fibrinolysis for Central Retinal Artery Occlusion: A Cohort Study and Updated Patient-Level Meta-Analysis.1 passage
• Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction.1 passage
• Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.1 passage
• Intravenous Magnesium Sulfate in Acute Stroke.1 passage
• Intravenous Recombinant Tissue-Type Plasminogen Activator: Influence on Outcome in Anterior Circulation Ischemic Stroke Treated by Mechanical Thrombectomy.1 passage
• Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.1 passage
• Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.1 passage
• Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review.1 passage
• Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.1 passage
• Intravenous Thrombolysis for Stroke and Presumed Stroke in Human Immunodeficiency Virus-Infected Adults: A Retrospective, Multicenter US Study.1 passage
• Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke.1 passage
• Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.1 passage
• Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus.1 passage
• Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.1 passage
• Intraventricular Hemorrhage Clearance in Human Neonatal Cerebrospinal Fluid: Associations With Hydrocephalus.1 passage
• Intravoxel Incoherent Motion Imaging in Small Vessel Disease: Microstructural Integrity and Microvascular Perfusion Related to Cognition.1 passage
• Intrinsic Coagulation Pathway, History of Headache, and Risk of Ischemic Stroke.1 passage
• Invasive Monitoring of Intracranial Pressure After Decompressive Craniectomy in Malignant Stroke.1 passage
• Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus.1 passage
• Investigation of the Hemodynamics Influencing Emboli Trajectories Through a Patient-Specific Aortic Arch Model.1 passage
• Iodine Sign as a Novel Predictor of Hematoma Expansion and Poor Outcomes in Primary Intracerebral Hemorrhage Patients.1 passage
• Iron Status and Risk of Stroke.1 passage
• Irregular Shape Identifies Ruptured Intracranial Aneurysm in Subarachnoid Hemorrhage Patients With Multiple Aneurysms.1 passage
• Irregular Shape of Intracranial Aneurysm Indicates Rupture Risk Irrespective of Size in a Population-Based Cohort.1 passage
• Is Anatomical Variations a Risk Factor for Cerebral Vasospasm in Anterior Communicating Complex Aneurysms Rupture?1 passage
• Is Endovascular Treatment Still Good for Ischemic Stroke in Real World?: A Meta-Analysis of Randomized Control Trial and Observational Study in the Last Decade.1 passage
• Is Functional Outcome Different in Posterior and Anterior Circulation Stroke?1 passage
• Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials.1 passage
• Is Unexplained Early Neurological Deterioration After Intravenous Thrombolysis Associated With Thrombus Extension?1 passage
• Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension.1 passage
• Is prophylactic anticoagulation for deep venous thrombosis common practice after intracerebral hemorrhage?1 passage
• Is the Cost-Effectiveness of Stroke Thrombolysis Affected by Proportion of Stroke Mimics?1 passage
• Is visual evaluation of aneurysm coiling a reliable study end point? Systematic review and meta-analysis.1 passage
• Ischemia in intracerebral hemorrhage is associated with leukoaraiosis and hematoma volume, not blood pressure reduction.1 passage
• Ischemia-Reperfusion Injury After Endovascular Thrombectomy for Ischemic Stroke.1 passage
• Ischemic Amnesia: Causes and Outcome.1 passage
• Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3.1 passage
• Ischemic Diffusion Lesion Reversal After Endovascular Treatment.1 passage
• Ischemic Stroke After Treatment of Intraprocedural Thrombosis During Stent-Assisted Coiling and Flow Diversion.1 passage
• Ischemic Stroke Occurs Less Frequently in Patients With COVID-19: A Multicenter Cross-Sectional Study.1 passage
• Ischemic Stroke Profile, Risk Factors, and Outcomes in India: The Indo-US Collaborative Stroke Project.1 passage
• Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.1 passage
• Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.1 passage
• Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.1 passage
• Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.1 passage
• Ischemic Stroke in Patients With Pulmonary Arteriovenous Fistulas.1 passage
• Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.1 passage
• Ischemic Stroke: What Does the Histological Composition Tell Us About the Origin of the Thrombus?1 passage
• Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.1 passage
• Ischemic stroke phenotype in patients with nonsustained atrial fibrillation.1 passage
• Island Sign: An Imaging Predictor for Early Hematoma Expansion and Poor Outcome in Patients With Intracerebral Hemorrhage.1 passage
• Isolated MCA disease in patients without significant atherosclerotic risk factors: a high-resolution magnetic resonance imaging study.1 passage
• Job strain and the risk of stroke: an individual-participant data meta-analysis.1 passage
• Journal Initiatives to Enhance Preclinical Research: Analyses of1 passage
• Kawasaki Disease May Increase the Risk of Subsequent Cerebrovascular Disease.1 passage
• Knowledge of Thrombolytic Therapy Amongst Hospital Staff: Preliminary Results and Treatment Implications.1 passage
• Labetalol Use Is Associated With Increased In-Hospital Infection Compared With Nicardipine Use in Intracerebral Hemorrhage.1 passage
• Lack of Consensus Among Stroke Experts on the Optimal Management of Patients With Acute Tandem Occlusion.1 passage
• Lacunar Infarcts and Intracerebral Hemorrhage Differences: A Nested Case-Control Analysis in the FHS (Framingham Heart Study).1 passage
• Lacunar Infarcts, but Not Perivascular Spaces, Are Predictors of Cognitive Decline in Cerebral Small-Vessel Disease.1 passage
• Large Vessel Occlusion Scales Increase Delivery to Endovascular Centers Without Excessive Harm From Misclassifications.1 passage
• Large Vessel Occlusion in Acute Stroke.1 passage
• Large Volumes of Critically Hypoperfused Penumbral Tissue Do Not Preclude Good Outcomes After Complete Endovascular Reperfusion: Redefining Malignant Profile.1 passage
• Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.1 passage
• Large but Nonstenotic Carotid Artery Plaque in Patients With a History of Embolic Stroke of Undetermined Source.1 passage
• Lau Kui Kai DPhil12*Lovelock29 passages
• Leakage Sign for Primary Intracerebral Hemorrhage: A Novel Predictor of Hematoma Growth.1 passage
• Left Atrial Appendage Thrombus Detected During Hyperacute Stroke Imaging Is Associated With Atrial Fibrillation.1 passage
• Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source.1 passage
• Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.1 passage
• Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.1 passage
• Left-sided strokes are more often recognized than right-sided strokes: the Rotterdam study.1 passage
• Leptomeningeal Collateral Flow Modifies Endovascular Treatment Efficacy on Large-Vessel Occlusion Strokes.1 passage
• Lesion Localization of Poststroke Lateropulsion.1 passage
• Less-Affected Hand Function Is Associated With Independence in Daily Living: A Longitudinal Study Poststroke.1 passage
• Letter by Acampa et al Regarding Article, "Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection".1 passage
• Letter by Agarwal et al Regarding Article, "Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era".1 passage
• Letter by Alipour Haris et al Regarding Article, "Marijuana Use Among Young Adults (18-44 Years of Age) and Risk of Stroke: A Behavioral Risk Factor Surveillance System Survey Analysis".1 passage
• Letter by Alves et al Regarding Article, "Effect of Right Insular Involvement on Death and Functional Outcome After Acute Ischemic Stroke in the IST-3 Trial (Third International Stroke Trial)".1 passage
• Letter by Anadani and Spiotta Regarding Article, "Blood Pressure After Endovascular Therapy for Ischemic Stroke (BEST): A Multicenter Prospective Cohort Study".1 passage
• Letter by Avasarala Regarding Article, "2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Letter by Baracchini and Pieroni Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic".1 passage
• Letter by Bos et al Regarding Article, "Intracranial Carotid Calcification on Cranial Computed Tomography: Visual Scoring Methods, Semiautomated Scores, and Volume Measurements in Patients With Stroke".1 passage
• Letter by Bosche and Macdonald regarding article, "relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study".1 passage
• Letter by Bourcier et al Regarding Article, "Per-Pass Analysis of Thrombus Composition in Patients With Acute Ischemic Stroke Undergoing Mechanical Thrombectomy".1 passage
• Letter by Bruno and Nichols Regarding Article, "Prestroke Disability Predicts Adverse Poststroke Outcome: A Registry-Based Prospective Cohort Study of Acute Stroke".1 passage
• Letter by Cai et al Regarding Article, "One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis".1 passage
• Letter by Cao et al Regarding Article, "Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy".1 passage
• Letter by Cao et al Regarding Article, "Intracranial Extension of Extracranial Vertebral Dissection Is Associated With an Increased Risk of Ischemic Events".1 passage
• Letter by Cao et al Regarding Article, "Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke".1 passage
• Letter by Castioni et al Regarding Article, "General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke".1 passage
• Letter by Chen et al Regarding Article, "Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis".1 passage
• Letter by Chen et al Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial".1 passage
• Letter by Corea et al Regarding Article, "Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Letter by Della Schiava et al Regarding Article "Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion".1 passage
• Letter by Dhillon and Lenthall Regarding Article, "Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time".1 passage
• Letter by Dijkland et al Regarding Article, "Development and Validation of a Predictive Model for Functional Outcome After Stroke Rehabilitation: The Maugeri Model".1 passage
• Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".1 passage
• Letter by Diplomatico and Barbi Regarding Article, "Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association".1 passage
• Letter by Dixit and Thomas Regarding Article, "Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Letter by Doshi et al Regarding Article, "Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis".1 passage
• Letter by Du et al Regarding Article, "Magnetic Resonance Imaging of Plaque Morphology, Burden, and Distribution in Patients With Symptomatic Middle Cerebral Artery Stenosis".1 passage
• Letter by Efendizade et al Regarding Article, "Effects of Collateral Status on Infarct Distribution Following Endovascular Therapy in Large Vessel Occlusion Stroke".1 passage
• Letter by Ellis and Sheets Regarding Article, "No Racial Difference in Rehabilitation Therapy Across All Post-Acute Care Settings in the Year Following a Stroke".1 passage
• Letter by Fenton and Bellman Regarding Article, "Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia: A Prospective Cohort Study".1 passage
• Letter by Freeman Regarding Article, "Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands)".1 passage
• Letter by Golomb and Hall Regarding Article, "Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic".1 passage
• Letter by Gong et al Regarding Article, "Predictors of Unexplained Early Neurological Deterioration After Endovascular Treatment for Acute Ischemic Stroke".1 passage
• Letter by Gong et al Regarding Article, "The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry".1 passage
• Letter by Gould Regarding Article, "Endovascular Thrombectomy for Acute Ischemic Strokes: Current US Access Paradigms and Optimization Methodology".1 passage
• Letter by Goyal and Ospel Regarding Article, "Direct Transfer to Angio-Suite Versus Computed Tomography-Transit in Patients Receiving Mechanical Thrombectomy: a Randomized Trial".1 passage
• Letter by Goyal and Ospel Regarding Article, "Multiphasic Computed Tomography Angiography Findings for Identifying Pseudo-Occlusion of the Internal Carotid Artery".1 passage
• Letter by Gross et al Regarding Article, "Immediate Vascular Imaging Needed for Efficient Triage of Patients With Acute Ischemic Stroke Initially Admitted to Nonthrombectomy Centers".1 passage
• Letter by Gu and Liu Regarding Article, "HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion".1 passage
• Letter by Halenarova and Taccone Regarding Article "Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage: Randomized Controlled Trial".1 passage
• Letter by He et al Regarding Article, "Signs of Pulmonary Infection on Admission Chest Computed Tomography Are Associated With Pneumonia or Death in Patients With Acute Stroke".1 passage
• Letter by Heldner et al Regarding Article, "Field Assessment Stroke Triage for Emergency Destination: A Simple and Accurate Prehospital Scale to Detect Large Vessel Occlusion Strokes".1 passage
• Letter by Ho et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".1 passage
• Letter by Hsieh and Lin Regarding Article, "Acute Reperfusion Therapy and Stroke Care in Asia After Successful Endovascular Trials".1 passage
• Letter by Hsieh and Sung Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".1 passage
• Letter by Iannuccelli et al Regarding Article, "Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke".1 passage
• Letter by Jayaraman et al Regarding Articles, "Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants" and "Effectiveness and Safety of Oral Anticoagulants among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study".1 passage
• Letter by Kallmünzer et al Regarding Article, "Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: a Systematic Review and Meta-Analysis".1 passage
• Letter by Kamtchum-Tatuene et al Regarding Article, "Mechanical Thrombectomy Improves Functional Outcomes Independent of Pretreatment With Intravenous Thrombolysis".1 passage
• Letter by Katsanos and Tsivgoulis Regarding Article, "Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment".1 passage
• Letter by Kawada Regarding Article, "Silent Brain Infarctions and Leukoaraiosis in Patients With Retinal Ischemia: A Prospective Single-Center Observational Study".1 passage
• Letter by Khan et al Regarding Article, "Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative".1 passage
• Letter by Kumaria and Tolias Regarding Article, "Vagus Nerve Stimulation Paired With Upper Limb Rehabilitation After Chronic Stroke: A Blinded Randomized Pilot Study".1 passage
• Letter by Kvernland et al Regarding Article, "Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications".1 passage
• Letter by Kwan et al Regarding Article, "Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?"1 passage
• Letter by L. Schlemm and E. Schlemm Regarding Article, "Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity".1 passage
• Letter by Lapin et al Regarding Article, "PROMIS GH (Patient-Reported Outcomes Measurement Information System Global Health) Scale in Stroke: A Validation Study".1 passage
• Letter by Lattanzi and Silvestrini Regarding Article, "Large but Nonstenotic Carotid Artery Plaque in Patients With a History of Embolic Stroke of Undetermined Source".1 passage
• Letter by Liu and Chen Regarding Article, "Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients".1 passage
• Letter by Liu and Zhang Regarding Article, "Relationship Between Impaired Consciousness and Injury of Ascending Reticular Activating System in Patients With Intracerebral Hemorrhage".1 passage
• Letter by Liu et al Regarding Article, "Leukoaraiosis Burden Significantly Modulates the Association Between Infarct Volume and National Institutes of Health Stroke Scale in Ischemic Stroke".1 passage
• Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".1 passage
• Letter by Malhotra and Wu Regarding Article, "Computed Tomography Angiography Versus Digital Subtraction Angiography for Postclipping Aneurysm Obliteration Detection: A Meta-Analysis".1 passage
• Letter by Mayer and Knoflach Regarding Article "Efficacy and Safety of Recanalization Therapy for Acute Ischemic Stroke With Large Vessel Occlusion: A Systematic Review".1 passage
• Letter by Mojadidi et al Regarding Article, "Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis".1 passage
• Letter by Morelli et al Regarding Article, "Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona".1 passage
• Letter by Moris et al Regarding Article, "One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis".1 passage
• Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)".1 passage
• Letter by Mulder et al Regarding Article, "2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Letter by Mulder et al Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Letter by Müller et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".1 passage
• Letter by Nabavizadeh et al Regarding Article, "Prediction of Blood-Brain Barrier Disruption and Intracerebral Hemorrhagic Infarction Using Arterial Spin-Labeling Magnetic Resonance Imaging".1 passage
• Letter by Nagai et al Regarding Article, "Antihypertensive Drug Use, Blood Pressure Variability, and Incident Stroke Risk in Older Adults: Three-City Cohort Study".1 passage
• Letter by Nastro Siniscalchi and Raffa Regarding Article, "Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source".1 passage
• Letter by Neugebauer and Jüttler Regarding Article, "Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies".1 passage
• Letter by Ng et al Regarding Article, "Cervical Carotid Pseudo-Occlusions and False Dissections: Intracranial Occlusions Masquerading as Extracranial Occlusions".1 passage
• Letter by Nielsen and Johnsen Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation".1 passage
• Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".1 passage
• Letter by Noubiap and Kamtchum-Tatuene Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".1 passage
• Letter by Pyrogianni and La Vecchia Regarding Article, "Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative".1 passage
• Letter by Qiao Regarding Article, "Minimally Invasive Surgery for Intracerebral Hemorrhage: An Updated Meta-Analysis of Randomized Controlled Trials".1 passage
• Letter by Rajendram et al Regarding Article, "Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China".1 passage
• Letter by Reale et al Regarding Article, "Clinically Confirmed Stroke With Negative Diffusion-Weighted Imaging Magnetic Resonance Imaging: Longitudinal Study of Clinical Outcomes, Stroke Recurrence, and Systematic Review".1 passage
• Letter by Reale et al Regarding Article, "Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis".1 passage
• Letter by Renú et al Regarding Article, "Frequency of Blood-Brain Barrier Disruption Postendovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients".1 passage
• Letter by Rezaei and Arjmand Regarding Article, "Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial".1 passage
• Letter by Romoli Regarding Article, "Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis".1 passage
• Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".1 passage
• Letter by Saber Regarding Article, "Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review".1 passage
• Letter by Samuels et al Regarding Article, "Decreases in Blood Pressure During Thrombectomy Are Associated With Larger Infarct Volumes and Worse Functional Outcome".1 passage
• Letter by Saver et al regarding article, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association".1 passage
• Letter by Scheitz et al Regarding Article, "Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient)".1 passage
• Letter by Semerano et al Regarding Article, "Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source".1 passage
• Letter by Sen and Powers regarding article, "Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke".1 passage
• Letter by Sharma and Rasmussen Regarding Article, "Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology".1 passage
• Letter by Shoar et al Regarding Article, "Has Outcome of Subarachnoid Hemorrhage Changed With Improvements in Neurosurgical Services?: Study of 2000 Patients Over 2 Decades From India".1 passage
• Letter by Sporns et al Regarding Article, "Thrombus Permeability in Admission Computed Tomographic Imaging Indicates Stroke Pathogenesis Based on Thrombus Histology".1 passage
• Letter by Stanley et al Regarding Article, "Primary Angiitis of the Central Nervous System Magnetic Resonance Imaging Spectrum of Parenchymal, Meningeal, and Vascular Lesions at Baseline".1 passage
• Letter by Steinman et al Regarding Article, "Wall Shear Stress and T1 Contrast Ratio Are Associated With Embolic Signals During Carotid Exposure in Endarterectomy".1 passage
• Letter by Tampaki et al Regarding Article, "Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk".1 passage
• Letter by Tan and Xu Regarding Article, "Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment".1 passage
• Letter by Tang et al Regarding Article, "General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The Anstroke Trial (Anesthesia During Stroke)".1 passage
• Letter by Thakkar and Doshi Regarding Article, "National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015".1 passage
• Letter by Tian and Lou Regarding Article, "Clinical Significance of Fluid-Attenuated Inversion Recovery Vascular Hyperintensities in Borderzone Infarcts".1 passage
• Letter by Trinh-Duc et al Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Letter by Tsivgoulis et al Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis".1 passage
• Letter by Tsuda Regarding Article, "Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women".1 passage
• Letter by Tsuda Regarding Article, "High-Sensitivity CRP (C-Reactive Protein) Is Associated With Incident Carotid Artery Plaque in Chinese Aged Adults".1 passage
• Letter by Uchino and Cho Regarding Article, "Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time".1 passage
• Letter by Urra and Amaro Regarding Article, "HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion".1 passage
• Letter by Wang et al Regarding Article, "Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage".1 passage
• Letter by Weiss et al Regarding Article, "1/2SH: A Simple, Accurate, and Reliable Method of Calculating the Hematoma Volume of Spontaneous Intracerebral Hemorrhage".1 passage
• Letter by Wen et al Regarding Article, "Pathophysiology of Intracranial Aneurysms: COX-2 Expression, Iron Deposition in Aneurysm Wall, and Correlation With Magnetic Resonance Imaging".1 passage
• Letter by Wu et al Regarding Article, "Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus".1 passage
• Letter by Wu et al Regarding Article, "Response to Late-Window Endovascular Revascularization Is Associated With Collateral Status in Basilar Artery Occlusion".1 passage
• Letter by Wu et al Regarding Article, "Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience".1 passage
• Letter by Xia et al Regarding Article, "Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion: A Population-Based Study (Dijon Stroke Registry)".1 passage
• Letter by Xia et al Regarding Article, "Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2".1 passage
• Letter by Xue et al Regarding Article, "Intracranial Extension of Extracranial Vertebral Dissection Is Associated With an Increased Risk of Ischemic Events".1 passage
• Letter by Yu et al Regarding Article, "Island Sign: An Imaging Predictor for Early Hematoma Expansion and Poor Outcome in Patients With Intracerebral Hemorrhage".1 passage
• Letter by Zheng Regarding Article, "Magnetic Resonance Imaging Versus Computed Tomography Angiography Based Selection for Endovascular Therapy in Patients With Acute Ischemic Stroke".1 passage
• Letter by Zhu and Ding Regarding Article, "Carotid Plaque Neovascularization Detected With Superb Microvascular Imaging Ultrasound Without Using Contrast Media".1 passage
• Letter by Zhu et al Regarding Article, "Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death".1 passage
• Letter by de Boysson and Pagnoux Regarding Article, "Diagnostic Yield and Safety of Brain Biopsy for Suspected Primary Central Nervous System Angiitis".1 passage
• Letter by turc et Al regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".1 passage
• Letter by van der Jagt and Suarez Regarding Article, "Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage: Randomized Controlled Trial".1 passage
• Leukoaraiosis Burden Significantly Modulates the Association Between Infarct Volume and National Institutes of Health Stroke Scale in Ischemic Stroke.1 passage
• Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).1 passage
• Leukocyte Count and Intracerebral Hemorrhage Expansion.1 passage
• Leukocytes, Collateral Circulation, and Reperfusion in Ischemic Stroke Patients Treated With Mechanical Thrombectomy.1 passage
• Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI.1 passage
• Lifestyle Factors and Early Clinical Outcome in Patients With Acute Stroke: A Population-Based Study.1 passage
• Lifestyle Interventions to Prevent Cardiovascular Events After Stroke and Transient Ischemic Attack: Systematic Review and Meta-Analysis.1 passage
• Limited reliability of computed tomographic perfusion acute infarct volume measurements compared with diffusion-weighted imaging in anterior circulation stroke.1 passage
• Linkage and Association Analysis Identifies TRAF1 Influencing Common Carotid Intima-Media Thickness.1 passage
• Linoleic Acid Status in Cell Membranes Inversely Relates to the Prevalence of Symptomatic Carotid Artery Disease.1 passage
• Lipid Changes Around the Final Menstrual Period Predict Carotid Subclinical Disease in Postmenopausal Women.1 passage
• Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.1 passage
• Lipoprotein(a) Levels and Recurrent Vascular Events After First Ischemic Stroke.1 passage
• Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage.1 passage
• Local Anesthesia Without Sedation During Thrombectomy for Anterior Circulation Stroke Is Associated With Worse Outcome.1 passage
• Location, Infarct Load, and 3-Month Outcomes of Delayed Cerebral Infarction After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Long Noncoding RNA H19 Promotes Neuroinflammation in Ischemic Stroke by Driving Histone Deacetylase 1-Dependent M1 Microglial Polarization.1 passage
• Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.1 passage
• Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease.1 passage
• Long-Term Clinical Impact of Vascular Brain Lesions on Magnetic Resonance Imaging in Older Adults in the Population.1 passage
• Long-Term Cognitive Decline After Stroke: An Individual Participant Data Meta-Analysis.1 passage
• Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability.1 passage
• Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).1 passage
• Long-Term Evolution of Functional Limitations in Stroke Survivors Compared With Stroke-Free Controls: Findings From 15 Years of Follow-Up Across 3 International Surveys of Aging.1 passage
• Long-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage: Patients With Multiple Aneurysms at Risk.1 passage
• Long-Term Exposure to Air Pollution and Survival After Ischemic Stroke.1 passage
• Long-Term Exposure to Ambient Air Pollution and Subclinical Cerebrovascular Disease in NOMAS (the Northern Manhattan Study).1 passage
• Long-Term Exposure to Particulate Matter Air Pollution Is a Risk Factor for Stroke: Meta-Analytical Evidence.1 passage
• Long-Term Impact of Urgent Secondary Prevention After Transient Ischemic Attack and Minor Stroke: Ten-Year Follow-Up of the EXPRESS Study.1 passage
• Long-Term Improvements After Multimodal Rehabilitation in Late Phase After Stroke: A Randomized Controlled Trial.1 passage
• Long-Term Morphological Changes of Symptomatic Lacunar Infarcts and Surrounding White Matter on Structural Magnetic Resonance Imaging.1 passage
• Long-Term Mortality in Children With Ischemic Stroke: A Nationwide Register-Based Cohort Study.1 passage
• Long-Term Outcome After Carotid Artery Stenting: A Population-Based Matched Cohort Study.1 passage
• Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome.1 passage
• Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.1 passage
• Long-Term Outcomes of Indirect Bypass for 629 Children With Moyamoya Disease: Longitudinal and Cross-Sectional Analysis.1 passage
• Long-Term Premorbid Blood Pressure and Cerebral Small Vessel Disease Burden on Imaging in Transient Ischemic Attack and Ischemic Stroke.1 passage
• Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds.1 passage
• Long-Term Risk of Dementia Among Survivors of Ischemic or Hemorrhagic Stroke.1 passage
• Long-Term Risk of Hemorrhagic Stroke in Young Patients With Congenital Heart Disease.1 passage
• Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts.1 passage
• Long-Term Risk of Stroke in Myocardial Infarction Survivors: Thirty-Year Population-Based Cohort Study.1 passage
• Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke: A Propensity Score-Matched Cohort With up to 10-Year Follow-Up.1 passage
• Long-Term Survival, Causes of Death, and Trends in 5-Year Mortality After Intracerebral Hemorrhage: The Tromsø Study.1 passage
• Long-Term Trends in Stroke Survivors Discharged to Care Homes: The South London Stroke Register.1 passage
• Long-term exposure to fine particulate matter, residential proximity to major roads and measures of brain structure.1 passage
• Longer Length of Delayed-Contrast Filling of Clot on 4-Dimensional Computed Tomographic Angiography Predicts Cardiogenic Embolism.1 passage
• Longitudinal Change of Perceived Salt Intake and Stroke Risk in a Chinese Population.1 passage
• Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.1 passage
• Los Angeles Motor Scale to Identify Large Vessel Occlusion: Prehospital Validation and Comparison With Other Screens.1 passage
• Low Blood Pressure, Comorbidities, and Ischemic Stroke Mortality in US Veterans.1 passage
• Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.1 passage
• Low Levels of Caveolin-1 Predict Symptomatic Bleeding After Thrombolytic Therapy in Patients With Acute Ischemic Stroke.1 passage
• Low Serum Calcium and Magnesium Levels and Rupture of Intracranial Aneurysms.1 passage
• Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).1 passage
• Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation.1 passage
• Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.1 passage
• Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.1 passage
• Low-Frequency Oscillations Are a Biomarker of Injury and Recovery After Stroke.1 passage
• Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours: A Comparative Effectiveness and Safety Study.1 passage
• Lower Coated-Platelet Levels Are Associated With Increased Mortality After Spontaneous Intracerebral Hemorrhage.1 passage
• Lower serum calcium level is associated with hemorrhagic transformation after thrombolysis.1 passage
• Luminal and Wall Changes in Intracranial Arterial Lesions for Predicting Stroke Occurrence.1 passage
• Lymphocytopenia Is an Independent Predictor of Unfavorable Functional Outcome in Spontaneous Intracerebral Hemorrhage.1 passage
• MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.1 passage
• MRI Vessel Wall Enhancement and Other Imaging Biomarkers in Pediatric Focal Cerebral Arteriopathy-Inflammatory Subtype.1 passage
• Machine Learning Approach to Identify Stroke Within 4.5 Hours.1 passage
• Machine Learning Automated Detection of Large Vessel Occlusion From Mobile Stroke Unit Computed Tomography Angiography.1 passage
• Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source.1 passage
• Machine Learning-Based Model for Prediction of Outcomes in Acute Stroke.1 passage
• Machine Learning-Enabled Automated Determination of Acute Ischemic Core From Computed Tomography Angiography.1 passage
• Magnesium and Risk of Bleeding Complications From Ventriculostomy Insertion.1 passage
• Magnetic Resonance Imaging Findings Related to Stroke Risk in Japanese Patients With Fabry Disease.1 passage
• Magnetic Resonance Imaging Measurement of Transmission of Arterial Pulsation to the Brain on Propranolol Versus Amlodipine.1 passage
• Magnetic Resonance Imaging Plaque Hemorrhage for Risk Stratification in Carotid Artery Disease With Moderate Risk Under Current Medical Therapy.1 passage
• Magnetic Resonance Imaging Selection for Endovascular Stroke Therapy: Workflow in the GOLIATH Trial.1 passage
• Magnetic Resonance Imaging Versus Computed Tomography Angiography Based Selection for Endovascular Therapy in Patients With Acute Ischemic Stroke.1 passage
• Magnetic Resonance Imaging and Clinical Factors Associated With Ischemic Stroke in Patients Suspected of Cervical Artery Dissection.1 passage
• Magnetic Resonance Imaging of Plaque Morphology, Burden, and Distribution in Patients With Symptomatic Middle Cerebral Artery Stenosis.1 passage
• Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic Stroke.1 passage
• Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy.1 passage
• Magnetic resonance imaging in experimental stroke and comparison with histology: systematic review and meta-analysis.1 passage
• Magnitude of Benefit of Combined Endovascular Thrombectomy and Intravenous Fibrinolysis in Large Vessel Occlusion Ischemic Stroke.1 passage
• Magnitude of Hematoma Volume Measurement Error in Intracerebral Hemorrhage.1 passage
• Majority of 30-Day Readmissions After Intracerebral Hemorrhage Are Related to Infections.1 passage
• Makin Stephen D.J. MRCPDoubal23 passages
• Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Management of Central Poststroke Pain: Systematic Review of Randomized Controlled Trials.1 passage
• Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.1 passage
• Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association.1 passage
• Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.1 passage
• Marijuana Use Among Young Adults (18-44 Years of Age) and Risk of Stroke: A Behavioral Risk Factor Surveillance System Survey Analysis.1 passage
• Marijuana Use and the Risk of Early Ischemic Stroke: The Stroke Prevention in Young Adults Study.1 passage
• Marine n-3 Polyunsaturated Fatty Acids and the Risk of Ischemic Stroke.1 passage
• Marital Transition and Risk of Stroke: How Living Arrangement and Employment Status Modify Associations.1 passage
• Marked Regional Variation in Acute Stroke Treatment Among Medicare Beneficiaries.1 passage
• Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.1 passage
• Maximal Admission Core Lesion Compatible With Favorable Outcome in Acute Stroke Patients Undergoing Endovascular Procedures.1 passage
• Mean Platelet Volume Does Not Predict Restenosis After Carotid Artery Stenting in Whites.1 passage
• Mean Platelet Volume as a Predictor for Restenosis After Carotid Angioplasty and Stenting.1 passage
• Measure of functional independence dominates discharge outcome prediction after inpatient rehabilitation for stroke.1 passage
• Measurement of perihematomal edema in intracerebral hemorrhage.1 passage
• Mechanical Thrombectomy Improves Functional Outcomes Independent of Pretreatment With Intravenous Thrombolysis.1 passage
• Mechanical Thrombectomy Outcomes With and Without Intravenous Thrombolysis in Stroke Patients: A Meta-Analysis.1 passage
• Mechanical Thrombectomy Outcomes With or Without Intravenous Thrombolysis.1 passage
• Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak: Decreased Activity, and Increased Care Delays.1 passage
• Mechanical Thrombectomy for Acute Ischemic Stroke: Considerations in Children.1 passage
• Mechanical Thrombectomy for Minor and Mild Stroke Patients Harboring Large Vessel Occlusion in the Anterior Circulation: A Multicenter Cohort Study.1 passage
• Mechanical Thrombectomy for Tandem Vertebrobasilar Stroke: Characteristics and Treatment Outcome.1 passage
• Mechanical Thrombectomy in Basilar Artery Occlusion: Clinical Outcomes Related to Posterior Circulation Collateral Score.1 passage
• Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0-5.1 passage
• Mechanical Thrombectomy in Medium Vessel Occlusions: Blind Exchange With Mini-Pinning Technique Versus Mini Stent Retriever Alone.1 passage
• Mechanical Thrombectomy in Patients With Ischemic Stroke With Prestroke Disability.1 passage
• Mechanical Thrombectomy in Patients With Milder Strokes and Large Vessel Occlusions.1 passage
• Mechanical Thrombectomy in Perioperative Strokes: A Case-Control Study.1 passage
• Mechanical Thrombectomy in and Outside the REVASCAT Trial: Insights From a Concurrent Population-Based Stroke Registry.1 passage
• Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology.1 passage
• Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases.1 passage
• Mediators of the Age Effect in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).1 passage
• Medical Treatment Failure for Symptomatic Vasospasm After Subarachnoid Hemorrhage Threatens Long-Term Outcome.1 passage
• Medications as Traumatic Reminders in Patients With Stroke/Transient Ischemic Attack-Induced Posttraumatic Stress Disorder.1 passage
• Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than Thrombolysis.1 passage
• Mendelian Genes and Risk of Intracerebral Hemorrhage and Small-Vessel Ischemic Stroke in Sporadic Cases.1 passage
• Mendelian Randomization Focused Analysis of Vitamin D on the Secondary Prevention of Ischemic Stroke.1 passage
• Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data.1 passage
• Menopausal Hot Flashes and Carotid Intima Media Thickness Among Midlife Women.1 passage
• Mesenchymal Behavior of the Endothelium Promoted by SMAD6 Downregulation Is Associated With Brain Arteriovenous Malformation Microhemorrhage.1 passage
• Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils.1 passage
• Meta-Analysis of Accuracy of the Spot Sign for Predicting Hematoma Growth and Clinical Outcomes.1 passage
• Meta-Analysis of Genome-Wide Association Studies Identifies Genetic Risk Factors for Stroke in African Americans.1 passage
• Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study.1 passage
• Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (II) Effect of Attrition on Follow-Up.1 passage
• Methodological Factors in Determining Risk of Dementia After Transient Ischemic Attack and Stroke: (III) Applicability of Cognitive Tests.1 passage
• Methodological factors in determining rates of dementia in transient ischemic attack and stroke: (I) impact of baseline selection bias.1 passage
• Methods of Implementation of Evidence-Based Stroke Care in Europe: European Implementation Score Collaboration.1 passage
• Mexican American Immigrants Demonstrate Better Functional Stroke Outcomes Compared With Mexican American Nonimmigrants.1 passage
• Mexican Americans Receive Less Intensive Stroke Rehabilitation Than Non-Hispanic Whites.1 passage
• MicroRNA Changes in Cerebrospinal Fluid After Subarachnoid Hemorrhage.1 passage
• Microbiological Etiologies of Pneumonia Complicating Stroke: A Systematic Review.1 passage
• Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke.1 passage
• Microbleeds and Outcome in Patients With Acute Ischemic Stroke and Atrial Fibrillation Taking Anticoagulants.1 passage
• Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.1 passage
• Microemboli After Successful Thrombectomy Do Not Affect Outcome but Predict New Embolic Events.1 passage
• Microstructural Damage in Normal-Appearing Brain Parenchyma and Neurocognitive Dysfunction in Adult Moyamoya Disease.1 passage
• Microstructural White Matter Abnormalities and Cognitive Impairment After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible Unruptured Brain Arteriovenous Malformations.1 passage
• Microvascular Brain Disease Progression and Risk of Stroke: The ARIC Study.1 passage
• Midlife Alcohol Consumption and the Risk of Stroke in the Atherosclerosis Risk in Communities Study.1 passage
• Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study.1 passage
• Migraine With Aura as Early Disease Marker in Hereditary Dutch-Type Cerebral Amyloid Angiopathy.1 passage
• Migraine and Cerebrovascular Atherosclerosis in Patients With Ischemic Stroke.1 passage
• Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.1 passage
• Mind-Body Interventions, Psychological Stressors, and Quality of Life in Stroke Survivors.1 passage
• Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies.1 passage
• Minimally Invasive Surgery for Intracerebral Hemorrhage.1 passage
• Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial.1 passage
• Misdiagnosis Worsens Prognosis in Subarachnoid Hemorrhage With Good Hunt and Hess Score.1 passage
• Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department.1 passage
• Misdiagnosis of Cervicocephalic Artery Dissection in the Emergency Department.1 passage
• Misery perfusion, blood pressure control, and 5-year stroke risk in symptomatic major cerebral artery disease.1 passage
• Mismatch Profile Influences Outcome After Mechanical Thrombectomy.1 passage
• Missed Ischemic Stroke Diagnosis in the Emergency Department by Emergency Medicine and Neurology Services.1 passage
• Missed strokes using computed tomography imaging in patients with vertigo: population-based cohort study.1 passage
• Mobile Interventional Stroke Team Model Improves Early Outcomes in Large Vessel Occlusion Stroke: The NYC MIST Trial.1 passage
• Mobile Interventional Stroke Teams Improve Outcomes in the Early Time Window for Large Vessel Occlusion Stroke.1 passage
• Mobile Interventional Stroke Teams Lead to Faster Treatment Times for Thrombectomy in Large Vessel Occlusion.1 passage
• Mobile Stroke Unit Computed Tomography Angiography Substantially Shortens Door-to-Puncture Time.1 passage
• Modafinil May Alleviate Poststroke Fatigue: A Randomized, Placebo-Controlled, Double-Blinded Trial.1 passage
• Modeling Ischemia in the Immature Brain: How Translational Are Animal Models?1 passage
• Modeling the Impact of Interhospital Transfer Network Design on Stroke Outcomes in a Large City.1 passage
• Modeling the Optimal Transportation for Acute Stroke Treatment: The Impact of the Drip-and-Drive Paradigm.1 passage
• Modifiable Cardiovascular Risk Factors in Patients With Sporadic Cerebral Cavernous Malformations: Obesity Matters.1 passage
• Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study.1 passage
• Modified Thrombolysis in Cerebral Infarction 2C/Thrombolysis in Cerebral Infarction 3 Reperfusion Should Be the Aim of Mechanical Thrombectomy: Insights From the ASTER Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization).1 passage
• Molecular Biomarkers and Drug Targets in Brain Arteriovenous and Cavernous Malformations: Where Are We?1 passage
• Molecular Magnetic Resonance Imaging of Vascular Inflammation After Recanalization in a Rat Ischemic Stroke Model.1 passage
• Monocyte Chemotactic Protein-1-Interleukin-6-Osteopontin Pathway of Intra-Aneurysmal Tissue Healing.1 passage
• Monocyte Count and 30-Day Case Fatality in Intracerebral Hemorrhage.1 passage
• Montreal Cognitive Assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration.1 passage
• Montreal Cognitive Assessment: One Cutoff Never Fits All.1 passage
• Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.1 passage
• Mortality Reduction for Fever, Hyperglycemia, and Swallowing Nurse-Initiated Stroke Intervention: QASC Trial (Quality in Acute Stroke Care) Follow-Up.1 passage
• Motor Recovery Prediction With Clinical Assessment and Local Diffusion Homogeneity After Acute Subcortical Infarction.1 passage
• Movement Behavior Patterns in People With First-Ever Stroke.1 passage
• Multicenter, Prospective, Controlled, Before-and-After, Quality Improvement Study (Stroke123) of Acute Stroke Care.1 passage
• Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes.1 passage
• Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial.1 passage
• Multilevel Models to Estimate Carotid Intima-Media Thickness Curves for Individual Cardiovascular Risk Evaluation.1 passage
• Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa.1 passage
• Multimodal Assessment of the Motor System in Patients With Chronic Ischemic Stroke.1 passage
• Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning.1 passage
• Multiparametric Magnetic Resonance Imaging for Prediction of Parenchymal Hemorrhage in Acute Ischemic Stroke After Reperfusion Therapy.1 passage
• Multiparametric Model for Penumbral Flow Prediction in Acute Stroke.1 passage
• Multiphasic Computed Tomography Angiography Findings for Identifying Pseudo-Occlusion of the Internal Carotid Artery.1 passage
• Multiple Chronic Conditions Explain Ethnic Differences in Functional Outcome Among Patients With Ischemic Stroke.1 passage
• Multiple Infarcts Are Associated With Long-Term Stroke Recurrence and All-Cause Mortality in Cryptogenic Stroke Patients.1 passage
• Multiple Soluble Components of the Glycocalyx Are Increased in Patient Plasma After Ischemic Stroke.1 passage
• Multivessel Occlusion in Patients Subjected to Thrombectomy: Prevalence, Associated Factors, and Clinical Implications.1 passage
• Multivitamin use and risk of stroke mortality: the Japan collaborative cohort study.1 passage
• Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice.1 passage
• NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.1 passage
• NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.1 passage
• NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.1 passage
• Nanoliposomes Reduce Stroke Injury Following Middle Cerebral Artery Occlusion in Mice.1 passage
• National Analysis of 2454 Pediatric Moyamoya Admissions and the Effect of Hospital Volume on Outcomes.1 passage
• National Institutes of Health Stroke Scale Item Profiles as Predictor of Patient Outcome: External Validation on Safe Implementation of Thrombolysis in Stroke-Monitoring Study Data.1 passage
• National Institutes of Health Stroke Scale Zero Strokes.1 passage
• National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.1 passage
• National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond.1 passage
• National Institutes of Health StrokeNet Training Core.1 passage
• National Practice Patterns of Obtaining Informed Consent for Stroke Thrombolysis.1 passage
• National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015.1 passage
• National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, 2008 to 2014.1 passage
• National institutes of health stroke scale item profiles as predictor of patient outcome: external validation on independent trial data.1 passage
• Nationwide Analysis of Endovascular Thrombectomy Provider Specialization for Acute Stroke.1 passage
• Nationwide Estimates of 30-Day Readmission in Patients With Ischemic Stroke.1 passage
• Nationwide Trends in Carotid Endarterectomy and Carotid Artery Stenting in the Post-CREST Era.1 passage
• Natural Course of Cerebral Cavernous Malformations in Children: A Five-Year Follow-Up Study.1 passage
• Natural Course of Moyamoya Disease in Patients With Prior Hemorrhagic Stroke.1 passage
• Natural History and Clinical Outcomes of Paravertebral Arteriovenous Shunts.1 passage
• Natural History of Hemodynamics in Vertebrobasilar Disease: Temporal Changes in the VERiTAS Study Cohort.1 passage
• Natural History of Perihematomal Edema and Impact on Outcome After Intracerebral Hemorrhage.1 passage
• Natural History of Ruptured but Untreated Intracranial Aneurysms.1 passage
• Natural history and management of basilar trunk artery aneurysms.1 passage
• Neighborhood Socioeconomic Status and Trajectories of Physical Health-Related Quality of Life Among Stroke Survivors.1 passage
• Nerve Stimulation Enhances Task-Oriented Training in Chronic, Severe Motor Deficit After Stroke: A Randomized Trial.1 passage
• Network Efficiency Mediates the Relationship Between Vascular Burden and Cognitive Impairment: A Diffusion Tensor Imaging Study in UK Biobank.1 passage
• Neurocognitive Performance After Cerebral Revascularization in Adult Moyamoya Disease.1 passage
• Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).1 passage
• Neuroimaging Determinants of Poststroke Cognitive Performance.1 passage
• Neuroimaging Identifies Patients Most Likely to Respond to a Restorative Stroke Therapy.1 passage
• Neuroimaging in Ischemic Stroke Is Different Between Men and Women in the DEFUSE 3 Cohort.1 passage
• Neuroimaging markers for early neurologic deterioration in single small subcortical infarction.1 passage
• Neurologic Examination at 24 to 48 Hours Predicts Functional Outcomes in Basilar Artery Occlusion Stroke.1 passage
• Neurologic Outcome Predictors in Pediatric Intracerebral Hemorrhage: A Prospective Study.1 passage
• Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke.1 passage
• Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults.1 passage
• Neuropathology of White Matter Lesions, Blood-Brain Barrier Dysfunction, and Dementia.1 passage
• Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).1 passage
• Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats.1 passage
• Neurorestorative Therapy of Stroke in Type 2 Diabetes Mellitus Rats Treated With Human Umbilical Cord Blood Cells.1 passage
• Neutrophil-Lymphocyte Ratio and Perihematomal Edema Growth in Intracerebral Hemorrhage.1 passage
• Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke.1 passage
• Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage.1 passage
• New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention.1 passage
• Newly Diagnosed Leptospirosis and Subsequent Hemorrhagic Stroke: A Nationwide Population-Based Cohort Study.1 passage
• NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.1 passage
• No Racial Difference in Rehabilitation Therapy Across All Post-Acute Care Settings in the Year Following a Stroke.1 passage
• No Racial Disparity in Outcome Measures After Endovascular Treatment for Stroke in the Elderly.1 passage
• No relationship of lipid-lowering agents to hematoma growth: pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trials studies.1 passage
• Nocturnal Desaturation in the Stroke Unit Is Associated With Wake-Up Ischemic Stroke.1 passage
• Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.1 passage
• Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.1 passage
• Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.1 passage
• Nonatheroscleotic Isolated Middle Cerebral Artery Disease May Be Early Manifestation of Moyamoya Disease.1 passage
• Nonatrial Fibrillation Patients With Complete P Wave Disappearance: An Overlooked Population With High Stroke Risk.1 passage
• Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN.1 passage
• Noncontrast Computed Tomography Hypodensities Predict Poor Outcome in Intracerebral Hemorrhage Patients.1 passage
• Noncontrast Computed Tomography Signs as Predictors of Hematoma Expansion, Clinical Outcome, and Response to Tranexamic Acid in Acute Intracerebral Hemorrhage.1 passage
• Noncontrast Computed Tomography e-Stroke Infarct Volume Is Similar to RAPID Computed Tomography Perfusion in Estimating Postreperfusion Infarct Volumes.1 passage
• Nonconvulsive Status Epilepticus in Acute Intracerebral Hemorrhage.1 passage
• Nonfocal Transient Neurological Attacks Are Associated With Cerebral Small Vessel Disease.1 passage
• Nongated Cardiac Computed Tomographic Angiograms for Detection of Embolic Sources in Acute Ischemic Stroke.1 passage
• Noninferiority Margins in Trials of Thrombectomy Devices for Acute Ischemic Stroke: Is the Bar Being Set Too Low?1 passage
• Noninvasive Assessment of Oxygen Extraction Fraction in Chronic Ischemia Using Quantitative Susceptibility Mapping at 7 Tesla.1 passage
• Noninvasive Ventilatory Correction in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.1 passage
• Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).1 passage
• Nonpsychotic Mental Disorders in Teenage Males and Risk of Early Stroke: A Population-Based Study.1 passage
• Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source: Interplay of Arterial and Atrial Disease.1 passage
• Normal-Appearing White Matter Integrity Is a Predictor of Outcome After Ischemic Stroke.1 passage
• Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke.1 passage
• Novel Diffusion-Weighted Imaging Score Showed Good Prognostic Value for Acute Basilar Artery Occlusion Following Endovascular Treatment: The Pons-Midbrain and Thalamus Score.1 passage
• Novel Interactive Data Visualization: Exploration of the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times) Data.1 passage
• Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.1 passage
• Novel Screening Tool for Stroke Using Artificial Neural Network.1 passage
• Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.1 passage
• Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.1 passage
• Novel score predicting gastrostomy tube placement in intracerebral hemorrhage.1 passage
• Number of Stent Retriever Passes Associated With Futile Recanalization in Acute Stroke.1 passage
• Nursing's Role in Successful Stroke Care Transitions Across the Continuum: From Acute Care Into the Community.1 passage
• Obesity Does Not Protect From Subarachnoid Hemorrhage: Pooled Analyses of 3 Large Prospective Nordic Cohorts.1 passage
• Obesity Paradox in Intracerebral Hemorrhage.1 passage
• Obesity increases risk of ischemic stroke in young adults.1 passage
• Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging: Atherosclerosis Risk in Communities Study.1 passage
• Observer Agreement on Computed Tomography Perfusion Imaging in Acute Ischemic Stroke.1 passage
• Obstructive Sleep Apnea as a Risk Factor for Intracerebral Hemorrhage.1 passage
• Obstructive Sleep Apnea in Acute Stroke: A Role for Systemic Inflammation.1 passage
• Occult anterograde flow is an under-recognized but crucial predictor of early recanalization with intravenous tissue-type plasminogen activator.1 passage
• Occurrence Rate of Delirium in Acute Stroke Settings: Systematic Review and Meta-Analysis.1 passage
• Occurrence and Predictors of Falls in People With Stroke: Six-Year Prospective Study.1 passage
• Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.1 passage
• One-Stop Management of Acute Stroke Patients: Minimizing Door-to-Reperfusion Times.1 passage
• One-Year Healthcare Utilization for Patients That Received Endovascular Treatment Compared With Control.1 passage
• One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis.1 passage
• One-Year Incidence, Time Trends, and Predictors of Recurrent Ischemic Stroke in Sweden From 1998 to 2010: An Observational Study.1 passage
• One-Year Outcome After Endovascular Treatment for Acute Basilar Artery Occlusion.1 passage
• One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis.1 passage
• Online Tool to Improve Stratification of Adverse Events in Stroke Clinical Trials.1 passage
• Operator Versus Core Lab Adjudication of Reperfusion After Endovascular Treatment of Acute Ischemic Stroke.1 passage
• Optimal Computed Tomographic Perfusion Scan Duration for Assessment of Acute Stroke Lesion Volumes.1 passage
• Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack.1 passage
• Optimal Medical Management of Asymptomatic Carotid Stenosis.1 passage
• Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.1 passage
• Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation.1 passage
• Optimal Timing of Diffusion-Weighted Imaging to Avoid False-Negative Findings in Patients With Transient Ischemic Attack.1 passage
• Optimal Tissue Reperfusion Estimation by Computed Tomography Perfusion Post-Thrombectomy in Acute Ischemic Stroke.1 passage
• Optimal Transport Destination for Ischemic Stroke Patients With Unknown Vessel Status: Use of Prehospital Triage Scores.1 passage
• Optimizating Clot Retrieval in Acute Stroke: The Push and Fluff Technique for Closed-Cell Stentrievers.1 passage
• Optimization of Prehospital Triage of Patients With Suspected Ischemic Stroke.1 passage
• Optimizing Emergency Stroke Transport Strategies Using Physiological Models.1 passage
• Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.1 passage
• Oral Carriage of1 passage
• Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease.1 passage
• Original and Modified Graeb Score Correlation With Intraventricular Hemorrhage and Clinical Outcome Prediction in Hyperacute Intracranial Hemorrhage.1 passage
• Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia.1 passage
• Orosomucoid, Carotid Plaque, and Incidence of Stroke.1 passage
• Outcome After Reperfusion Therapies in Patients With Large Baseline Diffusion-Weighted Imaging Stroke Lesions: A THRACE Trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke) Subgroup Analysis.1 passage
• Outcome After Thrombectomy and Intravenous Thrombolysis in Patients With Acute Ischemic Stroke: A Prospective Observational Study.1 passage
• Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis.1 passage
• Outcome Prediction Models for Endovascular Treatment of Ischemic Stroke: Systematic Review and External Validation.1 passage
• Outcome in Direct Versus Transfer Patients in the DAWN Controlled Trial.1 passage
• Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis.1 passage
• Outcomes After Direct Thrombectomy or Combined Intravenous and Endovascular Treatment Are Not Different.1 passage
• Outcomes Among Patients With Ischemic Stroke Treated With Intravenous tPA (Tissue-Type Plasminogen Activator) via Telemedicine.1 passage
• Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis.1 passage
• Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).1 passage
• Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan.1 passage
• Outcomes of Endovascular Treatment for Acute Intracranial Atherosclerosis-Related Large Vessel Occlusion.1 passage
• Outcomes of Large Vessel Occlusion Stroke in Patients Aged ≥90 Years.1 passage
• Outcomes of Primary and Secondary Carotid Artery Stenting.1 passage
• Outcomes of Spoke-Retained Telestroke Patients Versus Hub-Treated Patients After Intravenous Thrombolysis: Telestroke Patient Outcomes After Thrombolysis.1 passage
• Outcomes of Surgery for Brainstem Cavernous Malformations: A Systematic Review.1 passage
• Overestimation of Susceptibility Vessel Sign: A Predictive Marker of Stroke Cause.1 passage
• Overlap in the Genetic Architecture of Stroke Risk, Early Neurological Changes, and Cardiovascular Risk Factors.1 passage
• Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.1 passage
• Oxidized Low-Density Lipoprotein to High-Density Lipoprotein Ratio Predicts Recurrent Stroke in Minor Stroke or Transient Ischemic Attack.1 passage
• Oxygen Metabolic Stress and White Matter Injury in Patients With Cerebral Small Vessel Disease.1 passage
• Oxygenation-Sensitive Magnetic Resonance Imaging in Acute Ischemic Stroke Using T2'/R2' Mapping: Influence of Relative Cerebral Blood Volume.1 passage
• P-Wave Indices and Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis.1 passage
• P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack.1 passage
• PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial.1 passage
• PHASES Score for Prediction of Intracranial Aneurysm Growth.1 passage
• PHASES Score for the Management of Intracranial Aneurysm: A Cross-Sectional Population-Based Retrospective Study.1 passage
• PINGS (Phone-Based Intervention Under Nurse Guidance After Stroke): Interim Results of a Pilot Randomized Controlled Trial.1 passage
• PLUMBER Study (Prevalence of Large Vessel Occlusion Strokes in Mecklenburg County Emergency Response).1 passage
• PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients.1 passage
• PROMIS GH (Patient-Reported Outcomes Measurement Information System Global Health) Scale in Stroke: A Validation Study.1 passage
• Palliative Care for Hospitalized Patients With Stroke: Results From the 2010 to 2012 National Inpatient Sample.1 passage
• Pancreatic β-Cell Function and Prognosis of Nondiabetic Patients With Ischemic Stroke.1 passage
• Pandemic Guidance for Stroke Centers Aiding COVID-19 Treatment Teams.1 passage
• Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke.1 passage
• Paramedic Global Impression of Change During Prehospital Evaluation and Transport for Acute Stroke.1 passage
• Paramedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy - Magnesium).1 passage
• Parental Atrial Fibrillation and Stroke or Atrial Fibrillation in Young Adults.1 passage
• Parental Care-Seeking Behavior and Prehospital Timelines of Care in Childhood Arterial Ischemic Stroke.1 passage
• Parvovirus B19 Infection in Children With Arterial Ischemic Stroke.1 passage
• Patent Foramen Ovale and Cryptogenic Strokes in the Stroke in Young Fabry Patients Study.1 passage
• Path From Clinical Research to Implementation: Endovascular Treatment of Ischemic Stroke in the Netherlands.1 passage
• Pathogenesis and Risk Factors for Cerebral Infarct After Surgical Aortic Valve Replacement.1 passage
• Pathophysiology of Central Poststroke Pain: Motor Cortex Disinhibition and Its Clinical and Sensory Correlates.1 passage
• Pathophysiology of Intracranial Aneurysms: COX-2 Expression, Iron Deposition in Aneurysm Wall, and Correlation With Magnetic Resonance Imaging.1 passage
• Pathway Design for Acute Stroke Care in the Era of Endovascular Thrombectomy: A Critical Overview of Optimization Efforts.1 passage
• Patient- and Aneurysm-Specific Risk Factors for Intracranial Aneurysm Growth: A Systematic Review and Meta-Analysis.1 passage
• Patient-Reported Experience Measures in Stroke Care: A Systematic Review.1 passage
• Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.1 passage
• Patients With Undetermined Stroke Have Increased Atrial Fibrosis: A Cardiac Magnetic Resonance Imaging Study.1 passage
• Patterns and Implications of Intracranial Arterial Remodeling in Stroke Patients.1 passage
• Patterns and Outcomes of Endovascular Therapy in Mild Stroke.1 passage
• Patterns of Neointima Formation After Coil or Stent Treatment in a Rat Saccular Sidewall Aneurysm Model.1 passage
• Patterns of poststroke brain damage that predict speech production errors in apraxia of speech and aphasia dissociate.1 passage
• Pediatric Acute Stroke Protocol Activation in a Children's Hospital Emergency Department.1 passage
• Pediatric Cortical Vein Thrombosis: Frequency and Association With Venous Infarction.1 passage
• Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial.1 passage
• Per-Pass Analysis of Thrombus Composition in Patients With Acute Ischemic Stroke Undergoing Mechanical Thrombectomy.1 passage
• Perceived Unmet Rehabilitation Needs 1 Year After Stroke: An Observational Study From the Swedish Stroke Register.1 passage
• Percutaneous Endoscopic Gastrostomy and Mortality After Stroke in England From 2007 to 2018: A Retrospective Cohort Study.1 passage
• Perfusion Computed Tomography Accurately Quantifies Collateral Flow After Acute Ischemic Stroke.1 passage
• Perihematomal Edema After Intracerebral Hemorrhage in Patients With Active Malignancy.1 passage
• Perihematomal Edema Is Greater in the Presence of a Spot Sign but Does Not Predict Intracerebral Hematoma Expansion.1 passage
• Perihematomal Edema and Functional Outcomes in Intracerebral Hemorrhage: Influence of Hematoma Volume and Location.1 passage
• Perimesencephalic Hemorrhage: A Review of Epidemiology, Risk Factors, Presumed Cause, Clinical Course, and Outcome.1 passage
• Periodontal Disease, Regular Dental Care Use, and Incident Ischemic Stroke.1 passage
• Perioperative Antihypertensive Treatment in Patients With Spontaneous Intracerebral Hemorrhage.1 passage
• Perioperative Cerebral Microbleeds After Adult Cardiac Surgery.1 passage
• Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.1 passage
• Peripheral Blood MCEMP1 Gene Expression as a Biomarker for Stroke Prognosis.1 passage
• Periprocedural Intravenous Heparin During Endovascular Treatment for Ischemic Stroke: Results From the MR CLEAN Registry.1 passage
• Periprocedural Myocardial Infarction After Carotid Endarterectomy and Stenting: Systematic Review and Meta-Analysis.1 passage
• Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy.1 passage
• Perivascular adipose adiponectin correlates with symptom status of patients undergoing carotid endarterectomy.1 passage
• Permeability Surface of Deep Middle Cerebral Artery Territory on Computed Tomographic Perfusion Predicts Hemorrhagic Transformation After Stroke.1 passage
• Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.1 passage
• Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3.1 passage
• Persistently Elevated Microvascular Resistance Postrecanalization.1 passage
• Personalized Prehospital Triage in Acute Ischemic Stroke.1 passage
• Pervasive White Matter Fiber Degeneration in Ischemic Stroke.1 passage
• Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).1 passage
• Pharyngeal Electrical Stimulation for Treatment of Dysphagia in Subacute Stroke: A Randomized Controlled Trial.1 passage
• Phase 1/2a Trial of ISPASM.1 passage
• Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage.1 passage
• Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.1 passage
• Phenotypes of Chronic Covert Brain Infarction in Patients With First-Ever Ischemic Stroke: A Cohort Study.1 passage
• Phone and Video-Based Modalities of Central Blinded Adjudication of Modified Rankin Scores in an Endovascular Stroke Trial.1 passage
• Phosphatidylethanol Levels, As a Marker of Alcohol Consumption, Are Associated With Risk of Intracerebral Hemorrhage.1 passage
• Picturing the Size and Site of Stroke With an Expanded National Institutes of Health Stroke Scale.1 passage
• Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis.1 passage
• Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms: One-Year Outcomes.1 passage
• Plaque Distribution Correlates With Morphology of Lenticulostriate Arteries in Single Subcortical Infarctions.1 passage
• Plaque components in symptomatic moderately stenosed carotid arteries related to cerebral infarcts: the plaque at RISK study.1 passage
• Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.1 passage
• Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease.1 passage
• Plasma Estradiol and Testosterone Levels and Ischemic Stroke in Postmenopausal Women.1 passage
• Plasma Glial Fibrillary Acidic Protein in the Differential Diagnosis of Intracerebral Hemorrhage.1 passage
• Plasma Heme Oxygenase-1 Levels and Carotid Atherosclerosis.1 passage
• Plasma Sulfur Amino Acids and Risk of Cerebrovascular Diseases: A Nested Case-Control Study in the EPIC-Norfolk Cohort.1 passage
• Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study.1 passage
• Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source.1 passage
• Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants.1 passage
• Polygenic Risk for Depression Increases Risk of Ischemic Stroke: From the Stroke Genetics Network Study.1 passage
• Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies.1 passage
• Poor Outcome of Stroke Patients With Atrial Fibrillation in the Presence of Coexisting Spontaneous Echo Contrast.1 passage
• Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke.1 passage
• Population-Based Study of Cerebral Microbleeds in Stroke-Free Older Adults Living in Rural Ecuador: The Atahualpa Project.1 passage
• Portable Neuromonitoring Device Detects Large Vessel Occlusion in Suspected Acute Ischemic Stroke.1 passage
• Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke.1 passage
• Post-Thrombolysis Recanalization in Stroke Referrals for Thrombectomy: Incidence, Predictors, and Prediction Scores.1 passage
• Posterior Arterial Ischemic Stroke in Childhood.1 passage
• Posterior Reversible Encephalopathy Syndrome as an Overlooked Complication of Induced Hypertension for Cerebral Vasospasm: Systematic Review and Illustrative Case.1 passage
• Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.1 passage
• Postmortem Study Exploring Distribution and Patterns of Intracranial Artery Calcification.1 passage
• Postmortem Study of Validation of Low Signal on Fat-Suppressed T1-Weighted Magnetic Resonance Imaging as Marker of Lipid Core in Middle Cerebral Artery Atherosclerosis.1 passage
• Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation.1 passage
• Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis.1 passage
• Poststroke Cognitive Impairment Negatively Impacts Activity and Participation Outcomes: A Systematic Review and Meta-Analysis.1 passage
• Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Poststroke Epilepsy Is Associated With a High Mortality After a Stroke at Young Age: Follow-Up of Transient Ischemic Attack and Stroke Patients and Unelucidated Risk Factor Evaluation Study.1 passage
• Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association.1 passage
• Posttraumatic Stress Disorder and Risk for Stroke in Young and Middle-Aged Adults: A 13-Year Cohort Study.1 passage
• Posttraumatic Stress Disorder, Antidepressant Use, and Hemorrhagic Stroke in Young Men and Women: A 13-Year Cohort Study.1 passage
• Posttreatment National Institutes of Health Stroke Scale Is Superior to the Initial Score or Thrombolysis in Cerebral Ischemia for 3-Month Outcome.1 passage
• Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.1 passage
• Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.1 passage
• Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data.1 passage
• Practical Small Vessel Disease Score Relates to Stroke, Dementia, and Death.1 passage
• Preadmission Use of Glucocorticoids and 30-Day Mortality After Stroke.1 passage
• Predicting 10-Year and Lifetime Stroke Risk in Chinese Population.1 passage
• Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change.1 passage
• Predicting Clinical Outcomes of Large Vessel Occlusion Before Mechanical Thrombectomy Using Machine Learning.1 passage
• Predicting Collateral Status With Magnetic Resonance Perfusion Parameters: Probabilistic Approach With a Tmax-Derived Prediction Model.1 passage
• Predicting Dementia in Cerebral Small Vessel Disease Using an Automatic Diffusion Tensor Image Segmentation Technique.1 passage
• Predicting Domain-Specific Health-Related Quality of Life Using Acute Infarct Volume.1 passage
• Predicting Early Mortality of Acute Ischemic Stroke.1 passage
• Predicting Home and Community Walking Activity Poststroke.1 passage
• Predicting Infarct Core From Computed Tomography Perfusion in Acute Ischemia With Machine Learning: Lessons From the ISLES Challenge.1 passage
• Predicting Intracerebral Hemorrhage Expansion With Noncontrast Computed Tomography: The BAT Score.1 passage
• Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time.1 passage
• Predicting Longitudinal Progression in Functional Mobility After Stroke: A Prospective Cohort Study.1 passage
• Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.1 passage
• Predicting Modafinil-Treatment Response in Poststroke Fatigue Using Brain Morphometry and Functional Connectivity.1 passage
• Predicting Progression of Intracranial Arteriopathies in Childhood Stroke With Vessel Wall Imaging.1 passage
• Predicting Recovery Potential for Individual Stroke Patients Increases Rehabilitation Efficiency.1 passage
• Prediction Models for Clinical Outcome After a Carotid Revascularization Procedure.1 passage
• Prediction of Aneurysm Stability Using a Machine Learning Model Based on PyRadiomics-Derived Morphological Features.1 passage
• Prediction of Blood-Brain Barrier Disruption and Intracerebral Hemorrhagic Infarction Using Arterial Spin-Labeling Magnetic Resonance Imaging.1 passage
• Prediction of Clinical Outcome After Acute Ischemic Stroke: The Value of Repeated Noncontrast Computed Tomography, Computed Tomographic Angiography, and Computed Tomographic Perfusion.1 passage
• Prediction of Cognitive Recovery After Stroke: The Value of Diffusion-Weighted Imaging-Based Measures of Brain Connectivity.1 passage
• Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.1 passage
• Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study.1 passage
• Prediction of Early Reperfusion From Repeated Arterial Spin Labeling Perfusion Magnetic Resonance Imaging During Intravenous Thrombolysis.1 passage
• Prediction of Outcome After Aneurysmal Subarachnoid Hemorrhage.1 passage
• Prediction of Outcomes for Ruptured Aneurysm Surgery.1 passage
• Prediction of Recurrent Stroke or Transient Ischemic Attack After Noncardiogenic Posterior Circulation Ischemic Stroke.1 passage
• Prediction of Stroke Infarct Growth Rates by Baseline Perfusion Imaging.1 passage
• Prediction of Stroke Onset Is Improved by Relative Fluid-Attenuated Inversion Recovery and Perfusion Imaging Compared to the Visual Diffusion-Weighted Imaging/Fluid-Attenuated Inversion Recovery Mismatch.1 passage
• Prediction of Stroke Subtype and Recanalization Using Susceptibility Vessel Sign on Susceptibility-Weighted Magnetic Resonance Imaging.1 passage
• Prediction of Tissue Outcome and Assessment of Treatment Effect in Acute Ischemic Stroke Using Deep Learning.1 passage
• Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study.1 passage
• Predictive Value of Computed Tomography Angiography-Determined Occlusion Type in Stent Retriever Thrombectomy.1 passage
• Predictive Value of Pulse Pressure in Acute Ischemic Stroke for Future Major Vascular Events.1 passage
• Predictive Value of RAPID Assessed Perfusion Thresholds on Final Infarct Volume in SWIFT PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment).1 passage
• Predictive Value of Susceptibility Vessel Sign for Arterial Recanalization and Clinical Improvement in Ischemic Stroke.1 passage
• Predictors and Clinical Impact of Incident Lacunes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.1 passage
• Predictors and Functional Outcomes of Fast, Intermediate, and Slow Progression Among Patients With Acute Ischemic Stroke.1 passage
• Predictors and Outcomes of Dysphagia Screening After Acute Ischemic Stroke.1 passage
• Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.1 passage
• Predictors for Failure of Early Neurological Improvement After Successful Thrombectomy in the Anterior Circulation.1 passage
• Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic Stroke.1 passage
• Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.1 passage
• Predictors of Dysphagia in Acute Pontine Infarction.1 passage
• Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease.1 passage
• Predictors of Early Neurologic Deterioration in Acute Pontine Infarction.1 passage
• Predictors of Endovascular Treatment Among Stroke Codes Activated Within 6 Hours From Symptom Onset.1 passage
• Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice.1 passage
• Predictors of Good Outcome After Endovascular Therapy for Vertebrobasilar Occlusion Stroke.1 passage
• Predictors of Good Outcome After Stent-Retriever Thrombectomy in Acute Basilar Artery Occlusion.1 passage
• Predictors of In-Hospital Death After Aneurysmal Subarachnoid Hemorrhage: Analysis of a Nationwide Database (Swiss SOS [Swiss Study on Aneurysmal Subarachnoid Hemorrhage]).1 passage
• Predictors of Mortality in Acute Ischemic Stroke Intervention: Analysis of the North American Solitaire Acute Stroke Registry.1 passage
• Predictors of Outcome in Aneurysmal Subarachnoid Hemorrhage Patients: Observations From a Multicenter Data Set.1 passage
• Predictors of Parenchymal Hematoma After Mechanical Thrombectomy: A Multicenter Study1 passage
• Predictors of Restenosis Following Carotid Angioplasty and Stenting.1 passage
• Predictors of Stroke After Transient Ischemic Attack in Children.1 passage
• Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.1 passage
• Predictors of Unexpected Early Reocclusion After Successful Mechanical Thrombectomy in Acute Ischemic Stroke Patients.1 passage
• Predictors of Unexplained Early Neurological Deterioration After Endovascular Treatment for Acute Ischemic Stroke.1 passage
• Predictors of finding occult atrial fibrillation after cryptogenic stroke.1 passage
• Predictors of the Aspiration Component Success of a Direct Aspiration First Pass Technique (ADAPT) for the Endovascular Treatment of Stroke Reperfusion Strategy in Anterior Circulation Acute Stroke.1 passage
• Predominance of Nonatherosclerotic Internal Elastic Lamina Calcification in the Intracranial Internal Carotid Artery.1 passage
• Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke.1 passage
• Preexisting Mild Cognitive Impairment, Dementia, and Receipt of Treatments for Acute Ischemic Stroke.1 passage
• Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.1 passage
• Prehospital Acute Stroke Severity Scale to Predict Large Artery Occlusion: Design and Comparison With Other Scales.1 passage
• Prehospital Emergency Care in Childhood Arterial Ischemic Stroke.1 passage
• Prehospital Systolic Blood Pressure Is Related to Intracerebral Hemorrhage Volume on Admission.1 passage
• Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial.1 passage
• Prehospital Triage Accuracy in Patients With Stroke Symptoms Assessed Within 6 to 24 Hours or With an Unknown Time of Onset.1 passage
• Prehospital Triage Strategies for the Transportation of Suspected Stroke Patients in the United States.1 passage
• Prehospital Triage of Acute Stroke Patients During the COVID-19 Pandemic.1 passage
• Preliminary Examination of the Ability of a New Wearable Device to Capture Functional Hand Activity After Stroke.1 passage
• Premature ventricular complexes on screening electrocardiogram and risk of ischemic stroke.1 passage
• Prescription of Guideline-Based Medical Therapies at Discharge After Carotid Artery Stenting and Endarterectomy: An NCDR Analysis.1 passage
• Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.1 passage
• Presence of Anterior Communicating Artery Aneurysm Is Associated With Age, Bifurcation Angle, and Vessel Diameter.1 passage
• Prestroke Disability Predicts Adverse Poststroke Outcome: A Registry-Based Prospective Cohort Study of Acute Stroke.1 passage
• Prestroke Physical Activity and Adverse Health Outcomes After Stroke in the Atherosclerosis Risk in Communities Study.1 passage
• Prestroke Vascular Pathology and the Risk of Recurrent Stroke and Poststroke Dementia.1 passage
• Prevalence and Natural History of Superficial Siderosis: A Population-Based Study.1 passage
• Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation: WATCH-AF Registry.1 passage
• Prevalence and Outcomes of Medium Vessel Occlusions With Discrepant Infarct Patterns.1 passage
• Prevalence and Prognostic Significance of Malnutrition Risk in Patients With Acute Ischemic Stroke: Results From the Third China National Stroke Registry.1 passage
• Prevalence and Risk Factors of Acute Incidental Infarcts.1 passage
• Prevalence and Risk Factors of White Matter Lesions in Tibetan Patients Without Acute Stroke.1 passage
• Prevalence and Temporal Distribution of Fast and Slow Progressors of Infarct Growth in Large Vessel Occlusion Stroke.1 passage
• Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment.1 passage
• Prevalence of Depression Among Stroke Survivors: Racial-Ethnic Differences.1 passage
• Prevalence of Developmental Venous Anomalies Increases With Age.1 passage
• Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.1 passage
• Prevalence of Imaging Biomarkers to Guide the Planning of Acute Stroke Reperfusion Trials.1 passage
• Prevalence of Individuals Experiencing the Effects of Stroke in Canada: Trends and Projections.1 passage
• Prevalence of Intracranial Aneurysms in Patients With Systemic Vessel Aneurysms: A Nationwide Cohort Study.1 passage
• Prevalence of Intracranial Atherosclerotic Stenosis Using High-Resolution Magnetic Resonance Angiography in the General Population: The Atherosclerosis Risk in Communities Study.1 passage
• Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source.1 passage
• Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke.1 passage
• Prevalence of Positive Troponin and Echocardiogram Findings and Association With Mortality in Acute Ischemic Stroke.1 passage
• Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit.1 passage
• Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis.1 passage
• Prevalence of Stroke and Its Risk Factors in Urban Sri Lanka: Population-Based Study.1 passage
• Prevention of Stroke in Atrial Fibrillation After Coronary Stenting.1 passage
• Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Preventive Suboccipital Decompressive Craniectomy for Cerebellar Infarction: A Retrospective-Matched Case-Control Study.1 passage
• Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study.1 passage
• Primary Angiitis of the Central Nervous System: Magnetic Resonance Imaging Spectrum of Parenchymal, Meningeal, and Vascular Lesions at Baseline.1 passage
• Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association.1 passage
• Primary Multivessel Occlusions Treated With Mechanical Thrombectomy: A Multicenter Analysis and Systemic Literature Review.1 passage
• Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap).1 passage
• Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke.1 passage
• Prior Intravenous Stroke Thrombolysis Does Not Increase Complications of Carotid Endarterectomy.1 passage
• Problem-Solving Therapy During Outpatient Stroke Rehabilitation Improves Coping and Health-Related Quality of Life: Randomized Controlled Trial.1 passage
• Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.1 passage
• Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.1 passage
• Procedural Complications During Early Versus Late Endovascular Treatment in Acute Stroke: Frequency and Clinical Impact.1 passage
• Prognosis of Asymptomatic Carotid Artery Occlusion: Systematic Review and Meta-Analysis.1 passage
• Prognosis of Intracerebral Hemorrhage Related to Antithrombotic Use: An Observational Study From the Swedish Stroke Register (Riksstroke).1 passage
• Prognosis of Ischemic Stroke With Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria in Chinese Population.1 passage
• Prognostic Factors for Cognitive Decline After Intracerebral Hemorrhage.1 passage
• Prognostic Significance of Blood Pressure Variability on Beat-to-Beat Monitoring After Transient Ischemic Attack and Stroke.1 passage
• Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study.1 passage
• Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke: Systematic Review.1 passage
• Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies.1 passage
• Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.1 passage
• Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy.1 passage
• Progression of White Matter Disease and Cortical Thinning Are Not Related in Older Community-Dwelling Subjects.1 passage
• Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity.1 passage
• Progressive Cortical Neuronal Damage and Chronic Hemodynamic Impairment in Atherosclerotic Major Cerebral Artery Disease.1 passage
• Projected Temperature-Related Years of Life Lost From Stroke Due To Global Warming in a Temperate Climate City, Asia: Disease Burden Caused by Future Climate Change.1 passage
• Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia.1 passage
• Prolonged QTc interval predicts poststroke paroxysmal atrial fibrillation.1 passage
• Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients.1 passage
• Prophylactic Antiepileptic Drug Use and Outcome in the Ethnic/Racial Variations of Intracerebral Hemorrhage Study.1 passage
• Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis.1 passage
• Proportional Motor Recovery After Stroke: Implications for Trial Design.1 passage
• Proportional Recovery From Lower Limb Motor Impairment After Stroke.1 passage
• Prospective Implementation of the Ottawa Subarachnoid Hemorrhage Rule and 6-Hour Computed Tomography Rule.1 passage
• Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk.1 passage
• Prospective Trial of Cerebrospinal Fluid Filtration After Aneurysmal Subarachnoid Hemorrhage via Lumbar Catheter (PILLAR).1 passage
• Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.1 passage
• Protective Effect of ApoA1 (Apolipoprotein A1)-Milano in a Rat Model of Large Vessel Occlusion Stroke.1 passage
• Proteinuria, but Not eGFR, Predicts Stroke Risk in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort Study.1 passage
• Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.1 passage
• Provider Communication and Telepresence Enhance Veteran Satisfaction With Telestroke Consultations.1 passage
• Provincial Door-to-Needle Improvement Initiative Results in Improved Patient Outcomes Across an Entire Population.1 passage
• Pseudo-Occlusion of the Internal Carotid Artery Predicts Poor Outcome After Reperfusion Therapy.1 passage
• Psychiatric Hospitalization Increases Short-Term Risk of Stroke.1 passage
• Public Awareness of Stroke and the Appropriate Responses in China: A Cross-Sectional Community-Based Study (FAST-RIGHT)1 passage
• Public Health and Cost Benefits of Successful Reperfusion After Thrombectomy for Stroke.1 passage
• Purpose in life and cerebral infarcts in community-dwelling older people.1 passage
• Qualitative Study of Chinese Stroke Caregivers' Caregiving Experience During the COVID-19 Pandemic.1 passage
• Qualitative and Quantitative Wall Enhancement on Magnetic Resonance Imaging Is Associated With Symptoms of Unruptured Intracranial Aneurysms.1 passage
• Quality of Acute Care and Long-Term Quality of Life and Survival: The Australian Stroke Clinical Registry.1 passage
• Quality of Life Is Poorer for Patients With Stroke Who Require an Interpreter: An Observational Australian Registry Study.1 passage
• Quality of Life in Physical, Social, and Cognitive Domains Improves With Endovascular Therapy in the DEFUSE 3 Trial.1 passage
• Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin Labeling.1 passage
• Quantifying Infarct Growth and Secondary Injury Volumes: Comparing Multimodal Image Registration Measures.1 passage
• Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials.1 passage
• Quantitative Arterial Tortuosity Suggests Arteriopathy in Children With Cryptogenic Stroke.1 passage
• Quantitative Gait Impairments in Patients With Stroke or Transient Ischemic Attack: A Population-Based Approach.1 passage
• Quantitative Histogram Analysis on Intracranial Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study.1 passage
• Quantitative Intracerebral Hemorrhage Localization.1 passage
• Quantitative Lesion Water Uptake as Stroke Imaging Biomarker: A Tool for Treatment Selection in the Extended Time Window?1 passage
• Quantitative Lesion Water Uptake in Acute Stroke Computed Tomography Is a Predictor of Malignant Infarction.1 passage
• Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke.1 passage
• Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial.1 passage
• Quantitative assessment of changes in cerebral arteriovenous malformation hemodynamics after embolization.1 passage
• R1 passage
• RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke.1 passage
• RNA Sequencing Analysis of Intracranial Aneurysm Walls Reveals Involvement of Lysosomes and Immunoglobulins in Rupture.1 passage
• RNA-Sequencing Highlights Inflammation and Impaired Integrity of the Vascular Wall in Brain Arteriovenous Malformations.1 passage
• Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study.1 passage
• Racial Differences in Blood Pressure Control Following Stroke: The REGARDS Study.1 passage
• Racial Variation in Stroke Risk Among Women by Stroke Risk Factors.1 passage
• Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke.1 passage
• Racial and Socioeconomic Disparities in Gastrostomy Tube Placement After Intracerebral Hemorrhage in the United States.1 passage
• Racial/Ethnic variation in carotid artery revascularization utilization and outcomes: analysis from the National Cardiovascular Data Registry.1 passage
• Radial Artery Catheterization for Neuroendovascular Procedures.1 passage
• Radiographic Characteristics of Mild Ischemic Stroke Patients With Visible Intracranial Occlusion: The INTERRSeCT Study.1 passage
• Radiographic and Clinical Brain Infarcts in Cardiac and Diagnostic Procedures: A Systematic Review and Meta-Analysis.1 passage
• Radiosurgery for Cerebral Arteriovenous Malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-Eligible Patients: A Multicenter Study.1 passage
• Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient).1 passage
• Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke.1 passage
• Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).1 passage
• Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).1 passage
• Rapid Alteplase Administration Improves Functional Outcomes in Patients With Stroke due to Large Vessel Occlusions.1 passage
• Rapid Apparent Diffusion Coefficient Evolution After Early Revascularization.1 passage
• Rapid Assessment of Blood Pressure Variability and Outcome After Successful Thrombectomy.1 passage
• Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study.1 passage
• Rare1 passage
• Rare Coding Variation and Risk of Intracerebral Hemorrhage.1 passage
• Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage.1 passage
• Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study.1 passage
• Rates and Quality of Preinterventional Reperfusion in Patients With Direct Access to Endovascular Treatment.1 passage
• Rates and Risk Factors for Arterial Ischemic Stroke Recurrence in Children.1 passage
• Rates of Spinal Cord Infarction After Repair of Aortic Aneurysm or Dissection.1 passage
• Rates of ischemic stroke during warfarin treatment for atrial fibrillation.1 passage
• Rates, Predictors, and Outcomes of Early and Late Recurrence After Stroke: The North Dublin Population Stroke Study.1 passage
• Ratio of Apolipoprotein A-II/B Improves Risk Prediction of Postoperative Survival After Carotid Endarterectomy.1 passage
• Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.1 passage
• Readmission After Aneurysmal Subarachnoid Hemorrhage: A Nationwide Readmission Database Analysis.1 passage
• Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.1 passage
• Real-World Treatment Trends in Endovascular Stroke Therapy.1 passage
• Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.1 passage
• Reassessing the Stroke Belt: Using Small Area Spatial Statistics to Identify Clusters of High Stroke Mortality in the United States.1 passage
• Recanalization Modulates Association Between Blood Pressure and Functional Outcome in Acute Ischemic Stroke.1 passage
• Recanalization Rate per Retrieval Attempt in Mechanical Thrombectomy for Acute Ischemic Stroke.1 passage
• Recanalization in Cerebral Venous Thrombosis.1 passage
• Recent Nationwide Impact of Mechanical Thrombectomy on Decompressive Hemicraniectomy for Acute Ischemic Stroke.1 passage
• Reciprocal Interaction of 24-Hour Blood Pressure Variability and Systolic Blood Pressure on Outcome in Stroke Thrombolysis.1 passage
• Reclassification of Ischemic Stroke Etiological Subtypes on the Basis of High-Risk Nonstenosing Carotid Plaque.1 passage
• Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.1 passage
• Recommendations for Research Assessing Outcomes for Patients With Anticoagulant-Related Intracerebral Bleeds.1 passage
• Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update.1 passage
• Recovery and Prediction of Dynamic Precision Grip Force Control After Stroke.1 passage
• Recovery to Preinterventional Functioning, Return-to-Work, and Life Satisfaction After Treatment of Unruptured Aneurysms.1 passage
• Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.1 passage
• Recurrent Stroke: The Value of the CHA2DS2VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort.1 passage
• Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.1 passage
• Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth.1 passage
• Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy.1 passage
• Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging-Detected Vascular Brain Injury.1 passage
• Reduced Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas.1 passage
• Reduced Intravoxel Incoherent Motion Microvascular Perfusion Predicts Delayed Cerebral Ischemia and Vasospasm After Aneurysm Rupture.1 passage
• Reduced Venous Oxygen Saturation Associates With Increased Dependence of Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: A 7.0-T Magnetic Resonance Imaging Study.1 passage
• Reducing Readmissions After Stroke With a Structured Nurse Practitioner/Registered Nurse Transitional Stroke Program.1 passage
• Reduction in Cerebrospinal Fluid Volume as an Early Quantitative Biomarker of Cerebral Edema After Ischemic Stroke.1 passage
• Reduction of Diffusion-Weighted Imaging Contrast of Acute Ischemic Stroke at Short Diffusion Times.1 passage
• Reexamination of the Embolic Stroke of Undetermined Source Concept.1 passage
• Refined Sphenopalatine Ganglion Stimulator Placement and Intensity Setting to Augment Blood Flow and Neurologic Function.1 passage
• Refining 3 Measures to Construct an Efficient Functional Assessment of Stroke.1 passage
• Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.1 passage
• Reflux of Anterior Spinal Artery Predicts Recurrent Posterior Circulation Stroke in Bilateral Vertebral Artery Disease.1 passage
• Regional Arterial Spin Labeling Perfusion Defect Is Associated With Early Ischemic Recurrence in Patients With a Transient Ischemic Attack.1 passage
• Regional Comparison of Multiphase Computed Tomographic Angiography and Computed Tomographic Perfusion for Prediction of Tissue Fate in Ischemic Stroke.1 passage
• Regional Evaluation of the Severity-Based Stroke Triage Algorithm for Emergency Medical Services Using Discrete Event Simulation.1 passage
• Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease.1 passage
• Regional Intervention of Stroke Care to Increase Thrombolytic Therapy for Acute Ischemic Stroke.1 passage
• Regional Pediatric Acute Stroke Protocol: Initial Experience During 3 Years and 13 Recanalization Treatments in Children.1 passage
• Regional Variation in Transient Ischemic Attack and Minor Stroke in Alberta Emergency Departments.1 passage
• Regional availability of mechanical embolectomy for acute ischemic stroke in California, 2009 to 2010.1 passage
• Relation Between the Corticospinal Tract State and Activities of Daily Living in Patients With Intracerebral Hemorrhage.1 passage
• Relation of RhoA in Peripheral Blood Mononuclear Cells With Severity of Aneurysmal Subarachnoid Hemorrhage and Vasospasm.1 passage
• Relationship Between Changes in the Temporal Dynamics of the Blood-Oxygen-Level-Dependent Signal and Hypoperfusion in Acute Ischemic Stroke.1 passage
• Relationship Between Collateral Status, Contrast Transit, and Contrast Density in Acute Ischemic Stroke.1 passage
• Relationship Between Dietary Vitamin D and Deaths From Stroke and Coronary Heart Disease: The Japan Collaborative Cohort Study.1 passage
• Relationship Between Dual-Task Gait Speed and Walking Activity Poststroke.1 passage
• Relationship Between Impaired Consciousness and Injury of Ascending Reticular Activating System in Patients With Intracerebral Hemorrhage.1 passage
• Relationship Between Lesion Topology and Clinical Outcome in Anterior Circulation Large Vessel Occlusions.1 passage
• Relationship Between Step Counts and Cerebral Small Vessel Disease in Japanese Men.1 passage
• Relationship Between Venules and Perivascular Spaces in Sporadic Small Vessel Diseases.1 passage
• Relationship Between Visceral Infarction and Ischemic Stroke Subtype.1 passage
• Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.1 passage
• Relationship between white matter hyperintensities, cortical thickness, and cognition.1 passage
• Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.1 passage
• Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.1 passage
• Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke.1 passage
• Relative Influence of Capillary Index Score, Revascularization, and Time on Stroke Outcomes From the Interventional Management of Stroke III Trial.1 passage
• Relative distributions: a novel method for examining trends between stroke onset and thrombolysis time.1 passage
• Relevance of blood-brain barrier disruption after endovascular treatment of ischemic stroke: dual-energy computed tomographic study.1 passage
• Reliability and limitations of automated arrhythmia detection in telemetric monitoring after stroke.1 passage
• Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.1 passage
• Remote Ischemic Conditioning Alters Methylation and Expression of Cell Cycle Genes in Aneurysmal Subarachnoid Hemorrhage.1 passage
• Remote Ischemic Conditioning May Improve Outcomes of Patients With Cerebral Small-Vessel Disease.1 passage
• Remote Lower White Matter Integrity Increases the Risk of Long-Term Cognitive Impairment After Ischemic Stroke in Young Adults.1 passage
• Renal Dysfunction Is Associated With Poststroke Discharge Disposition and In-Hospital Mortality: Findings From Get With The Guidelines-Stroke.1 passage
• Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source.1 passage
• Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study.1 passage
• Renal Safety of Multimodal Brain Imaging Followed by Endovascular Therapy.1 passage
• Repeat Flow Diversion for Cerebral Aneurysms Failing Prior Flow Diversion: Safety and Feasibility From Multicenter Experience.1 passage
• Repeated Endovascular Thrombectomy in Patients With Acute Ischemic Stroke: Results From a Nationwide Multicenter Database.1 passage
• Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion.1 passage
• Repeated Mechanical Endovascular Thrombectomy for Recurrent Large Vessel Occlusion: A Multicenter Experience.1 passage
• Reperfusion Beyond 6 Hours Reduces Infarct Probability in Moderately Ischemic Brain Tissue.1 passage
• Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States.1 passage
• Reperfusion of very low cerebral blood volume lesion predicts parenchymal hematoma after endovascular therapy.1 passage
• Reperfusion within 6 hours outperforms recanalization in predicting penumbra salvage, lesion growth, final infarct, and clinical outcome.1 passage
• Replication of Top Loci From COL4A1/2 Associated With White Matter Hyperintensity Burden in Patients With Ischemic Stroke.1 passage
• Rescue Stenting for Failed Mechanical Thrombectomy in Acute Ischemic Stroke: A Multicenter Experience.1 passage
• Residential Proximity to Major Roadways and Risk of Incident Ischemic Stroke in NOMAS (The Northern Manhattan Study).1 passage
• Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.1 passage
• Residual high-grade stenosis after recanalization of extracranial carotid occlusion in acute ischemic stroke.1 passage
• Resistant Atherosclerosis: The Need for Monitoring of Plaque Burden.1 passage
• Response by Alemseged et al to Letter Regarding Article, "Response to Late-Window Endovascular Revascularization Is Associated With Collateral Status in Basilar Artery Occlusion".1 passage
• Response by Anetsberger and Gempt to Letter Regarding Article "Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage".1 passage
• Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".1 passage
• Response by Baird et al to Letter Regarding Article, "Door-in-Door-Out Time at Primary Stroke Centers May Predict Outcome for Emergent Large Vessel Occlusion Patients".1 passage
• Response by Banerjee et al to Letter Regarding Article, "Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy".1 passage
• Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".1 passage
• Response by Berndt et al to Letter Regarding Article, "Thrombus Permeability in Admission Computed Tomographic Imaging Indicates Stroke Pathogenesis Based on Thrombus Histology".1 passage
• Response by Bondonno et al to Letter Regarding Article, "Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women".1 passage
• Response by Boulouis and Schwamm to Letter Regarding Article, "Immediate Vascular Imaging Needed for Efficient Triage of Patients With Acute Ischemic Stroke Initially Admitted to Nonthrombectomy Centers".1 passage
• Response by Boulouis et al to Letter Regarding Article, "Primary Angiitis of the Central Nervous System: Magnetic Resonance Imaging Spectrum of Parenchymal, Meningeal, and Vascular Lesions at Baseline".1 passage
• Response by Brinjikji et al to Letter Regarding Article, "Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke".1 passage
• Response by Brinjikji to Letter Regarding Article "Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke".1 passage
• Response by Béjot and Duloquin to Letter Regarding Article, "Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion: A Population-Based Study (Dijon Stroke Registry)".1 passage
• Response by Cappellari and Toni to Letter Regarding Article, "General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke".1 passage
• Response by Chan and O'Kelly to Letter Regarding Article, "Declining Admission and Mortality Rates for Subarachnoid Hemorrhage in Canada Between 2004 and 2015".1 passage
• Response by Chang and Sansing to Letter Regarding Article, "Bexarotene Enhances Macrophage Erythrophagocytosis and Hematoma Clearance in Experimental Intracerebral Hemorrhage".1 passage
• Response by Chen et al to Letter Regarding Article, "Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity".1 passage
• Response by Chen et al to Letter Regarding Article, "Endovascular Hypothermia in Acute Ischemic Stroke: A Pilot Study of Selective Intra-Arterial Cold Saline Infusion".1 passage
• Response by Chen et al to Letter Regarding Article, "Magnetic Resonance Imaging of Plaque Morphology, Burden, and Distribution in Patients With Symptomatic Middle Cerebral Artery Stenosis".1 passage
• Response by Choi and Jang to Letter Regarding Article, "Multiphasic Computed Tomography Angiography Findings for Identifying Pseudo-Occlusion of the Internal Carotid Artery".1 passage
• Response by Choi et al to Letter Regarding Article, "HbA1c (Glycated Hemoglobin) Levels and Clinical Outcome Post-Mechanical Thrombectomy in Patients With Large Vessel Occlusion".1 passage
• Response by Darcourt and Cognard to Letter Regarding Article, "Predictive Value of Susceptibility Vessel Sign for Arterial Recanalization and Clinical Improvement in Ischemic Stroke".1 passage
• Response by Denti and Schulz to Letter Regarding Article, "Impact on Prehospital Delay of a Stroke Preparedness Campaign: A SW-RCT (Stepped-Wedge Cluster Randomized Controlled Trial)".1 passage
• Response by Di Meglio et al to Letter Regarding Article, "Intracranial Extension of Extracranial Vertebral Artery Dissection Is Associated With an Increased Risk of Ischemic Events".1 passage
• Response by Di Tullio et al to Letter Regarding Article, "Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial".1 passage
• Response by Diegoli et al to Letter Regarding Article, "Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era".1 passage
• Response by Dolmans et al to Letter Regarding Article, "Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study".1 passage
• Response by Doubal et al to Letter Regarding Article, "Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis".1 passage
• Response by Duffy et al to Letter Regarding Article, "Per-Pass Analysis of Thrombus Composition in Patients With Acute Ischemic Stroke Undergoing Mechanical Thrombectomy".1 passage
• Response by Ehrlich et al to Letter Regarding Article, "Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience".1 passage
• Response by Falkstedt et al to Letters Regarding Article, "Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study Among 45 000 Swedish Men".1 passage
• Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?".1 passage
• Response by Feng et al to Letter Regarding Article, "Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications".1 passage
• Response by Fitzgerald and Brinjikji to Letter Regarding Article, "Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source".1 passage
• Response by Flint et al to Letter Regarding Article, "Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment".1 passage
• Response by Fujita et al to Letter Regarding Article, "Detrimental Effect of Chronic Hypertension on Leptomeningeal Collateral Flow in Acute Ischemic Stroke".1 passage
• Response by Fukuda-Doi et al to Letter Regarding Article, "Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2".1 passage
• Response by Golsari and Thomalla to Letter Regarding Article, "Silent Brain Infarctions and Leukoaraiosis in Patients With Retinal Ischemia: A Prospective Single-Center Observational Study".1 passage
• Response by Grossberg et al to Letter Regarding Article, "Cervical Carotid Pseudo-Occlusions and False Dissections: Intracranial Occlusions Masquerading as Extracranial Occlusions".1 passage
• Response by Guida and Scrutinio to Letter Regarding Article, "Development and Validation of a Predictive Model for Functional Outcome After Stroke Rehabilitation: The Maugeri Model".1 passage
• Response by Hajdu et al to Letter Regarding Article, "Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?"1 passage
• Response by Han and Sharma to Letter Regarding Article, "Prestroke Disability Predicts Adverse Poststroke Outcome: A Registry-Based Prospective Cohort Study of Acute Stroke".1 passage
• Response by Hastrup and Andersen to Letter Regarding Article, "Prehospital Acute Stroke Severity Scale to Predict Large Artery Occlusion: Design and Comparison With Other Scales".1 passage
• Response by Hastrup et al to Letter Regarding Article, "Prehospital Acute Stroke Severity Scale to Predict Large Artery Occlusion: Design and Comparison With Other Scales".1 passage
• Response by Higuchi and Kitagawa to Letter Regarding Article, "Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke".1 passage
• Response by Ho Jang and Kwon to Letter Regarding Article, "Relationship Between Impaired Consciousness and Injury of Ascending Reticular Activating System in Patients With Intracerebral Hemorrhage".1 passage
• Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])".1 passage
• Response by Jadhav et al to Letter Regarding Article, "Interfacility Transfer Directly to the Neuroangiography Suite in Acute Ischemic Stroke Patients Undergoing Thrombectomy".1 passage
• Response by Johnson and Söderholm to Letter Regarding Article, "Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort".1 passage
• Response by Jordan et al to Letter Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".1 passage
• Response by Jung et al to Letter Regarding Article, "Takotsubo-Like Myocardial Dysfunction in Ischemic Stroke: A Hospital-Based Registry and Systematic Literature Review".1 passage
• Response by Kaesmacher et al to Letter Regarding Article, "Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0-5".1 passage
• Response by Kauw et al to Letter Regarding Article, "Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction".1 passage
• Response by Khosravani et al to Letter Regarding Article, "Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic".1 passage
• Response by Kim and Bae to Letter Regarding Article, "Magnetic Resonance Imaging Versus Computed Tomography Angiography Based Selection for Endovascular Therapy in Patients With Acute Ischemic Stroke".1 passage
• Response by Kim and Ha to Letter Regarding Article, "Clinical Significance of Fluid-Attenuated Inversion Recovery Vascular Hyperintensities in Borderzone Infarcts".1 passage
• Response by Kimberley and Dawson Regarding Article, "Vagus Nerve Stimulation Paired With Upper Limb Rehabilitation After Chronic Stroke: A Blinded Randomized Pilot Study".1 passage
• Response by Koganemaru and Mima to Letter Regarding Article, "Gait-Synchronized Rhythmic Brain Stimulation Improves Poststroke Gait Disturbance: A Pilot Study".1 passage
• Response by Komatsu and Iguchi to Letter Regarding Article, "Large but Nonstenotic Carotid Artery Plaque in Patients With a History of Embolic Stroke of Undetermined Source".1 passage
• Response by Lau and Rothwell to Letter Regarding Article, "Antiplatelet treatment after transient ischemic attack and ischemic stroke in patients with cerebral microbleeds in 2 large cohorts".1 passage
• Response by Lee and Ovbiagele to Letter Regarding Article, "Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis".1 passage
• Response by Li to Letter Regarding Article, "Island Sign: An Imaging Predictor for Early Hematoma Expansion and Poor Outcome in Patients With Intracerebral Hemorrhage".1 passage
• Response by Lima et al to Letter Regarding Article, "Field Assessment Stroke Triage for Emergency Destination: A Simple and Accurate Prehospital Scale to Detect Large Vessel Occlusion Strokes".1 passage
• Response by Luby et al to Letter Regarding Article, "Frequency of Blood-Brain Barrier Disruption Postendovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients".1 passage
• Response by Löwhagen Hendén and Rentzos to Letter Regarding Article, "General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The Anstroke Trial (Anesthesia During Stroke)".1 passage
• Response by Mainz et al to Letter Regarding Article, "Disentangling Sex Differences in Use of Reperfusion Therapy in Patients With Acute Ischemic Stroke".1 passage
• Response by Mayer and Hoke to Letter Regarding Article, "Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study".1 passage
• Response by Mayer and Viarasilpa to Letter Regarding Article, "CTA-for-All: Impact of Emergency Computed Tomographic Angiography for All Patients With Stroke Presenting Within 24 Hours of Onset".1 passage
• Response by Mechtouff and Nighoghossian to Letter Regarding Article "Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion".1 passage
• Response by Mistry and Khatri to Letter Regarding Article, "Blood Pressure After Endovascular Therapy for Ischemic Stroke (BEST): A Multicenter Prospective Cohort Study".1 passage
• Response by Mossavar-Rahmani and Wassertheil-Smoller to Letters Regarding Article, "Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative".1 passage
• Response by Mulder et al to Letter Regarding Article, "Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands)".1 passage
• Response by Murthy et al to Letter Regarding Article, "Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis".1 passage
• Response by Nguyen et al to Letter Regarding Article, "Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology".1 passage
• Response by Ntaios et al to Letter Regarding Article, "Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis".1 passage
• Response by Oshida et al to Letter Regarding Article, "Wall Shear Stress and T1 Contrast Ratio Are Associated With Embolic Signals During Carotid Exposure in Endarterectomy".1 passage
• Response by Ospel and Goyal to Letter Regarding Article, "Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source".1 passage
• Response by Parekh and Desai to Letter Regarding Article, "Marijuana Use Among Young Adults (18-44 Years of Age) and Risk of Stroke: A Behavioral Risk Factor Surveillance System Survey Analysis".1 passage
• Response by Park and Bae to Letter Regarding Article, "One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis".1 passage
• Response by Pase et al to Letter Regarding Article, "Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia: A Prospective Cohort Study".1 passage
• Response by Pennlert et al to Letter Regarding Article, "Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation".1 passage
• Response by Petersen et al to Letter Regarding Article, "Decreases in Blood Pressure During Thrombectomy Are Associated With Larger Infarct Volumes and Worse Functional Outcome".1 passage
• Response by Pfaff et al to Letter Regarding Article, "Direct Transfer to Angio-Suite Versus Computed Tomography-Transit in Patients Receiving Mechanical Thrombectomy: a Randomized Trial".1 passage
• Response by Powers and Rabinstein to Letter Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association".1 passage
• Response by Rinaldo and Brinjikji to Letter Regarding Article, "Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke: Analysis of Data From 2016 to 2018".1 passage
• Response by Rodemerk et al to Letter Regarding Article, "Pathophysiology of Intracranial Aneurysms: COX-2 Expression, Iron Deposition in Aneurysm Wall, and Correlation With Magnetic Resonance Imaging".1 passage
• Response by Rumalla and Burkhardt to Letter Regarding Article, "Recent Nationwide Impact of Mechanical Thrombectomy on Decompressive Hemicraniectomy for Acute Ischemic Stroke".1 passage
• Response by Sagris et al to Letter Regarding Article, "Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis".1 passage
• Response by Salehi Omran and Kamel to Letter Regarding Article, "National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015".1 passage
• Response by Saver et al to Letter Regarding Article, "Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review".1 passage
• Response by Shahjouei and Zand to Letter Regarding Article, "Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis".1 passage
• Response by Shi and Liu to Letter Regarding Article, "IL (Interleukin)-15 Bridges Astrocyte-Microglia Crosstalk and Exacerbates Brain Injury Following Intracerebral Hemorrhage".1 passage
• Response by Singfer and Defreyne to Letter Regarding Article, "Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients".1 passage
• Response by Singh and Dhandapani to Letter Regarding Article, "Has Outcome of Subarachnoid Hemorrhage Changed With Improvements in Neurosurgical Services?: Study of 2000 Patients Over 2 Decades From India".1 passage
• Response by Smith and Gupta to Letter Regarding Article, "Computed Tomography Angiography Versus Digital Subtraction Angiography for Postclipping Aneurysm Obliteration Detection: A Meta-Analysis".1 passage
• Response by Sparr and Bieri to Letter Regarding Article, "Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time".1 passage
• Response by Sperber et al to Letter Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)".1 passage
• Response by Sposato et al to Letter Regarding Article, "Effect of Right Insular Involvement on Death and Functional Outcome After Acute Ischemic Stroke in the IST-3 Trial (Third International Stroke Trial)".1 passage
• Response by Steinberg et al to Letter Regarding Article, "Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2A Study".1 passage
• Response by Strambo and Michel to Letter Regarding Article, "Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery Occlusion: Cognitive, Visual, and Disability Outcomes".1 passage
• Response by Sugiyama and Tominaga to Letter Regarding Article, "Blood Flow Into Basilar Tip Aneurysms: A Predictor for Recanalization After Coil Embolization".1 passage
• Response by Tanaka et al to Letter Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".1 passage
• Response by Vagal et al to Letter Regarding Article, "Collateral Clock Is More Important Than Time Clock for Tissue Fate: A Natural History Study of Acute Ischemic Strokes".1 passage
• Response by Wang and Johnston to Letter Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)".1 passage
• Response by Werring and Charidimou to Letter Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis".1 passage
• Response by Wetmore et al to Letter Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".1 passage
• Response by Xu and Fan to Letter Regarding Article, "High-Sensitivity CRP (C-Reactive Protein) Is Associated With Incident Carotid Artery Plaque in Chinese Aged Adults".1 passage
• Response by Yang et al to Letter Regarding Article, "Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death".1 passage
• Response by Yoshimura et al to Letter Regarding Article, "Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient)".1 passage
• Response by Yu and Kapral to Letter Regarding Article, "One-Year Home-Time and Mortality After Thrombolysis Compared With Nontreated Patients in a Propensity-Matched Analysis".1 passage
• Response by Zamani et al to Letter Regarding Article, "Carotid Plaque Neovascularization Detected With Superb Microvascular Imaging Ultrasound Without Using Contrast Media".1 passage
• Response by Zhang and Xie to Letter Regarding Article, "Spotty Calcium on Cervicocerebral Computed Tomography Angiography Associates With Increased Risk of Ischemic Stroke".1 passage
• Response by Ziai et al to Letter Regarding Article, "Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage".1 passage
• Response by Zinman et al to Letter Regarding Article, "Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk".1 passage
• Response by de Havenon et al to Letter Regarding Article, "Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome".1 passage
• Response by de Jonge and van der Worp to Letter Regarding Article, "Signs of Pulmonary Infection on Admission Chest Computed Tomography Are Associated With Pneumonia or Death in Patients With Acute Stroke".1 passage
• Response by de Ridder et al to Letter Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2) Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".1 passage
• Response to Letter Regarding Article, "Clinically Confirmed Stroke With Negative Diffusion-Weighted Imaging Magnetic Resonance Imaging: Longitudinal Study of Clinical Outcomes, Stroke Recurrence, and Systematic Review".1 passage
• Response to Letter Regarding Article, "Intracranial Carotid Calcification on Cranial Computed Tomography: Visual Scoring Methods, Semiautomated Scores, and Volume Measurements in Patients With Stroke".1 passage
• Response to Letter Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis".1 passage
• Response to Letter Regarding Article, "Leukoaraiosis Burden Significantly Modulates the Association Between Infarct Volume and National Institutes of Health Stroke Scale in Ischemic Stroke".1 passage
• Response to Letter Regarding Article, "Relevance of Blood-Brain Barrier Disruption After Endovascular Treatment of Ischemic Stroke: Dual-Energy Computed Tomographic Study".1 passage
• Response to Letter Regarding Article, "Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Community-Dwelling Older People".1 passage
• Response to Letter Regarding Article,"Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies".1 passage
• Response to letter regarding article, "Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke".1 passage
• Response to letter regarding article, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association".1 passage
• Response to letter regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".1 passage
• Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.1 passage
• Resting-State Functional Connectivity Magnetic Resonance Imaging and Outcome After Acute Stroke.1 passage
• Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome1 passage
• Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2).1 passage
• Rethinking Consent for Stroke Trials in Time-Sensitive Situations: Insights From the COVID-19 Pandemic.1 passage
• Rethinking Thrombolysis in Cerebral Infarction 2b: Which Thrombolysis in Cerebral Infarction Scales Best Define Near Complete Recanalization in the Modern Thrombectomy Era?1 passage
• Retinal Artery Occlusion and the Risk of Stroke Development: Twelve-Year Nationwide Cohort Study.1 passage
• Retinal Microvascular Calibers Are Associated With Enlarged Perivascular Spaces in the Brain.1 passage
• Retinal Vasculature Fractal and Stroke Mortality.1 passage
• Retrobulbar Spot Sign Predicts Thrombolytic Treatment Effects and Etiology in Central Retinal Artery Occlusion.1 passage
• Retrospective Methods Analysis of Semiautomated Intracerebral Hemorrhage Volume Quantification From a Selection of the STICH II Cohort (Early Surgery Versus Initial Conservative Treatment in Patients With Spontaneous Supratentorial Lobar Intracerebral Haematomas).1 passage
• Return to Employment After Stroke in Young Adults: How Important Is the Speed and Energy Cost of Walking?1 passage
• Revascularization of High-Grade Carotid Stenosis Restores Global Cerebral Energy Metabolism.1 passage
• Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke.1 passage
• Revised Framingham Stroke Risk Score, Nontraditional Risk Markers, and Incident Stroke in a Multiethnic Cohort.1 passage
• Rheumatic Mitral Valve Disease Is Associated With Worse Outcomes in Stroke: A Thailand National Database Study.1 passage
• Right Hemispheric Homologous Language Pathways Negatively Predicts Poststroke Naming Recovery.1 passage
• Risk Analysis of Unruptured Intracranial Aneurysms: Prospective 10-Year Cohort Study.1 passage
• Risk Factor Characterization of Ischemic Stroke Subtypes Among West Africans.1 passage
• Risk Factors Associated With the Presence of Unruptured Intracranial Aneurysms.1 passage
• Risk Factors and Cognitive Relevance of Cortical Cerebral Microinfarcts in Patients With Ischemic Stroke or Transient Ischemic Attack.1 passage
• Risk Factors for Acute Ischemic Stroke Caused by Anterior Large Vessel Occlusion.1 passage
• Risk Factors for Postprocedural Arterial Ischemic Stroke in Children With Cardiac Disease.1 passage
• Risk Factors for Poststroke Cognitive Decline: The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke).1 passage
• Risk Factors for Pregnancy-Associated Stroke in Women With Preeclampsia.1 passage
• Risk Factors for Severe Residual Headache in Cerebral Venous Thrombosis.1 passage
• Risk Factors for Stroke in Patients With Sepsis and Bloodstream Infections.1 passage
• Risk Factors for Unruptured Intracranial Aneurysms and Subarachnoid Hemorrhage in a Prospective Population-Based Study.1 passage
• Risk Factors for and Clinical Consequences of Multiple Intracranial Aneurysms: A Systematic Review and Meta-Analysis.1 passage
• Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis.1 passage
• Risk Factors of Subacute Thrombosis After Intracranial Stenting for Symptomatic Intracranial Arterial Stenosis.1 passage
• Risk Factors of Sudden Death From Subarachnoid Hemorrhage.1 passage
• Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases.1 passage
• Risk Profile of Symptomatic Lacunar Stroke Versus Nonlobar Intracerebral Hemorrhage.1 passage
• Risk Reduction of Cerebral Stroke After Stereotactic Radiosurgery for Small Unruptured Brain Arteriovenous Malformations.1 passage
• Risk Score for Neurological Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms.1 passage
• Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.1 passage
• Risk and Secondary Prevention of Stroke Recurrence: A Population-Base Cohort Study.1 passage
• Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study.1 passage
• Risk of Arterial Ischemic Events After Intracerebral Hemorrhage.1 passage
• Risk of Brain Arteriovenous Malformation Hemorrhage Before and After Stereotactic Radiosurgery.1 passage
• Risk of Distal Embolization From tPA (Tissue-Type Plasminogen Activator) Administration Prior to Endovascular Stroke Treatment.1 passage
• Risk of Intracerebral Hemorrhage and Mortality After Convexity Subarachnoid Hemorrhage in Cerebral Amyloid Angiopathy.1 passage
• Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use: A Case-Time-Control Study.1 passage
• Risk of Intracranial Hemorrhage Following Intravenous tPA (Tissue-Type Plasminogen Activator) for Acute Stroke Is Low in Children.1 passage
• Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.1 passage
• Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage.1 passage
• Risk of Nursing Home Admission in Cerebral Small Vessel Disease.1 passage
• Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.1 passage
• Risk of Pulmonary Embolism After Cerebral Venous Thrombosis.1 passage
• Risk of Recurrent Arterial Ischemic Stroke in Childhood: A Prospective International Study.1 passage
• Risk of Shunting After Aneurysmal Subarachnoid Hemorrhage: A Collaborative Study and Initiation of a Consortium.1 passage
• Risk of Stroke After the International Classification of Diseases-Ninth Revision Discharge Code Diagnosis of Hypertensive Encephalopathy.1 passage
• Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study.1 passage
• Risk of Stroke in Patients With Heart Failure: A Population-Based 30-Year Cohort Study.1 passage
• Risk of Stroke in Patients With Short-Run Atrial Tachyarrhythmia.1 passage
• Risk of thromboembolic events in atrial fibrillation with chronic kidney disease.1 passage
• Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19: A Multicenter Cohort Study.1 passage
• Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin.1 passage
• Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.1 passage
• Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.1 passage
• Role of Acute Lesion Topography in Initial Ischemic Stroke Severity and Long-Term Functional Outcomes.1 passage
• Role of Apparent Diffusion Coefficient Gradient Within Diffusion Lesions in Outcomes of Large Stroke After Thrombectomy.1 passage
• Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study.1 passage
• Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review.1 passage
• Role of Computed Tomography Perfusion in Identification of Acute Lacunar Stroke Syndromes.1 passage
• Role of Prestroke Vascular Pathology in Long-Term Prognosis After Stroke: The Rotterdam Study.1 passage
• Role of imaging in current acute ischemic stroke workflow for endovascular therapy.1 passage
• Roles of Changing Physical Function and Caregiver Burden on Quality of Life in Stroke: A Longitudinal Dyadic Analysis.1 passage
• Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.1 passage
• Routing Ambulances to Designated Centers Increases Access to Stroke Center Care and Enrollment in Prehospital Research.1 passage
• Rupture Risk of Small Unruptured Intracranial Aneurysms in Japanese Adults.1 passage
• S100B Serum Elevation Predicts In-Hospital Mortality After Brain Arteriovenous Malformation Rupture.1 passage
• SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections.1 passage
• SARS-CoV-2 and Stroke in a New York Healthcare System.1 passage
• SCENT Trial.1 passage
• SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.1 passage
• SLEAP SMART (Sleep Apnea Screening Using Mobile Ambulatory Recorders After TIA/Stroke): A Randomized Controlled Trial.1 passage
• STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.1 passage
• Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.1 passage
• Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.1 passage
• Safety and Efficacy of Solitaire Stent Thrombectomy: Individual Patient Data Meta-Analysis of Randomized Trials.1 passage
• Safety and Outcome of Carotid Dissection Stenting During the Treatment of Tandem Occlusions: A Pooled Analysis of TITAN and ETIS.1 passage
• Safety and Outcome of Endovascular Treatment in Prestroke-Dependent Patients.1 passage
• Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke Onset.1 passage
• Safety and Outcomes of Intravenous Thrombolysis in Posterior Versus Anterior Circulation Stroke: Results From the Safe Implementation of Treatments in Stroke Registry and Meta-Analysis.1 passage
• Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke.1 passage
• Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.1 passage
• Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke.1 passage
• Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial.1 passage
• Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.1 passage
• Safety of Carotid Revascularization in Patients With a History of Coronary Heart Disease.1 passage
• Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience.1 passage
• Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.1 passage
• Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.1 passage
• Safety of Pregnancy After Cerebral Venous Thrombosis: A Systematic Review.1 passage
• Safety of Pregnancy After Cerebral Venous Thrombosis: Results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 PREGNANCY Study.1 passage
• Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting: A Randomized Clinical Trial.1 passage
• Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.1 passage
• Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis.1 passage
• Safety, Feasibility, and Efficacy of Vagus Nerve Stimulation Paired With Upper-Limb Rehabilitation After Ischemic Stroke.1 passage
• Scavenging Free Iron Reduces Arteriolar Microvasospasms After Experimental Subarachnoid Hemorrhage.1 passage
• Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Screening and Treatment for Osteoporosis After Stroke.1 passage
• Second-Generation Hydrogel Coils for the Endovascular Treatment of Intracranial Aneurysms: A Randomized Controlled Trial.1 passage
• Secondary Medium Vessel Occlusions: When Clots Move North.1 passage
• Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.1 passage
• Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection.1 passage
• Selective Serotonin Reuptake Inhibitors and Intracerebral Hemorrhage Risk and Outcome.1 passage
• Selective Vulnerability of Cortical Border Zone to Microembolic Infarct.1 passage
• Self-Administered Computer Therapy for Apraxia of Speech: Two-Period Randomized Control Trial With Crossover.1 passage
• Self-Reported Fatigue Predicts Incident Stroke in a General Population: EPIC-Norfolk Prospective Population-Based Study.1 passage
• Self-Reported Stroke Risk Stratification: Reasons for Geographic and Racial Differences in Stroke Study.1 passage
• Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic stroke.1 passage
• Sensitivity of Early Brain Computed Tomography to Exclude Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.1 passage
• Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%.1 passage
• Sensitivity of the Edinburgh Criteria for Lobar Intracerebral Hemorrhage in Hereditary Cerebral Amyloid Angiopathy.1 passage
• Serious Adverse Events and Their Impact on Functional Outcome in Acute Ischemic Stroke in the WAKE-UP Trial.1 passage
• Serum 25-Hydroxyvitamin D Concentrations and Ischemic Stroke and Its Subtypes.1 passage
• Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).1 passage
• Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke.1 passage
• Serum Hepatocyte Growth Factor Is Probably Associated With 3-Month Prognosis of Acute Ischemic Stroke.1 passage
• Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study.1 passage
• Serum Leptin Levels and the Risk of Stroke: The Framingham Study.1 passage
• Serum MicroRNA-Based Risk Prediction for Stroke.1 passage
• Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis.1 passage
• Serum NfL (Neurofilament Light Chain) Levels and Incident Stroke in Adults With Diabetes Mellitus.1 passage
• Serum Ngb (Neuroglobin) Is Associated With Brain Metabolism and Functional Outcome of Aneurysmal Subarachnoid Hemorrhage.1 passage
• Serum Potassium Is Positively Associated With Stroke and Mortality in the Large, Population-Based Malmö Preventive Project Cohort.1 passage
• Serum Soluble Corin is Decreased in Stroke.1 passage
• Serum Sphingosine-1-Phosphate Levels Are Associated With Severity and Outcome in Patients With Cerebral Ischemia.1 passage
• Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.1 passage
• Serum Zinc Levels and Incidence of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.1 passage
• Severe Lesions Involving Cortical Cholinergic Pathways Predict Poorer Functional Outcome in Acute Ischemic Stroke.1 passage
• Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events.1 passage
• Sex Differences and Functional Outcome After Intravenous Thrombolysis.1 passage
• Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2.1 passage
• Sex Differences in Long-Term Quality of Life Among Survivors After Stroke in the INSTRUCT.1 passage
• Sex Differences in Management and Outcomes of Acute Ischemic Stroke With Large Vessel Occlusion.1 passage
• Sex Differences in Outcome After Endovascular Stroke Therapy for Acute Ischemic Stroke.1 passage
• Sex Differences in the Presentation, Care, and Outcomes of Transient Ischemic Attack: Results From the Ontario Stroke Registry.1 passage
• Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).1 passage
• Sex and Stroke in Thrombolyzed Patients and Controls.1 passage
• Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry.1 passage
• Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes.1 passage
• Sex, Smoking, and Risk for Subarachnoid Hemorrhage.1 passage
• Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.1 passage
• Sex-related clustering of intracranial aneurysms within families.1 passage
• Shape of the Central Sulcus and Disability After Subcortical Stroke: A Motor Reserve Hypothesis.1 passage
• Shared and Distinct Rupture Discriminants of Small and Large Intracranial Aneurysms.1 passage
• Shifting Perceptions of Risk and Reward: Use of Anticoagulation in Patients With Acute Brain Ischemia and Atrial Fibrillation: Nine-Year Data From a National Acute Stroke Registry (National Acute Stroke Israeli Survey [NASIS]).1 passage
• Shifting the CARASIL paradigm: report of a non-Asian family and literature review.1 passage
• Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation.1 passage
• Short Time Interval Between Neurologic Event and Carotid Surgery Is Not Associated With an Increased Procedural Risk.1 passage
• Short-Term Double Layer Mesh Stent Patency for Emergent or Elective Carotid Artery Stenting.1 passage
• Short-Term Exposure to Fine Particulate Matter and Risk of Ischemic Stroke.1 passage
• Short-Term Outcome and In-Hospital Complications After Acute Cerebral Infarcts in Multiple Arterial Territories.1 passage
• Short-Term Outcome of Ischemic Stroke Patients With Systemic Malignancy.1 passage
• Short-term blood pressure variability in acute stroke: post hoc analysis of the controlling hypertension and hypotension immediately post stroke and continue or stop post-stroke antihypertensives collaborative study trials.1 passage
• Shorter Intensive Care Unit Stays? The Majority of Post-Intravenous tPA (Tissue-Type Plasminogen Activator) Symptomatic Hemorrhages Occur Within 12 Hours of Treatment.1 passage
• Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?1 passage
• Sickle Cell Trait and Risk of Ischemic Stroke in Young Adults.1 passage
• Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage.1 passage
• Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study.1 passage
• Significance of Nonfocal Symptoms in Patients With Transient Ischemic Attack.1 passage
• Significance of intraventricular hemorrhage in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial results.1 passage
• Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial.1 passage
• Significant period between presentation and diagnosis in basilar artery occlusion: five cases and the lessons learned.1 passage
• Signs of Pulmonary Infection on Admission Chest Computed Tomography Are Associated With Pneumonia or Death in Patients With Acute Stroke.1 passage
• Silencing of Long Noncoding RNA Nespas Aggravates Microglial Cell Death and Neuroinflammation in Ischemic Stroke.1 passage
• Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis.1 passage
• Silent Brain Infarction in Patients With Asymptomatic Carotid Artery Atherosclerotic Disease.1 passage
• Silent Brain Infarctions and Leukoaraiosis in Patients With Retinal Ischemia: A Prospective Single-Center Observational Study.1 passage
• Similar Outcomes for Contact Aspiration and Stent Retriever Use According to the Admission Clot Burden Score in ASTER.1 passage
• Simultaneous Multiple Intracerebral Hemorrhages (SMICH).1 passage
• Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.1 passage
• Single-Nucleotide Polymorphism 309T>G in the MDM2 Promoter Determines Functional Outcome After Stroke.1 passage
• Site Experience and Outcomes in the Trevo Acute Ischemic Stroke (TRACK) Multicenter Registry.1 passage
• Site-Specific Relationship Between Intracranial Aneurysm and Aortic Aneurysm.1 passage
• Size of Ruptured Intracranial Aneurysms Is Decreasing: Twenty-Year Long Consecutive Series of Hospitalized Patients.1 passage
• Sleep Duration and Stroke: Prospective Cohort Study and Mendelian Randomization Analysis.1 passage
• Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Community-Dwelling Older People.1 passage
• Sleep-Disordered Breathing Is Associated With Recurrent Ischemic Stroke.1 passage
• Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.1 passage
• Smoking Causes Fatal Subarachnoid Hemorrhage: A Case-Control Study of Finnish Twins.1 passage
• Smoking Cessation in Stroke Survivors in the United States: A Nationwide Analysis.1 passage
• Smoking Paradox in Stroke Survivors?: Uncovering the Truth by Interpreting 2 Sets of Data.1 passage
• Smoking Status and Functional Outcomes After Acute Ischemic Stroke.1 passage
• Smoking and Risk of Ischemic Stroke in Young Men.1 passage
• Smoking-Thrombolysis Relationship Depends on Ischemic Stroke Subtype.1 passage
• Sociodemographic Disparities in Long-Term Mortality Among Stroke Survivors in the United States.1 passage
• Socioeconomic Conditions in Childhood, Adolescence, and Adulthood and the Risk of Ischemic Stroke.1 passage
• Socioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation.1 passage
• Socioeconomic Status and the Quality of Acute Stroke Care: The China National Stroke Registry.1 passage
• Socioeconomic Status and the Risk of Stroke Recurrence: Persisting Gaps Observed in a Nationwide Swedish Study 2001 to 2012.1 passage
• Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.1 passage
• Soluble CD40L Is a Useful Marker to Predict Future Strokes in Patients With Minor Stroke and Transient Ischemic Attack.1 passage
• Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage.1 passage
• Somatosensory Deficits After Ischemic Stroke.1 passage
• Sonothrombolysis in Patients With Acute Ischemic Stroke With Large Vessel Occlusion: An Individual Patient Data Meta-Analysis.1 passage
• Specific Lobar Affection Reveals a Rostrocaudal Gradient in Functional Outcome in Spontaneous Intracerebral Hemorrhage.1 passage
• Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow: A Randomized, Sham-Controlled Trial.1 passage
• Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism.1 passage
• Spontaneous Cervical Artery Dissection in Vascular Ehlers-Danlos Syndrome: A Cohort Study.1 passage
• Spontaneous Intracerebral Hemorrhage.1 passage
• Spot Sign in Acute Intracerebral Hemorrhage in Dynamic T1-Weighted Magnetic Resonance Imaging.1 passage
• Spot Urine Sodium-to-Potassium Ratio Is a Predictor of Stroke.1 passage
• Spotty Calcium on Cervicocerebral Computed Tomography Angiography Associates With Increased Risk of Ischemic Stroke.1 passage
• Spouses of Stroke Survivors Report Reduced Health-Related Quality of Life Even in Long-Term Follow-Up: Results From Sahlgrenska Academy Study on Ischemic Stroke.1 passage
• Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (1 passage
• Stagnating National Declines in Stroke Mortality Mask Widespread County-Level Increases, 2010-2016.1 passage
• Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI.1 passage
• Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.1 passage
• Statin Pretreatment and Microembolic Signals in Large Artery Atherosclerosis.1 passage
• Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke.1 passage
• Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack.1 passage
• Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting Study.1 passage
• Stenting as a Rescue Treatment After Failure of Mechanical Thrombectomy for Anterior Circulation Large Artery Occlusion.1 passage
• Stepwise Regression and Latent Profile Analyses of Locomotor Outcomes Poststroke.1 passage
• Stereotactic Catheter Ventriculocisternostomy for Clearance of Subarachnoid Hemorrhage: A Matched Cohort Study.1 passage
• Stereotactic Radiosurgery for Pediatric Versus Adult Brain Arteriovenous Malformations.1 passage
• Stereotactic Radiosurgery for Unruptured Versus Ruptured Pediatric Brain Arteriovenous Malformations.1 passage
• Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression Is Stroke Mimic.1 passage
• Streamlined Poststroke Treatment Order Sets During the SARS-CoV-2 Pandemic: Simplifying While Not Compromising Care.1 passage
• Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).1 passage
• Strictly Lobar Cerebral Microbleeds Are Associated With Cognitive Impairment.1 passage
• Strictly Lobar Microbleeds Reflect Amyloid Angiopathy Regardless of Cerebral and Cerebellar Compartments.1 passage
• Stroke3249 passages
• Stroke Acute Management and Outcomes During the COVID-19 Outbreak: A Cohort Study From the Madrid Stroke Network.1 passage
• Stroke Among Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.1 passage
• Stroke Among Young West Africans: Evidence From the SIREN (Stroke Investigative Research and Educational Network) Large Multisite Case-Control Study.1 passage
• Stroke Care and Application of Thrombolysis in Ibero-America: Report From the SITS-SIECV Ibero-American Stroke Register1 passage
• Stroke Care in the United Kingdom During the COVID-19 Pandemic.1 passage
• Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic.1 passage
• Stroke Disparities: From Observations to Actions: Inaugural Edward J. Kenton Lecture 2020.1 passage
• Stroke Etiology Modifies the Effect of Endovascular Treatment in Acute Stroke.1 passage
• Stroke Etiology and Thrombus Computed Tomography Characteristics in Patients With Acute Ischemic Stroke: A MR CLEAN Registry Substudy.1 passage
• Stroke Genetics: Turning Discoveries into Clinical Applications.1 passage
• Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows.1 passage
• Stroke Incidence and Case Fatality According to Rural or Urban Residence: Results From the French Brest Stroke Registry.1 passage
• Stroke Incidence and Outcomes in Northeastern Greece: The Evros Stroke Registry.1 passage
• Stroke Incidence by Major Pathological Type and Ischemic Subtypes in the Auckland Regional Community Stroke Studies: Changes Between 2002 and 2011.1 passage
• Stroke Incidence by Sex Across the Lifespan.1 passage
• Stroke Is the Leading Cause of Death in Rural Gadchiroli, India: A Prospective Community-Based Study.1 passage
• Stroke Laterality Did Not Modify Outcomes in the HERMES Meta-Analysis of Individual Patient Data of 7 Trials.1 passage
• Stroke Legislation Impacts Distribution of Certified Stroke Centers in the United States.1 passage
• Stroke Location Is an Independent Predictor of Cognitive Outcome.1 passage
• Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications.1 passage
• Stroke Neurologist's Perspective on the New Endovascular Trials.1 passage
• Stroke Outcome Prediction by Blood Pressure Variability, Heart Rate Variability, and Baroreflex Sensitivity.1 passage
• Stroke Patients With Faster Core Growth Have Greater Benefit From Endovascular Therapy.1 passage
• Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis.1 passage
• Stroke Prevention in Older Adults: Recent Advances.1 passage
• Stroke Prevention: A Lifetime of Lessons.1 passage
• Stroke Prognostic Scores and Data-Driven Prediction of Clinical Outcomes After Acute Ischemic Stroke.1 passage
• Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.1 passage
• Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient Ischemic Attack.1 passage
• Stroke Risk Factor Status and Use of Stroke Prevention Medications Among Hispanic/Latino Adults in HCHS/SOL.1 passage
• Stroke Risk and Mortality in Patients With Ventricular Assist Devices.1 passage
• Stroke Self-Management Support Improves Survivors' Self-Efficacy and Outcome Expectation of Self-Management Behaviors.1 passage
• Stroke Thrombolysis in a Centralized and a Decentralized System (Helsinki and Telemedical Project for Integrative Stroke Care Network).1 passage
• Stroke Treatment Academic Industry Roundtable Recommendations for Individual Data Pooling Analyses in Stroke.1 passage
• Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.1 passage
• Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial).1 passage
• Stroke and Circulating Extracellular RNAs.1 passage
• Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.1 passage
• Stroke and Neurodegeneration Induce Different Connectivity Aberrations in the Insula.1 passage
• Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.1 passage
• Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study.1 passage
• Stroke in Commercial Flights.1 passage
• Stroke in Duchenne Muscular Dystrophy: A Retrospective Longitudinal Study in 54 Patients.1 passage
• Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors.1 passage
• Stroke in Patients With Peripheral Artery Disease.1 passage
• Stroke in Women.1 passage
• Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.1 passage
• Stroke, Physical Function, and Death Over a 15-Year Period in Older Australian Women.1 passage
• StrokeCog Markov Model: Projected Prevalent and Incident Cases of Stroke and Poststroke Cognitive Impairment to 2035 in Ireland.1 passage
• Strokes Associated With Pregnancy and Puerperium: A Nationwide Study by the Japan Stroke Society.1 passage
• Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.1 passage
• Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn?1 passage
• Subacute AMD3100 Treatment Is Not Efficient in Neonatal Hypoxic-Ischemic Rats.1 passage
• Subarachnoid Extension Predicts Lobar Intracerebral Hemorrhage Expansion.1 passage
• Subarachnoid and Subdural Hemorrhages in Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid Angiopathy.1 passage
• Subclinical Atrial Fibrillation Burden and Adverse Clinical Outcomes in Patients With Permanent Pacemakers.1 passage
• Subclinical Vascular Brain Lesions in Young Adults With Acute Ischemic Stroke.1 passage
• Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study.1 passage
• Subjective memory complaints and the risk of stroke.1 passage
• Subpial Hemorrhage of the Neonate.1 passage
• Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China.1 passage
• Substitution of Linoleic Acid for Other Macronutrients and the Risk of Ischemic Stroke.1 passage
• Substitutions of Oatmeal and Breakfast Food Alternatives and the Rate of Stroke.1 passage
• Successful Reperfusion With Intravenous Thrombolysis Preceding Mechanical Thrombectomy in Large-Vessel Occlusions.1 passage
• Successful Reperfusion With Mechanical Thrombectomy Is Associated With Reduced Disability and Mortality in Patients With Pretreatment Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score ≤6.1 passage
• Sudden Recanalization: A Game-Changing Factor in Endovascular Treatment of Large Vessel Occlusion Strokes.1 passage
• Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia: A Prospective Cohort Study.1 passage
• Sulcal effacement with preserved gray-white junction: a sign of reversible ischemia.1 passage
• Summary of Evidence on Early Carotid Intervention for Recently Symptomatic Stenosis Based on Meta-Analysis of Current Risks.1 passage
• Superficial Cerebellar Microbleeds and Cerebral Amyloid Angiopathy: A Magnetic Resonance Imaging/Positron Emission Tomography Study.1 passage
• Surgeon case volume and 30-day mortality after carotid endarterectomy among contemporary medicare beneficiaries: before and after national coverage determination for carotid artery stenting.1 passage
• Surgical Decision Making in Brain Hemorrhage.1 passage
• Survival and Outcome After Poor-Grade Aneurysmal Subarachnoid Hemorrhage in Elderly Patients.1 passage
• Suspected Large Vessel Occlusion: Should Emergency Medical Services Transport to the Nearest Primary Stroke Center or Bypass to a Comprehensive Stroke Center With Endovascular Capabilities?1 passage
• Swallowing, Oral Motor, Motor Speech, and Language Impairments Following Acute Pediatric Ischemic Stroke.1 passage
• Symptomatic Carotid Occlusion Is Frequently Associated With Microembolization.1 passage
• Symptomatic Intracranial Atherosclerosis With Impaired Distal Perfusion: A Case Study.1 passage
• Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Chinese Ischemic Stroke Patients: The ASIAN Score.1 passage
• Symptomatic Patients Remain at Substantial Risk of Arterial Disease Complications Before and After Endarterectomy or Stenting.1 passage
• Symptomatic carotid atherosclerotic disease: correlations between plaque composition and ipsilateral stroke risk.1 passage
• Synergism of Short-Term Air Pollution Exposures and Neighborhood Disadvantage on Initial Stroke Severity.1 passage
• Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke: Primary Results of the STRATIS Registry.1 passage
• Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis.1 passage
• Systematic Review of Malpractice Litigation in the Diagnosis and Treatment of Acute Stroke.1 passage
• Systematic Review of the Cost and Cost-Effectiveness of Rapid Endovascular Therapy for Acute Ischemic Stroke.1 passage
• Systematic Review on Kinematic Assessments of Upper Limb Movements After Stroke.1 passage
• Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients.1 passage
• Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage.1 passage
• Systolic blood pressure and mortality after stroke: too low, no go?1 passage
• T2-Weighted-Fluid-Attenuated Inversion Recovery Hyperintensity on Magnetic Resonance Imaging Is Associated With Aggressive Symptoms in Patients With Dural Arteriovenous Fistulas.1 passage
• THSD1 (Thrombospondin Type 1 Domain Containing Protein 1) Mutation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage.1 passage
• TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke.1 passage
• Takotsubo-Like Myocardial Dysfunction in Ischemic Stroke: A Hospital-Based Registry and Systematic Literature Review.1 passage
• Targeting Chemokine Receptor CXCR4 and Translocator Protein for Characterization of High-Risk Plaque in Carotid Stenosis Ex Vivo.1 passage
• Teaching Impact on Telestroke Nurse Recognition of Large Vessel Occlusion Computerized Tomography Perfusion Patterns.1 passage
• Telemedicine Can Replace the Neurologist on a Mobile Stroke Unit.1 passage
• Telemedicine Cognitive Behavioral Therapy for Anxiety After Stroke: Proof-of-Concept Randomized Controlled Trial.1 passage
• Telemedicine Quality and Outcomes in Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Telemedicine for Follow-Up of Rare Neurological Disease.1 passage
• Telephone Assessment and Skill-Building Kit for Stroke Caregivers: A Randomized Controlled Clinical Trial.1 passage
• Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial.1 passage
• Temporal Course of Dynamic Cerebral Autoregulation in Patients With Intracerebral Hemorrhage.1 passage
• Temporal Evolution of Poststroke Cognitive Impairment Using the Montreal Cognitive Assessment.1 passage
• Temporal Profile of Blood-Brain Barrier Breakdown in Reversible Cerebral Vasoconstriction Syndrome.1 passage
• Temporal Profile of Pneumonia After Stroke.1 passage
• Temporal Trends in Emergency Medical Services and General Practitioner Use for Acute Stroke After Australian Public Education Campaigns.1 passage
• Temporal Trends in Ischemic Stroke Incidence in Younger Adults in the Framingham Study.1 passage
• Temporal Trends in Sex Differences With Regard to Stroke Incidence: The Dijon Stroke Registry (1987-2012).1 passage
• Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS.1 passage
• Temporal Trends in Stroke-Related Memory Change: Results From a US National Cohort 1998-2016.1 passage
• Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership.1 passage
• Ten-Year Temporal Trends in Medical Complications After Acute Intracerebral Hemorrhage in the United States.1 passage
• Tenecteplase Thrombolysis for Acute Ischemic Stroke.1 passage
• Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.1 passage
• Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.1 passage
• Test Accuracy of Informant-Based Cognitive Screening Tests for Diagnosis of Dementia and Multidomain Cognitive Impairment in Stroke.1 passage
• Test Accuracy of the Montreal Cognitive Assessment in Screening for Early Poststroke Neurocognitive Disorder: The Nor-COAST Study.1 passage
• Texture Analysis of T1-Weighted and Fluid-Attenuated Inversion Recovery Images Detects Abnormalities That Correlate With Cognitive Decline in Small Vessel Disease.1 passage
• Thalamic Diaschisis in Acute Ischemic Stroke: Occurrence, Perfusion Characteristics, and Impact on Outcome.1 passage
• Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.1 passage
• The 2CAN Score.1 passage
• The Atherosclerosis Risk Variant rs2107595 Mediates Allele-Specific Transcriptional Regulation of1 passage
• The Basilar Artery on Computed Tomography Angiography Prognostic Score for Basilar Artery Occlusion.1 passage
• The Capillary Index Score as a Marker of Viable Cerebral Tissue: Proof of Concept-The Capillary Index Score in the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Trial.1 passage
• The Evolution of Personalized Behavioral Intervention Technology: Will It Change How We Measure or Deliver Rehabilitation?1 passage
• The FAST-ED App: A Smartphone Platform for the Field Triage of Patients With Stroke.1 passage
• The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry.1 passage
• The Protective Effect of Middle Cerebral Artery Calcification on Symptomatic Middle Cerebral Artery Infarction.1 passage
• The SITS Open Study: A Prospective, Open Label Blinded Evaluation Study of Thrombectomy in Clinical Practice.1 passage
• The Stockholm Stroke Triage Project: Outcomes of Endovascular Thrombectomy Before and After Triage Implementation.1 passage
• The Story of Intracerebral Hemorrhage: From Recalcitrant to Treatable Disease.1 passage
• The VASOGRADE: A Simple Grading Scale for Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.1 passage
• Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial.1 passage
• Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.1 passage
• Third European Stroke Science Workshop.1 passage
• Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.1 passage
• Thomas Willis Lecture: Is Translational Stroke Research Broken, and if So, How Can We Fix It?1 passage
• Three-Dimensional Map of Neonatal Arterial Ischemic Stroke Distribution From Early Multimodal Brain Imaging.1 passage
• Thrombectomy Complications in Large Vessel Occlusions: Incidence, Predictors, and Clinical Impact in the ETIS Registry.1 passage
• Thrombectomy Outcomes of Intracranial Atherosclerosis-Related Occlusions.1 passage
• Thrombectomy Results in Reduced Hospital Stay, More Home-Time, and More Favorable Living Situations in DEFUSE 3.1 passage
• Thrombectomy With and Without Computed Tomography Perfusion Imaging in the Early Time Window: A Pooled Analysis of Patient-Level Data.1 passage
• Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery Occlusion: Cognitive, Visual, and Disability Outcomes.1 passage
• Thrombectomy for M1-Middle Cerebral Artery Occlusion: Angiographic Aspect of the Arterial Occlusion and Recanalization: A Preliminary Observation.1 passage
• Thrombectomy in Acute Stroke With Tandem Occlusions From Dissection Versus Atherosclerotic Cause.1 passage
• Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study.1 passage
• Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries.1 passage
• Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.1 passage
• Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop?1 passage
• Thrombolysis in Postoperative Stroke.1 passage
• Thrombophilia Testing After Ischemic Stroke: Why, When, and What?1 passage
• Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke.1 passage
• Thrombus Histology Suggests Cardioembolic Cause in Cryptogenic Stroke.1 passage
• Thrombus Imaging Characteristics and Outcomes in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment.1 passage
• Thrombus Length Estimation on Delayed Gadolinium-Enhanced T1.1 passage
• Thrombus Length Predicts Lack of Post-Thrombolysis Early Recanalization in Minor Stroke With Large Vessel Occlusion.1 passage
• Thrombus Migration Paradox in Patients With Acute Ischemic Stroke.1 passage
• Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study.1 passage
• Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke.1 passage
• Thrombus Permeability Is Associated With Improved Functional Outcome and Recanalization in Patients With Ischemic Stroke.1 passage
• Thrombus Permeability in Admission Computed Tomographic Imaging Indicates Stroke Pathogenesis Based on Thrombus Histology.1 passage
• Thrombus Volume as a Predictor of Nonrecanalization After Intravenous Thrombolysis in Acute Stroke.1 passage
• Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.1 passage
• Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.1 passage
• Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).1 passage
• Time From Imaging to Endovascular Reperfusion Predicts Outcome in Acute Stroke.1 passage
• Time From Symptoms to Carotid Endarterectomy or Stenting and Perioperative Risk.1 passage
• Time Matters: Adjusted Analysis of the Influence of Direct Transfer to Angiography-Suite Protocol in Functional Outcome.1 passage
• Time Metrics to Endovascular Thrombectomy in 3 Triage Concepts: A Prospective, Observational Study (NEUROSQUAD).1 passage
• Time Trends in Race-Ethnic Differences in Do-Not-Resuscitate Orders After Stroke.1 passage
• Time Trends in Survival Following First Hemorrhagic or Ischemic Stroke Between 1991 and 2015 in the Rotterdam Study.1 passage
• Time course and predictors of neurological deterioration after intracerebral hemorrhage.1 passage
• Time to Decision and Treatment With tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit.1 passage
• Time to Evacuation and Functional Outcome After Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation.1 passage
• Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.1 passage
• Time trends in incidence and case fatality of ischemic stroke: the tromsø study 1977-2010.1 passage
• Time-Dependent Computed Tomographic Perfusion Thresholds for Patients With Acute Ischemic Stroke.1 passage
• Time-Dependent Thrombus Resolution After Tissue-Type Plasminogen Activator in Patients With Stroke and Mice.1 passage
• Time-Resolved C-Arm Computed Tomographic Angiography Derived From Computed Tomographic Perfusion Acquisition: New Capability for One-Stop-Shop Acute Ischemic Stroke Treatment in the Angiosuite.1 passage
• Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.1 passage
• Timing and Dose of Upper Limb Motor Intervention After Stroke: A Systematic Review.1 passage
• Timing and Relevance of Clinical Improvement After Mechanical Thrombectomy in Patients With Acute Ischemic Stroke.1 passage
• Timing of Carotid Revascularization Procedures After Ischemic Stroke.1 passage
• Timing of Decompressive Hemicraniectomy for Stroke: A Nationwide Inpatient Sample Analysis.1 passage
• Timing of Incident Stroke Risk After Cervical Artery Dissection Presenting Without Ischemia.1 passage
• Timing of Occurrence Is the Most Important Characteristic of Spot Sign.1 passage
• Timing of Percutaneous Endoscopic Gastrostomy for Acute Ischemic Stroke: An Observational Study From the US Nationwide Inpatient Sample.1 passage
• Tissue Protrusion With Attenuation Is Associated With Ischemic Brain Lesions After Carotid Artery Stenting.1 passage
• Tissue-Selective Salvage of the White Matter by Successful Endovascular Stroke Therapy.1 passage
• To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.1 passage
• To Treat or Not to Treat?1 passage
• To treat or not to treat? Pilot survey for minor and rapidly improving stroke.1 passage
• Top Priorities for Cerebroprotective Studies-A Paradigm Shift: Report From STAIR XI.1 passage
• Totaled health risks in vascular events score predicts clinical outcome and symptomatic intracranial hemorrhage in chinese patients after thrombolysis.1 passage
• Towards Improved Translational Stroke Research: Progress and Perspectives of the Recent National Institute of Neurological Disorders and Stroke Consensus Group Meeting.1 passage
• Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions.1 passage
• Trained Immunity Characteristics Are Associated With Progressive Cerebral Small Vessel Disease.1 passage
• Training Standards in Neuroendovascular Surgery: Program Accreditation and Practitioner Certification.1 passage
• Training and Certifying Users of the National Institutes of Health Stroke Scale.1 passage
• Training for Walking Efficiency With a Wearable Hip-Assist Robot in Patients With Stroke: A Pilot Randomized Controlled Trial.1 passage
• Trajectories in Leisure-Time Physical Activity and Risk of Stroke in Women in the California Teachers Study.1 passage
• Trajectories of Vasomotor Symptoms and Carotid Intima Media Thickness in the Study of Women's Health Across the Nation.1 passage
• Trajectory Groups of 24-Hour Systolic Blood Pressure After Acute Ischemic Stroke and Recurrent Vascular Events.1 passage
• Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign.1 passage
• Transcranial Direct Current Stimulation Does Not Improve Language Outcome in Subacute Poststroke Aphasia.1 passage
• Transcranial Direct Current Stimulation Potentiates Improvements in Functional Ability in Patients With Chronic Stroke Receiving Constraint-Induced Movement Therapy.1 passage
• Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell Disease.1 passage
• Transcranial Doppler in Acute COVID-19 Infection: Unexpected Associations.1 passage
• Transfer to High-Volume Centers Associated With Reduced Mortality After Endovascular Treatment of Acute Stroke.1 passage
• Transient Cerebral Arteriopathy, Postvaricella Arteriopathy, and Focal Cerebral Arteriopathy or the Unique Susceptibility of the M1 Segment in Children With Stroke.1 passage
• Transient Ischemic Attack Results in Delayed Brain Atrophy and Cognitive Decline.1 passage
• Transient Vestibular Symptoms Preceding Posterior Circulation Stroke: A Prospective Multicenter Study.1 passage
• Translesional Pressure Gradient Alters Relationship Between Blood Pressure and Recurrent Stroke in Intracranial Stenosis.1 passage
• Transoceanic Management and Treatment of Aneurysmal Subarachnoid Hemorrhage: A 10-Year Experience.1 passage
• Treatment Restrictions and the Risk of Death in Patients With Ischemic Stroke or Intracerebral Hemorrhage.1 passage
• Treatment Scoring of Unruptured Intracranial Aneurysms.1 passage
• Treatment and Long-Term Outcomes of Primary Central Nervous System Vasculitis.1 passage
• Treatment and Outcome in Stroke Patients With Acute M2 Occlusion and Minor Neurological Deficits.1 passage
• Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.1 passage
• Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19: Experience From Paris.1 passage
• Treatment-Relevant Findings in Transesophageal Echocardiography After Stroke: A Prospective Multicenter Cohort Study.1 passage
• Trends and Factors Associated With Concordance Between International Classification of Diseases, Ninth and Tenth Revision, Clinical Modification Codes and Stroke Clinical Diagnoses.1 passage
• Trends in Age of First-Ever Stroke Following Increased Incidence and Life Expectancy in a Low-Income Chinese Population.1 passage
• Trends in Door-to-Thrombolysis Time in the Safe Implementation of Stroke Thrombolysis Registry: Effect of Center Volume and Duration of Registry Membership.1 passage
• Trends in Incidence of Intracranial and Spinal Arteriovenous Shunts: Hospital-Based Surveillance in Okayama, Japan.1 passage
• Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014.1 passage
• Trends in Stroke Incidence and 28-Day Case Fatality in a Nationwide Stroke Registry of a Multiethnic Asian Population.1 passage
• Trends in Stroke Recurrence in Mexican Americans and Non-Hispanic Whites.1 passage
• Trends in endovascular therapy and clinical outcomes within the nationwide Get With The Guidelines-Stroke registry.1 passage
• Trends of r-tPA (Recombinant Tissue-Type Plasminogen Activator) Treatment and Treatment-Influencing Factors in Acute Ischemic Stroke.1 passage
• Triage of 5 Noncontrast Computed Tomography Markers and Spot Sign for Outcome Prediction After Intracerebral Hemorrhage.1 passage
• Trials in Sleep Apnea and Stroke: Learning From the Past to Direct Future Approaches.1 passage
• Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes.1 passage
• Troponin Improves the Yield of Transthoracic Echocardiography in Ischemic Stroke Patients of Determined Stroke Subtype.1 passage
• True First-Pass Effect.1 passage
• Tumor Necrosis Factor Receptor 1 and 2 Are Associated With Risk of Intracerebral Hemorrhage.1 passage
• Tumor-Like Presentation of Primary Angiitis of the Central Nervous System.1 passage
• Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial.1 passage
• Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.1 passage
• Twenty-Four-Hour Reocclusion After Successful Mechanical Thrombectomy: Associated Factors and Long-Term Prognosis.1 passage
• Twenty-Year Time Trends in Long-Term Case-Fatality and Recurrence Rates After Ischemic Stroke Stratified by Etiology.1 passage
• Two-State Kinetic Model of Rates of Stroke Recurrence in the POINT Study Population.1 passage
• Two-layered susceptibility vessel sign on 3-tesla T2*-weighted imaging is a predictive biomarker of stroke subtype.1 passage
• Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.1 passage
• Type of anesthesia and differences in clinical outcome after intra-arterial treatment for ischemic stroke.1 passage
• Ultra-Early Cerebral Thrombosis Formation After Experimental Subarachnoid Hemorrhage Detected on T2* Magnetic Resonance Imaging.1 passage
• Ultraearly Intravenous Thrombolysis for Acute Ischemic Stroke in Mobile Stroke Unit and Hospital Settings.1 passage
• Ultrasound Markers of Carotid Atherosclerosis and Cognition: The Northern Manhattan Study.1 passage
• Ultrasound and Clinical Predictors of Recurrent Ischemia in Symptomatic Internal Carotid Artery Occlusion.1 passage
• Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial.1 passage
• Uncertainties and Controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients With Patent Foramen Ovale.1 passage
• Under-Enrollment of Women in Stroke Clinical Trials: What Are the Causes and What Should Be Done About It?1 passage
• Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection.1 passage
• Unequal Local Progress Towards Healthy People 2020 Objectives for Stroke and Coronary Heart Disease Mortality.1 passage
• Unexplained Variation for Hospitals' Use of Inpatient Rehabilitation and Skilled Nursing Facilities After an Acute Ischemic Stroke.1 passage
• Unit for Neurorehabilitation South Tyrol, Bolzano, Italy (L.S.).Van der26 passages
• Unit, University of Oxford, United Kingdom.Correspondence to23 passages
• Unruptured Arteriovenous Malformations: Do We Have an Answer After the Final Follow-Up of ARUBA? A Bayesian Viewpoint.1 passage
• Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients.1 passage
• Urban-Rural Inequities in Acute Stroke Care and In-Hospital Mortality.1 passage
• Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke.1 passage
• Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke).1 passage
• Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age.1 passage
• Use of Antiplatelet Agents Is Associated With Intraplaque Hemorrhage on Carotid Magnetic Resonance Imaging: The Plaque at Risk Study.1 passage
• Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage.1 passage
• Use of Emergency Medical Services and Timely Treatment Among Ischemic Stroke.1 passage
• Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy.1 passage
• Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.1 passage
• Use of Statins After Ischemic Stroke in Young Adults and Its Association With Long-Term Outcome.1 passage
• Use of Statins and Outcomes in Intracerebral Hemorrhage Patients.1 passage
• Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.1 passage
• Use of a 3-Item Short-Form Version of the Barthel Index for Use in Stroke: Systematic Review and External Validation.1 passage
• Use of follow-up imaging in isolated perimesencephalic subarachnoid hemorrhage: a meta-analysis.1 passage
• Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.1 passage
• Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy.1 passage
• Using Human Genetics to Understand Mechanisms in Ischemic Stroke Outcome: From Early Brain Injury to Long-Term Recovery.1 passage
• Using standard first-pass perfusion computed tomographic data to evaluate collateral flow in acute ischemic stroke.1 passage
• Utility of Apical Lung Assessment on Computed Tomography Angiography as a COVID-19 Screen in Acute Stroke.1 passage
• Utility of Computed Tomographic Perfusion in Thrombolysis for Minor Stroke.1 passage
• Utility of Screening for Cerebral Vasospasm Using Digital Subtraction Angiography.1 passage
• Utility of Severity-Based Prehospital Triage for Endovascular Thrombectomy: ACT-FAST Validation Study.1 passage
• Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients.1 passage
• Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study.1 passage
• Utilization of a Smartphone Platform for Electronic Informed Consent in Acute Stroke Trials.1 passage
• Vagus Nerve Stimulation Paired With Upper Limb Rehabilitation After Chronic Stroke.1 passage
• Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment.1 passage
• Validating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke.1 passage
• Validating the TeleStroke Mimic Score: A Prediction Rule for Identifying Stroke Mimics Evaluated Over Telestroke Networks.1 passage
• Validation of Noninvasive In Vivo Compound Ultrasound Strain Imaging Using Histologic Plaque Vulnerability Features.1 passage
• Validation of Wall Enhancement as a New Imaging Biomarker of Unruptured Cerebral Aneurysm.1 passage
• Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.1 passage
• Validation of a Smartphone Application in the Evaluation and Treatment of Acute Stroke in a Comprehensive Stroke Center.1 passage
• Validation of the 9-Point and 24-Point Hematoma Expansion Prediction Scores and Derivation of the PREDICT A/B Scores.1 passage
• Validation of the Intracerebral Hemorrhage Score in Uganda.1 passage
• Validation of the Simplified Stroke-Thrombolytic Predictive Instrument to Predict Functional Outcomes in Chinese Patients.1 passage
• Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke.1 passage
• Validity of shape as a predictive biomarker of final infarct volume in acute ischemic stroke.1 passage
• Value of Computed Tomographic Perfusion-Based Patient Selection for Intra-Arterial Acute Ischemic Stroke Treatment.1 passage
• Value of Vascular and Non-Vascular Pattern on Computed Tomography Perfusion in Patients With Acute Isolated Aphasia.1 passage
• Values of Baseline Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score for Treatment Decision of Acute Basilar Artery Occlusion.1 passage
• Variations in acute hospital stroke care and factors influencing adherence to quality indicators in 6 European audits.1 passage
• Vascular Anatomy Predicts the Risk of Cerebral Ischemia in Patients Randomized to Carotid Stenting Versus Endarterectomy.1 passage
• Vascular Neurologists as Directors of Stroke Centers in the United States.1 passage
• Vascular Risk Factor Profiles Differ Between Magnetic Resonance Imaging-Defined Subtypes of Younger-Onset Lacunar Stroke.1 passage
• Vascular Tissue-Type Plasminogen Activator Promotes Intracranial Aneurysm Formation.1 passage
• Vascular Tortuosity May Be Associated With Cervical Artery Dissection.1 passage
• Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.1 passage
• Venous Thrombotic Recurrence After Cerebral Venous Thrombosis: A Long-Term Follow-Up Study.1 passage
• Vertebral Artery Patency and Thrombectomy in Basilar Artery Occlusions.1 passage
• Vertebrobasilar Artery Calcification and Outcomes in Posterior Circulation Large Vessel Occlusion Thrombectomy.1 passage
• Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset).1 passage
• Vessel Wall Enhancement and Blood-Cerebrospinal Fluid Barrier Disruption After Mechanical Thrombectomy in Acute Ischemic Stroke.1 passage
• Vessel Wall Imaging of Evolving Unruptured Intracranial Aneurysms.1 passage
• Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis: A Meta-Analysis.1 passage
• Visual Aids for Patient, Family, and Physician Decision Making About Endovascular Thrombectomy for Acute Ischemic Stroke.1 passage
• Vitamin D Status and Risk of Stroke: The Rotterdam Study.1 passage
• Volumetric and Spatial Accuracy of Computed Tomography Perfusion Estimated Ischemic Core Volume in Patients With Acute Ischemic Stroke.1 passage
• Vulnerability to Infarction During Cerebral Ischemia in Migraine Sufferers.1 passage
• WEAVE Trial: Final Results in 152 On-Label Patients.1 passage
• Wake-Up Stroke Is Associated With Greater Nocturnal Mean Arterial Pressure Variability.1 passage
• Wall Shear Stress and T1 Contrast Ratio Are Associated With Embolic Signals During Carotid Exposure in Endarterectomy.1 passage
• Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.1 passage
• Weekend Effect in Carotid Endarterectomy.1 passage
• Weekend Effect in Children With Stroke in the Nationwide Inpatient Sample.1 passage
• When to Stop.1 passage
• Where to Focus Efforts to Reduce the Black-White Disparity in Stroke Mortality: Incidence Versus Case Fatality?1 passage
• Which Acute Ischemic Stroke Patients Are Fast Progressors?: Results From the ESCAPE Trial Control Arm.1 passage
• Which Imaging Approach Should Be Used for Stroke of Unknown Time of Onset?1 passage
• Which Road to Recovery?: Factors Influencing Postacute Stroke Discharge Destinations: A Delphi Study.1 passage
• White Matter Abnormalities in Spontaneous Subarachnoid Hemorrhage: A Tract-Based Spatial Statistics Study.1 passage
• White Matter Damage Relates to Oxygen Saturation in Children With Sickle Cell Anemia Without Silent Cerebral Infarcts.1 passage
• White Matter Hyperintensities Are Under Strong Genetic Influence.1 passage
• White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline.1 passage
• White Matter Hyperintensity Burden and Collateral Circulation in Large Vessel Occlusion Stroke.1 passage
• White Matter Hyperintensity Volume Influences Symptoms in Patients Presenting With Minor Neurological Deficits.1 passage
• White Matter Hyperintensity Volume and Outcome of Mechanical Thrombectomy With Stentriever in Acute Ischemic Stroke.1 passage
• White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome After Acute Ischemic Stroke.1 passage
• White Matter Hyperintensity-Adjusted Critical Infarct Thresholds to Predict a Favorable 90-Day Outcome.1 passage
• White Matter Imaging Correlates of Early Cognitive Impairment Detected by the Montreal Cognitive Assessment After Transient Ischemic Attack and Minor Stroke.1 passage
• White Matter Integrity in Tanzanian Children With Sickle Cell Anemia: A Diffusion Tensor Imaging Study.1 passage
• White Matter Lesion Progression: Genome-Wide Search for Genetic Influences.1 passage
• White Matter Lesions Double the Risk of Post-Thrombolytic Intracerebral Hemorrhage.1 passage
• White Matter Microstructure Improves Stroke Risk Prediction in the General Population.1 passage
• White matter edema at the early stage of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.1 passage
• White matter ischemic changes in hyperacute ischemic stroke: voxel-based analysis using diffusion tensor imaging and MR perfusion.1 passage
• White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.1 passage
• White matter perivascular spaces on magnetic resonance imaging: marker of cerebrovascular amyloid burden?1 passage
• Whole Grain Consumption and Risk of Ischemic Stroke: Results From 2 Prospective Cohort Studies.1 passage
• Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage.1 passage
• Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of Stroke.1 passage
• Why Are Only Some Subcortical Ischemic Lesions on Diffusion Magnetic Resonance Imaging Associated With Stroke Symptoms in Small Vessel Disease?1 passage
• Why Are Women Less Represented in Intracerebral Hemorrhage Trials?1 passage
• Withdrawal of Life-Sustaining Treatment Mediates Mortality in Patients With Intracerebral Hemorrhage With Impaired Consciousness.1 passage
• Women Who Have Ischemic Strokes Have a Higher Burden of Left Atrial Fibrosis Than Men.1 passage
• Workflow Intervals of Endovascular Acute Stroke Therapy During On- Versus Off-Hours: The MR CLEAN Registry.1 passage
• Workup for Perinatal Stroke Does Not Predict Recurrence.1 passage
• YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).1 passage
• Yiin Gabriel S.C. DPhil1Li Linxin DPhil1Bejot Yannick PhD2Rothwell23 passages
• Young Women Had More Strokes Than Young Men in a Large, United States Claims Sample.1 passage
• Younger Age and Depressive Symptoms Predict High Risk of Generalized Anxiety After Stroke and Transient Ischemic Attack.1 passage
• Younger Stroke Patients With Large Pretreatment Diffusion-Weighted Imaging Lesions May Benefit From Endovascular Treatment.1 passage
• sTRAIL-R2 (Soluble TNF [Tumor Necrosis Factor]-Related Apoptosis-Inducing Ligand Receptor 2) a Marker of Plaque Cell Apoptosis and Cardiovascular Events.1 passage
• β-Blockers, Pneumonia, and Outcome After Ischemic Stroke: Evidence From Virtual International Stroke Trials Archive.1 passage
• γ-Glutamyl Transferase as a Risk Factor for All-Cause or Cardiovascular Disease Mortality Among 5912 Ischemic Stroke.1 passage